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ABSTRACT
INVESTIGATING tRNA RELEASE FROM THE BACTERIAL RIBOSOME
Ian S. Farrell
Barry S. Cooperman
Translation of mRNA into proteins is integral in all living organisms, and takes
place on the ribosome. In recent years, the X-ray crystal structures of biologically
relevant ribosome complexes came into light, and the advance of kinetic studies was soon
to follow, leading to a better understanding of the general ribosomal mechanism.
However, there still remains some ambiguity in certain ribosome functions.
Ribosomal protein L1 initially became relevant in the early 1980s when it was
determined that ribosomes lacking L1 showed a decreased capacity for in vitro protein
synthesis. Later, it was shown that the L1-stalk is a highly mobile region of the ribosome,
and that it may be involved in the release of deacylated-tRNA from the exit-site, after
translocation. By using a fluorescently labeled L1 reconstituted ribosome as an E-site
probe we were able to study the release of deacylated-tRNA from translocating
ribosomes in a time-resolved manner. The movement of the L1-stalk with relation to the
deacylated-tRNA was measured using fluorescence resonance energy transfer (FRET)
measurements between labeled L1 and labeled tRNAs (L/t FRET).

Further, the

movement of deacylated-tRNA with relation to the P-site tRNA was measured using
fluorescently labeled tRNAs (t/t FRET), and the release of deacylated-tRNA was
measured using changes in anisotropy. We demonstrate that the deacylated-tRNA can be
released from the ribosome via three possible different pathways, depending on the
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conditions. Further, in Chapter V, we begin to demystify the interaction that the E-site
region of the ribosome has with deacylated-tRNAs in solution, and demonstrate the
changes on deacylated-tRNA release when excess tRNAs are present.
The optimization of the creation of a viable E-site probe will prove to be
important for future studies in both kinetic work and single molecule work when focusing
on tRNA interaction with the E-site of the ribosome.
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Chapter I: Introduction
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1.1 Protein Synthesis and the Ribosome
Deoxyribonucleic acids (DNAs), ribonucleic acids (RNAs), and proteins are
known as the building blocks of life because they are responsible for storing and
expressing the genetic information that makes up all living organisms. As described by
the central dogma of molecular biology (Crick, 1970), DNAs are both replicated by
DNA polymerases in order to preserve the genetic material (Kornberg, 1969; Watson
and Crick, 1953a; Watson and Crick, 1953b), and transcribed into mRNAs by RNA
polymerases. The mRNAs are subsequently translated into the amino acid sequences that
compose proteins (Figure 1.1). DNA and mRNA are both composed of nucleotides
containing the bases, adenine (A), cytosine (C), guanine (G), and either thymine (T) in
DNA or uracil (U) in mRNA. The unique mRNA sequence is translated with the help of
transfer RNA (tRNA) and the ribosome machinery. Initiation of ribosome mediated
protein synthesis begins with recognition of an AUG mRNA codon, followed by triplets
of nucleotides that code for different amino acids. The linker between the mRNA codon
and the amino acid is tRNA. In bacterial cells there are about 40 tRNA molecules, each
composed of about 76 nucleotides. Amino acids are added to a conserved -CCA end of
the tRNA via an esterification utilizing amino acid-specific tRNA-synthetases and ATP
(Figure 1.2). tRNA-synthetases have both a catalytic and editing site in order to ensure
the correct amino acid addition to a specific tRNA. The tRNA also contains an anticodon
stem-loop that recognizes the mRNA codon that codes for the specific amino acid. These
steps ensure that the cognate amino acids get correctly added to the peptide chain.

"!
!

1.2 Ribosome Components
The ribosome is a complex molecular machine that is utilized to translate mRNA
sequences into specific polypeptides through repeated cycles of tRNA selection and
peptide elongation. In both prokaryotes and eukaryotes the ribosome is made up of
approximately two-thirds ribosomal RNA (rRNA) and one-third ribosomal proteins. My
thesis work has been performed entirely with prokaryotic ribosomes. The Escherichia
Coli (E. Coli) ribosome is a 2.5 MDa ribonucleoprotein assembly with a long dimension
of ~200 Å, and a sedimentation coefficient of 70S. The ribosome is composed of a large
(50S) and a small (30S) subunit. Each subunit can further be broken down into its rRNA
and protein constituents. The large subunit is composed of 23S and 5S rRNA, and 34
different proteins labeled L1 through L36. Interestingly the Ser-2 of large subunit protein
L12 can be acetylated to form L7, and the dimer formed between L7/L12 interacts with
L10 to form what is called L8. The small subunit is composed of 16S rRNA, and 21
different proteins (S1-S21) (Table 1.1). Each ribosome has three main tRNA-binding
sites; the aminoacyl (A) site, the peptidyl (P) site, and the exit (E) site located at the
subunit interface. tRNAs progress through these sites in a stepwise fashion during the
course of peptide elongation, as described below.
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1.3 Bacterial Translation Cycle
1.3.1 Initiation
Protein synthesis in prokaryotic cells begins when mRNA binds to the 30S
subunit of the ribosome. The anti-Shine-Dalgarno sequence at the 3’ end of the 16S
rRNA binds to the Shine-Dalgarno (SD) sequence of the mRNA and positions the AUG
start codon in the P-site of the small subunit. With the help of three initiation factors (IF1, IF-2, and IF-3) the initiator tRNA (fMet-tRNAfMet) binds to the AUG codon in a 30S
pre- P-site, and the 50S subunit combines with the 30S initiation complex (30SIC) to
form the 70SIC, placing fMet-tRNAfMet into the P-site. With an empty A-site, this
initiation complex is ready to proceed to the peptide elongation phase of protein synthesis
(Figure 1.3).

1.3.2 Peptide Elongation
Peptide elongation begins when a ternary complex consisting of elongation factorTu (EF-Tu)bound with GTP, and an aminoacyl-tRNA corresponding to cognate codon in
the A-site arrive at the A-site of the ribosome. Proofreading at this point allows for
discrimination between cognate and non-cognate codon-anticodon interactions. If the
aminoacyl-tRNA anticodon is cognate with the mRNA in the A-site, GTP hydrolysis
rapidly occurs allowing for tRNA accommodation into the A-site, and peptide bond
formation (Pape et. al, 1998) (Figure 1.4, Figure 1.5). At this point the peptide and
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nascent chain remain bound to the tRNA in the A-site while the deacylated-tRNA is
located in the P-site. Experiments initially done by Noller and coworkers provided
evidence that the tRNAs in a post-peptide bond formation, pre-translocation state can
sample hybrid states in which the peptidyl-tRNA can simultaneously occupy the 30S Asite and the 50S P-site (A/P) and the deacylated tRNA can simultaneously occupy the
30S P-site and the 50S E-site (P/E) (Moazed and Noller 1989). Further single molecule
evidence on pre-translocation ribosomes provided evidence that the classical (A/A, P/P)
and the hybrid (A/P, P/E) tRNAs are in a dynamic equilibrium (Blanchard et al., 2004),
next, elongation factor G (EF-G) bound with GTP facilitates the translocation of the
tRNAfMet, and the new peptidyl-tRNA to the E and P-sites, respectively.

This

translocation proceeds via a kinetically competent intermediate (INT), in which the
peptidyl-tRNA occupies the A/P hybrid state before completing translocation and
occupying the P/P site (Pan et al., 2007) (Figure 1.6). The tRNA translocation is
concomitant with mRNA movement by one codon, putting a new codon in the A-site,
ready for the next cognate tRNA-ternary complex to enter and turnover the cycle (Frank
et al., 2007). Elongation and translocation continue until a stop codon (UAA, UAG, or
UGA) enters the A-site.

1.3.3 Termination of Protein Synthesis and Ribosomal Recycling
Once a stop codon reaches the A-site of a ribosome, either release factor 1 (RF-1,
stop codon UAA or UAG) or release factor 2 (RF-2, stop codon UAA or UGA) binds and
catalyzes the hydrolysis of the ester bond between the completed protein and the P-site
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tRNA, causing the release and final folding of the protein, and the rapid dissociation of
the RF by RF-3 and GTP (Zaviolov et al., 2002). Finally, ribosome recycling factor
(RRF), acting with EF-G and IF-3 removes the mRNA and tRNA from the ribosome and
dissociates the 70S into the 30S and 50S subunits (Reviewed by: Kisselev and
Buckingham, 2000; Rao and Varshney, 2001; Vesper and Wilson, 2006). At this
point, the factors and subunits are ready to reinitiate protein synthesis.

1.3.4 Ribosome Movements During Translocation
The ribosome undergoes many conformational changes during translocation, not
the least of which are subunit ratcheting and L1 stalk movement. Early cryo-electron
microscopy (Cryo-EM) work demonstrated that the binding of EF-G.GTP to a pretranslocational ribosome induces a rotation of the 30S subunit relative to the 50S subunit
of about 3°- 10° in the direction of mRNA movement (Frank et al., 2000) (Figure 1.7);
further, the L1 stalk domain, consisting of ribosomal protein L1 and helices 76-78 of 23S
rRNA moves ~20 Å towards the body of the ribosome (Figure 1.8) (Valle et al., 2003;
Frank et al., 2007; Connell et al., 2007). These movements, along with the tRNA
hybrid state formation, also seen in early cryo-EM structures, creates an “unlocked”
ribosome formation from which translocation can occur. It was originally thought that
addition of EF-G.GTP to a pre-translocation complex causes these unlocking movements;
however,

single-molecule

fluorescence

resonance

energy

transfer

(smFRET)

measurements later showed that individually, hybrid state formation (Blanchard et al.,
2004; Munro et al, 2007), L1 stalk closure (Fei et al., 2008; Cornish et al., 2009), and
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subunit ratcheting (Cornish et al, 2009) could be spontaneously achieved in pretranslocation complexes creating an equilibrium between locked and unlocked states.
The manner in which these three structural transitions occur is highly debated, and still
widely unknown. The current model is that these movements are uncoupled so that,
although it is possible for all three to occur and create an unlocked complex in the
absence of EF-G.GTP, it is a very low probability event. However, the presence of EFG.GTP stabilizes a ratcheted conformation, in which the rate of P/E hybrid state
formation and L1 stalk closure become accelerated (Munro et al., 2009, 2010).

1.4 Ribosome Structure
1.4.1 X-ray Crystallography
Ribosomeology was advanced exponentially in 2001 when Noller and coworkers
first reported the low resolution structure of a 70S ribosome from Thermus thermophilus
at 5.5 Å resolution (Yusupov et al., 2001). Previous to this, the essentially complete
atomic structures of the 50S (Haloarcula marismortui, 2.4 Å, Ban et al., 2000) and 30S
(Thermus thermophilus, 2.0 Å, Wimberly et al., 2000) subunits were solved, and are still
currently used for the basis of phasing and/or molecular interpretation of all structures of
the ribosome or its subunits.

Cate and coworkers solved the first high-resolution

structure of a 70S ribosome in 2005, with a 3.5 Å resolution structure of an empty E. coli
ribosome (Schuwirth et al., 2005). However, more important to our work is the highresolution structure of the ribosome with functional ligands attached; for example, the
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Thermus thermophilus ribosome with mRNA and tRNA solved at 2.8 Å resolution by
Ramakrishnan and coworkers in 2006 (Selmer et al., 2006). This particular structure
shows the 70S ribosome reconstructed with mRNA, cognate A- and P-site tRNA, and
non-cognate E-site tRNA in a pretranslocation complex. Also, the more recent highresolution structures solved by Ramakrishnan and coworkers, with either EFTu.aminoacyl-tRNA (Schmeing et al., 2009), or EF-G (Gao et al., 2009) bound to the
70S ribosome, with the latter structure showing the ribosome stabilized in a posttranslocation state, provides more insight into the elongation phase of protein synthesis.
Of particular interest to me is the structure of the highly mobile L1 stalk region on
the ribosome. Because of the high mobility of this region, the L1-stalk (as well as the
L7/L12 stalk) is partly or completely disordered in most high-resolution structures of the
ribosome or the 50S subunit. However, the ribosomal protein L1 has been solved in
isolation. The first structure of the Thermus thermophilus L1 was solved by Nikonov and
colleagues at 1.86 Å resolution in 1996 (Nikonov et al., 1996); however, this structure
did little to determine how the L1 interacted with the ribosome. It wasn’t until 2003
when the structure of the Sulfolobus acidocaldarius L1 in complex with a specific 55nucleotide fragment of 23S rRNA from Thermus thermophilus was solved at 2.65 Å
resolution and was able to be incorporated into the Thermus thermophilus 70S structure,
and the Deinococcus radiodurans 50S structure, that we had a good understanding of
what L1 looked like on a ribosome (Nikulin et al., 2003). Later, a structure of the
bacterial Thermus thermophilus L1 was modeled into the E. coli ribosome to provide an
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even better look into the contacts between L1, tRNA and 23S rRNA (Nevskaya et al.,
2006).

1.4.2 Cryo-electron Microscopy (Cryo-EM)
Cryo-EM has provided images of functional complexes of both prokaryotic and
eukaryotic ribosomes with resolution below 10 Å (Mitra and Frank, 2006; Halic et al.,
2005; Chandramouli et al., 2008; Taylor et al., 2007; Li et al., 2008). Although this
resolution is well below the high resolution of X-ray crystallography, cryo-EM has the
advantage of being able to image ribosomes frozen in specific functional states. As
mentioned previously, this is of significant importance when looking at the movements
associated with translocation, specifically hybrid state formation and L1 movement
(Valle et al, 2003; Connell et al, 2007). Furthermore, a recent cryo-EM study showed the
progression of tRNA movement during translocation in 50 distinct three-dimensional
reconstructions, showing the tRNA in classical, hybrid and various novel intermediate
states, that will prove to be useful to my thesis work (Fischer et al., 2010).

1.5 Ribosomal Protein L1
The ribosomal protein L1 is one of the largest proteins in the 50S subunit, and is
located near the exit site on a protuberance that is also composed of helices 76-78 from
the 23S rRNA. In E. coli, L1 is composed of 234 amino acids, and folds into two
domains with both the N- and C-termini of the protein located in domain I (Nikonov et
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al., 1996). Originally L1 was of profound interest because of its RNA binding activity.
Not only does L1 bind rRNA in the L1 protuberance, it also has the ability to bind its
own mRNA, thereby acting as its own repressor, and mediating autogenous regulation of
translation by binding to a region within the leader sequence of the polycistronic mRNA
of the L11 operon coding for ribosomal proteins L1 and L11 (Gourse et al., 1986). Early
crystal structures were determined with the L1 protein bound to both mRNA (Nevskaya
et al., 2006) and rRNA (Nikulin et al., 2003), at similar locations within domain I
(Figure 1.9).
Early biochemical results showed that E. coli ribosomes lacking L1 displayed 4060% reduced capacity for in vitro protein synthesis (Subramanian and Dabbs, 1980). It
wasn’t until two years later that the reason for the reduced protein synthesis was shown to
be a direct result of L1 being important for the binding of tRNA to the ribosomal P-site
(Sander, 1982).
The early cryo-EM information obtained by Valle and coworkers showed a large
movement of the L1 protuberance towards the ribosome body upon binding of EF-G.
This observation led to the hypothesis that, in the EF-G bound ribosome, the L1
protuberance makes a direct interaction with the elbow of a deacylated-tRNA in the P/E
hybrid configuration and possibly is involved in translocation of the newly deacylated
tRNA (Valle et al., 2003). These hypothesis were later corroborated with smFRET
experiments in which the L1 protuberance was shown to occupy at least two (Fei et al.,
2008), or three (Cornish et al., 2009) distinct structural states depending on the positions
and acylation states of the tRNAs bound to the ribosome. For the majority of this thesis I
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utilize a fluorescently labeled L1 that was originally introduced by Fei and coworkers,
and was shown to be a more than adequate marker for probing the P- and E-site tRNA
interaction with L1.

1.6 Deacylated-tRNA Release From the E-site
Two fundamentally different roles of the E-site have been put forward. One,
introduced by Nierhaus and colleagues, suggests an “allosteric three-site model” of
elongation, characterized by the following four features. 1) The ribosome contains three
tRNA-binding sites, A-, P-, and E-, the latter being specific for deacylated tRNA. 2) The
deacylated-tRNA does not fall off during translocation but moves from P- to E- site. 3)
The two tRNAs that are present on the ribosome both before and after translocation
undergo codon-anticodon interaction. 4) The ribosome can adopt two conformational
states, pre-translocational and post-translocational; the first of which has high affinities
for tRNA in the A- and P-sites, and the latter, which has high affinities for tRNA in the Pand E-sites. (Gnirke et al., 1989; Rheinberger and Nierhaus, 1986). In contrast,
Wintermeyer and colleagues proposed a second role of the E-site, suggesting that during
translocation the deacylated-tRNA binds to the E-site transiently, promoting its release
from the P-site (Lill and Wintermeyer, 1987; Lill et al., 1988; Semenkov et al., 1996).
In this model, the E-site bound state exists as a transient intermediate, rather than a stable
product of translocation. One of the largest inconsistencies between these two models is
whether or not the deacylated-tRNA remains bound to the E-site after translocation;
however, this contradiction can be explained by differences in preparation, specifically
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buffer conditions. Nierhaus and colleagues worked with a more physiological buffer
containing 4.5 mM Mg2+ and the polyamines spermine and spermidine, while
Wintermeyer and colleagues primarily used a buffer with 7 mM Mg2+ and no polyamines.
An experiment performed by Wintermeyer and colleagues, showed that either high Mg2+
(15-18 mM) or the presence of polyamines (as in Nierhaus’s buffer conditions), results in
less deacylated-tRNA from being released from the E-site instantaneously, whereas, in
the buffer conditions with 7 mM Mg2+ and lacking polyamines, 85% of the deacylatedtRNA was released instantaneously (Semenkov et al., 1996). It is important to gain a
better understanding of how deacylated-tRNA behaves in the E-site because the
occupancy of the E-site has been linked to many different functions on the ribosome. For
example, it has been postulated that an E-site occupied with a tRNA is involved in
maintaining the reading frame at the decoding center (Reviewed by: Nierhaus, 2006).
Further, occupancy at the E-site has been speculated to be involved in regulation of
programmed frameshifting as seen on -1 frameshifting by Léger and colleagues (Léger et
al., 2007), and +1 frameshifting by Liao and colleagues (Liao et al., 2008). Moreover,
recent single molecule work done in our lab has shown that tRNA occupancy in the Esite inhibits EF-G assisted translocation (Chen et al., Manuscript submitted).
In the following thesis work, I will provide further evidence for three different
pathways of deacylated-tRNA release from the ribosome by utilizing a fluorescently
labeled ribosomal protein L1 as a specific E-site probe, and by following the FRET
changes of fluorescently labeled tRNAs as they move into and out of the P/E hybrid state
and E/E site.

This site specifically labeled L1 has been shown to provide FRET

interactions with labeled tRNA in the P/P, P/E, and E/E sites, the latter two having
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similar FRET signals (Fei et al., 2008). Because of the highly mobile nature of the L1
protuberance, I also follow deacylated-tRNA release by FRET changes between the
deacylated-tRNA and the peptidyl-tRNA in the P-site.

By combining these two

techniques along with the anisotropy change for a labeled deacylated-tRNA, I am able to
provide distinct kinetic mechanisms for the release of deacylated-tRNA that depends on
both buffer conditions and acylation state of the P-site tRNA that are novel, and that
correspond nicely with the previous biochemical work, as well as current cryo-EM
studies (Agrawal et al., 1999; Fischer et al., 2010).
In my most recent work, I studied the supposed allosteric interaction between the
A-site and E-site tRNAs by measuring the rate of release of deacylated-tRNA through the
loss of L1-tRNA FRET in a post-translocation complex. As mentioned above, Nierhaus
and colleagues first introduced the theory of an “Allosteric Three-site Model” in 1986
(Rheinberger and Nierhaus, 1986). They utilized a poly-U mRNA and radioactively
labeled tRNAs in order to show that addition of tRNA at the A-site, causes release of
deacylated-tRNA from the E-site.

This study drew criticisms in literature that

reinterpreted the data as a chase of E-site tRNA by the deacylated tRNA present in the Asite substrate (Robertson and Wintermeyer, 1987).

Baranov and Ryabova raised

further criticism, and explained the data as a release and rebinding of the deacylatedtRNA to the A-site after translocation (Baranov and Ryabova, 1988). Both of these
criticisms were valid considering the homopolymeric nature of the mRNA used, giving
rise to the fact that all three binding sites contained the same codon, and it was virtually
impossible to prove the site location of the deacylated-tRNA. These concerns were
addressed in 1989, with the introduction of a heteropolymeric mRNA for translocation
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studies. Nierhaus and colleagues showed that by adding an aminoacyl-tRNA that was
non-cognate for the E-site to a translocated complex, the release of E-site tRNA was
increased (Gnirke et al., 1989). They went on to state that a competition between the
newly added tRNA and the E-site bound deacylated-tRNA was unlikely because the
newly added tRNA is non-cognate for the E-site; a sound theory given the previous
biochemical data (Rheinberger et al., 1986). However, in my following thesis work I
will go on to show that even non-cognate tRNA is able to compete for replacement of the
deacylated-tRNA in an E’ (Fischer et al., 2010) or E2 (Agrawal et al., 1999) site that I
claim the tRNA is located in under the above conditions. My work shows that addition
of a ternary complex to a POST translocated complex does not drastically increase the
amount of deacylated-tRNA that is released any more than is seen with only deacylatedtRNA added in excess to the complex.
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Ribosome

Small Subunit

Large Subunit

Sedimentation
Coefficient

70S

30S

50S

Molecular Weight
(kD)

2520

930

1590

16S, 1542 nts

23S, 2904 nts

RNA
Major
Minor

5S, 120 nts

Molecular Weight
(kD)

1664

560

1104

Proportion of Mass

66%

60%

70%

21 polypeptides

34 polypeptides

Proteins
Molecular Weight
(kD)

857

370

487

Percentage of Mass

34%

40%

30%

!
Table 1.1 Components of E. coli Ribosomes
This table is adapted from (Voet et al., 2006).
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Replication

Transcription

Translation
!!
Figure 1.1 The Central Dogma of Molecular Biology
Figure
adapted
(Crick,dogma
1970)
Figure
1.1. from
Central

of molecular biology.

This figure is adapted from (Crick, 1970)
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Amino acid + ATP

aminoacyl-AMP + PPi
aminoacyl-tRNA + AMP !

aminoacyl-AMP + tRNA

Figure 1.2 Aminoacyl-tRNA Charging Reaction
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Figure 1.3 Overview of Bacterial Translation
This figure is taken from (Schmeing and Ramakrishnan, 2009).
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Figure 1.4 Mechanism of EF-Tu-dependent Binding of Aminoacyl-tRNA to the
Ribosomal A-site. EF-Tu (light green) is depicted in three conformations: the GTPbound form, the transient GTP-activated form on the ribosome (G domain dark green)
and the GDP-bound form, which dissociates from the ribosome.
This figure is taken from (Pape et al., 1998).
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Figure 1.5 Mechanism of Peptide Bond Formation
This figure is taken from (Schmeing and Ramakrishnan, 2009).
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Figure 1.6 Mechanism of Translocation Showing Stepwise Movement of tRNA After
GTP Hydrolysis
EF-G.GTP binding to the PRE complex and GTP hydrolysis are rapidly followed
by formation of the INT which is more slowly converted to POST complex. Thiostrepton
and viomycin inhibit INT formation, whereas spectinomycin selectively inhibits INT
disappearance.
This figure and text is taken from (Pan et al., 2007).
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Figure 1.7 Relative Ribosomal Subunit Rotation
A and B: Cryo-EM images of 70S-Puromycin samples before (A) and after (B) addition
of EF-G.GDPNP, note the red arrows indicating the 30S subunit rotation, as well as the
L1 protuberance movement. C: Schematic showing the rotation of the 30S subunit
around the h27 helix.
This figure was adapted from (A and B: Valle et al., 2003, C: Fischer et al., 2010).
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Figure 1.8 L1 Stalk Movements
Cryo-EM images of the 50S subunit in the open form without EF-G.GDPNP bound
(semi-transparent pink) and the closed form with EF-G.GDPNP bound (solid blue).
This figure was taken from (Valle et al., 2003).
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Figure 1.9 Crystal Structure of L1
The crystal structure of L1 bound to either A) mRNA or B) a 23S rRNA fragment.
This figure was adapted from A. Nevskaya et al., 2006; B. Nikulin et al., 2003
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Chapter II: Materials and Methods
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2.1 Materials
2.1.1 Buffers
The following buffers were prepared in 18 ! Milli-Q purified water, and the pH
was adjusted at 25 °C, unless otherwise stated.
Buffer A (Wintermeyer Buffer): 50 mM Tris-HCl, pH 7.5, 30 mM NH4Cl, 70 mM KCl,
7 mM MgCl2, 1 mM DTT; T50A30K70M7D1
Buffer B (Nierhaus Buffer): 20 mM Hepes-KOH, pH 7.6 @ 0° C, 150 mM NH4Ac, 4.5
mM MgAc2, 4 mM "-mercaptoethanol, 2 mM spermidine, 0.05 mM spermine;
H20A150M4.5B4S2Sp0.05
Buffer C: 50 mM Tris-HCl, pH 7.5, 5 mM NH4Ac, 100 mM KCl, 0.5 mM CaAc2, 15
mM MgAc2, 5 mM

putrescine, 1 mM spermidine, 6 mM "-mercaptoethanol,

T50A5K100Ca0.5M15P5S1B6
Ribosome Lysis Buffer: 20 mM Tris-HCl, pH 7.5, 100 mM NH4Cl, 10 mM MgAc2, 0.5
mM Ethylenediaminetetraacetic Acid (EDTA), 3 mM "-mercaptoethanol
Ribosome Cushion Buffer: 1.1 M Sucrose in 20 mM Tris-HCl, pH 7.5, 500 mM NH4Cl,
10 mM MgAc2, 0.5 mM (EDTA), 3 mM "-mercaptoethanol
Ribosome Wash Buffer: 20 mM Tris-HCl, pH 7.5, 500 mM NH4Cl, 10 mM MgAc2, 0.5
mM (EDTA), 3 mM "-mercaptoethanol
70S TC Zonal Buffer: 10 mM Tris-HCl, pH 7.5, 60 mM NH4Cl, 7 mM MgAc2, 0.25
mM EDTA, 3 mM "-mercaptoethanol
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MRE 600 Ribosome Storage Buffer: 50 mM Tris-HCl, pH 7.5, 70 mM NH4Cl, 30 mM
KCl, 7 mM MgAc2, 0.5 mM EDTA, 1 mM DTT
MRE 600 Subunit Storage Buffer: 20 mM Tris-HCl, pH 7.5, 100 mM NH4Cl, 10 mM
MgCl2, 1 mM !-mercaptoethanol
Subunit Separation Buffer: 20 mM Tris-HCl, pH 7.5, 200 mM NH4Cl, 2 mM MgCl2, 2
mM !-mercaptoethanol
L1 Lysis Buffer: 50 mM NaH2PO4, pH 7.0, 300 mM NaCl, 1 mM PMSF
L1 Wash Buffer: 50 mM NaH2PO4, pH 7.0, 300 mM NaCl
L1 Storage Buffer: 20 mM Tris-HCl, pH 7.5, 400 mM NH4Cl, 4 mM MgCl, 0.2 mM
EDTA, T20M4A400B4E0.2
L1 Labeling Buffer: 50 mM Tris-HCl, pH 7.5, 400 mM NH4Cl
Reconstitution Buffer: 10 mM Tris-HCl, pH 7.5, 150 mM NH4Cl, 8 mM MgAc2, 5 mM
!-mercaptoethanol, T10MAc8A150B5
Reconstitution Cushion Buffer: 20 mM Tris-HCl, pH 7.5, 200 mM NH4Cl, 2 mM
MgAc2, 2 mM !-mercaptoethanol, 1.1 M Sucrose
Buffer RS1: 0.02 M Tris-HCl, pH 7.3, 0.01 M MgCl2, 0.3 M NaCl, 0.5 mM EDTA, 6
mM !-mercaptoethanol
Buffer RS2: 50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 10 mM !-mercaptoethanol
Buffer RS3: 10 mM NaH2PO4, pH 7.2, 1 mM EDTA, 5 mM !-mercaptoethanol, 10%
Glycerol
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Buffer D: 20 mM NH4Ac, pH 5.0, 10 mM MgAc2, and 400 mM NaCl
Buffer E: 20 mM NH4Ac, pH 5.0, 10 mM MgAc2, and 400 mM NaCl, 30% ethanol
(v/v)
Buffer F: 20 mM NH4Ac, pH 7.0, 10 mM MgAc2, and 400 mM NaCl
Buffer G: 20 mM NH4Ac, pH 7.0, 10 mM MgAc2, and 400 mM NaCl, 30% ethanol (v/v)
Buffer H: 50 mM NaAc, pH 5.0
Buffer I: 50 mM NaAc, pH 5.0, 1 M NaCl
SOC Media: 2% w/v bacto-tryptone, 0.5% w/v bacto-yeast extract, 10 mM NaCl, 2.5
mM KCl, 10 mM MgCl2, 20 mM glucose

2.1.2 Reagents
All aqueous solutions were prepared in diethyl pyrocarbonate (DEPC) treated
water, in which 0.1% (v/v) DEPC (Sigma-Aldrich) was added to 18 ! Milli-Q purified
water, incubated overnight, and then autoclaved (Sambrook and Russell, 2001).
The E. coli tRNAs used as well as the Yeast tRNAPhe were purchased from
Chemical Block (Moscow, Russia) and used without further purification, unless
otherwise noted.
Rhodamine 110 (Rhd110) was purchased from Sigma-Aldrich.

Rhd110,

C20H15ClN2O3, M.W. 366.80, has maximum absorbance at 499 nm and maximum
emission at 521 nm in methanol. The corresponding wavelengths in aqueous solution at
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pH 7.0 are 496 nm (extinction coefficient, 90,000 cm-1 M-1) and 530 nm, respectively.
The CyDyeTM reagents used were purchased from GE Healthcare. Cy3 hydrazide,
M.W. 765.95, has a maximum absorbance at 550 nm (extinction coefficient, 150,000 M-1
cm-1), and a maximum emission at 570 nm. The Cy5 hydrazide, M.W. 791.99, has a
maximum absorbance at 649 nm (extinction coefficient, 250,000 M-1 cm-1), and a
maximum emission at 670 nm. The Cy3 and Cy5 maleimide dyes, M.W. 791.0 and
817.0 respectively, have the same spectroscopic properties as the hydrazide cohorts.
Stock solutions of ampicillin and chloramphenicol (Sigma-Aldrich) were made in
water to 20 mg/mL and 15 mg/mL, respectively. Stock solutions of puromycin were
made in the respective buffers prior to use and the pH was adjusted to 7.5.
Stock solutions of ATP were made to 100 mM and the pH was adjusted to 7.5.
Stock solutions of 100 mM GTP were purchased from GE.

2.2 Methods
2.2.1 Ribosome Preparations
2.2.1.1 70S Ribosomes From MRE 600 Cells
Tight-coupled 70S ribosomes were prepared from E. coli MRE 600 cells as
described (Rodnina and Wintermeyer, 1995) with slight modifications. Approximately
65 g of frozen cells (15-L culture) were resuspended in 100 mL of Ribosome Lysis
Buffer and opened by French press (SML Instruments, Inc.) at 10 K-12 K psi. To
eliminate cell debris, the opened cells were centrifuged at 15 K rpm for 30 min (SS-34
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rotor) then the supernatant was removed and re-centrifuged for 60 min in an SS-34 rotor.
The supernatant, now called S30, was layered on top of 22 mL of Ribosome Cushion
Buffer and centrifuged at 30 K rpm, for 21 hours, in a Ti 45 Beckman rotor. The
supernatant of this centrifugation (S100) is removed and used to prepare aminoacyltRNA synthetases. The pellets were resuspended in 35 mL of Ribosome Wash Buffer,
transferred to SS34 centrifuge tubes, and centrifuged at 15 K rpm for 15 min to remove
any left over debris. The supernatant was layered on top of 10 mL of Ribosome Cushion
Buffer and centrifuged at 30 K rpm for 21 hours in a Ti 45 Beckman rotor. This step was
repeated two more times and the final pellets were resuspended in 70S TC Zonal Buffer.
The tight-coupled 70S ribosomes were isolated from the subunits by zonal centrifugation
in a Beckman Ti 50 rotor (20 K rpm, 16 hours) on a gradient from 10% to 50% sucrose in
the desired buffer for future experiments. Concentration was determined by A260 with 1
A260 equal to 26 pmol 70S.
2.2.1.2 Subunits from MRE 600 Cells
Ribosomes were prepared as described above; however, after the final
centrifugation, the pellets were resuspended in Subunit Separation Buffer. The lower
Mg2+ concentration of the Subunit Separation Buffer will facilitate the subunit
dissociation and allow purification of 30S and 50S. The subunits were then separated
from the 70S and each other by zonal centrifugation in a Beckman Ti 50 rotor (20 K rpm,
16 hours) on a gradient from 7.4% to 50% sucrose in Subunit Separation Buffer. The
concentration was determined for the 30S and 50S using A260 with 1 A260 equaling 39
pmol 50S and 78 pmol 30S.
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2.2.1.3 70S Ribosomes From –L1 Cells
Cells for ribosomes lacking the large subunit protein L1 (MV17-10, originally used
by Subramanian and Dabbs, 1980) were a kind gift from Dr. Knud Nierhaus (MaxPlanck Institute, Germany), and were grown in 15 L Luria-Bertani (LB) media for 18
hours. Approximately 65 g of the frozen cells were resuspended in Ribosome Lysis
Buffer, and then the protocol for purification of MRE-600 70S was followed until the
Zonal centrifugation. Prior to the zonal centrifugation, an analytical 70S TC separation
was performed using Zonal Buffer containing either 1, 6, 7, or 8 mM Mg2+ in order to
determine the optimum Mg2+ concentration for 70S TC formation. 70S ribosomes were
the dominant form at Mg2+ concentrations above 6 mM; therefore, the zonal
centrifugation was performed with 6 mM Mg2+, just like for the MRE 600 ribosomes.
Absence of the L1 protein as determined by SDS-PAGE analysis of the 70S –L1
ribosomes proved inconclusive due to the similar, SDS-PAGE analyzed, molecular
weights of L1 (26,700 Da), S2 (28,300 Da), S3 (28,200 Da), and especially S4 (26,700
Da). Therefore, subunit separation was necessary in order to conclude that L1 was
indeed absent.
2.2.1.4 Subunits from –L1 Cells
The –L1 ribosomes were prepared as described above, and resuspended in Subunit
Separation Buffer. The –L1 ribosomal subunits were then separated from the 70S by
zonal centrifugation in a Beckman Ti 50 rotor (20 K rpm, 16 hours) on a gradient from
7.4% to 50% sucrose in Subunit Separation Buffer (Figure 2.1 A). The 30S and 50S
were collected and the 50S were analyzed by SDS-PAGE to ensure that the subunits
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lacked ribosomal protein L1 (Figure 2.1 B).

2.2.2 mRNA Preparations
mRNA022 was prepared by transforming pTZ118 plasmid containing the 022
sequence under a T7 promoter (provided by C. Gualerzi, University of Camerino) into
JM109 cells. The plasmid was extracted from cells using Qiagen Plasmid Maxi kit, and
linearized by the restriction enzyme HindIII. In vitro transcription was conducted using
the EPICENTRE Ampliscribe T7 Flash Transcription Kit. mRNA was isolated from
other components in the reaction mixture by precipitation with 2.5 M pre-chilled LiCl on
ice for 30 min, and then ethanol precipitated two times (2.5 volume of 95% ethanol, and
1/10 volume of 0.3 M NaAc (pH 5.2), > 1 hour at -20°C). The purity was confirmed by
urea-PAGE (Figure 2.2 A) and A260/A280 (2.0 ± 0.2) and the concentration was
determined by A260 using the extinction coefficient of 0.04 mg/A260.
022MFK-mRNA was purchased from Dharmacon (Lafayette, CO) with the
sequence GGG AAG GAG GUA AAA AUG UUU AAA CGU AAA UCU ACU
(initiator codon underlined). Both the transcribed mRNA022 and the purchased
022MFK-mRNA were tested for activity by the amount of [35S]-fMet-tRNAfMet bound to
the ribosome as a function of mRNA concentration (Figure 2.2 B).
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2.2.3 Protein Preparations
2.2.3.1 Preparation of Protein Factors
The cloned elongation factors EF-G (E. coli) and EF-Tu (S. aureus), C-terminally
His-tagged, were provided as kind gifts from Drs. Wilson and Noller (University of
California, Santa Cruz), and Dr. M. Sassanfar (Harvard University), respectively. Dr. T.
Ueda (University of Tokyo) kindly provided the E. coli N-terminal His-tagged initiation
factors, IF-1, IF-2, and IF-3. Finally, Dr. Y.M. Hou provided the PheRS and LysRS.
The protein factors were all purified (by me: EF-Tu, EF-G; or by others in the lab:
Initiation factors) from either Ni-NTA (Qiagen) or TALON Superflow (Clonetech) metal
affinity columns. The EF-G underwent further purification via FPLC Mono-Q column
using a gradient of 50 mM - 350 mM KCl in in 50 mM Tris-HCl (pH 7.5), 10 mM
MgCl2, 0.5 mM EDTA, and 6 mM 2-mercaptoethanol. The proteins were dialyzed
against Buffer A lacking Mg2+ overnight, and then dialyzed against Buffer A for 3 hours.
The Bradford Assay (Bradford, 1976) was used to determine the final protein
concentrations, and SDS-PAGE was used to ensure the final purity of the protein factors.
As with the mRNA, the activity of each of the initiation factors was determined by
measuring the amount of [35S]-fMet-tRNAfMet bound to tight-coupled 70S ribosomes.
Each of the initiation factors measured promoted initiator tRNA binding to the ribosome
to reach a plateau of ~0.5-0.6 [35S]-fMet-tRNAfMet /70S. The remaining unbound
ribosomes are a result of either inactive ribosomes, or the binding of the non-radioactive
tRNAfMet.
The activity of EF-Tu was measured by binding of [14C]-GDP. Varying amounts of
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purified EF-Tu were added to an excess of [14C]-GDP, in 20 mM Tris-HCl, pH 7.6, 100
mM NH4Cl, 10 mM MgCl2, and incubated for 20 min at room temperature. The EF-Tu.
[14C]-GDP complexes were collected on 0.45 µm nitrocellulose filters (Millipore), and
washed with 4 x 1 mL of the above buffer. The concentration of active EF-Tu measured
via this assay is then used to determine the corrected EF-Tu concentration used in all
future experiments and is typically 65-75% of those determined by Bradford Assay.
(Figure 2.3)
2.2.3.2 Preparation of Ribosomal Protein L1
2.2.3.2.1 Wild Type L1 Expression and Purification
The expression and purification of L1 was optimized through various growing
conditions and purification techniques and is summarized in Chapter III. Below are the
best conditions for growing and purification.
A clone of the E. coli ribosomal protein L1 was a kind gift from Dr. R. Zimmerman
(University of Massachusetts).

The cells were initially grown on an LB-agar plate

containing 50 µg ampicillin/mL at 37 °C overnight. A single colony was selected from
the plates, and grown in 5 mL LB containing 50 µg ampicillin/mL at 37 °C for 18 hours,
until the solution became visibly cloudy with cell density. Pre-warmed large-scale LB
growths were then inoculated with 1/1000 volume of the overnight culture, and grown to
an OD595 of ~0.8. IPTG was added to a final concentration of 1 mM, and the growth
temperature was dropped to ~20 °C, in order to limit the amount of L1 inclusion bodies,
and grown for 18 hours. The cells were centrifuged into a pellet, quick-frozen and stored
at -80 °C.
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Approximately 8 g of frozen cells were resuspended in 30 mL L1 Lysis buffer with
1/100 Protease Inhibitor Cocktail Set 1 (Calbiochem) by light vortexing and
homogenizer. French press (12 K- 16 K psi), performed 3 times, was used to open the
cells which were then centrifuged at 16,000 rcf (relative centrifugal force, as measured
by: RCF= [r (2!N)2]/g; where r is the rotational radius of the rotor, N is rotational speed,
and g is the earth’s gravitational acceleration. rcf can be used in place of rpm when the
rotor used for the centrifugation changes, both rpm and rcf are readily available readouts
on the centrifuge) for 20 mins at 4 °C. The supernatant was then added to TALON
Superflow (Clonetech) resin which was previously washed three times with ~10 bed
volumes of L1 Wash Buffer. The supernatant/resin mixture was gently agitated for 60
min at 4 °C on a platform shaker. The mixture was gently centrifuged at 700 rcf for 5
min to pellet the resin, and the supernatant was removed and saved for SDS-PAGE
analysis. The resin was washed with 10 bed volumes of L1 Wash Buffer for 10 min at 4
°C, and again centrifuged at 700 rcf for 5 min. The above was repeated 2 more times for
a total of 3 washes. After the final wash, the resin was resuspended in ~15-20 mL of
Wash Buffer and put into a column for elution. The His-tagged L1 was eluted from the
resin using a 25 mM, 50 mM, 150 mM, and 300 mM imidazole stepwise gradient in L1
Wash Buffer. The fractions containing L1, as determined by 12% SDS-PAGE (Figure
3.4 B), were pooled and dialyzed against L1 Storage Buffer without Mg2+ overnight, then
against L1 Storage Buffer for 3 hours. The dialyzed samples were concentrated through
4-mL Millipore centrifugal tubes with a molecular weight cutoff of 10,000 in a SLA1500 rotor at 7500 rcf. The concentration of the final sample was determined through
Bradford Assay, using bovine serum albumin (BSA) as the standard. The Coomassie
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Brilliant Blue G-250 (Bradford reagent) reacts primarily with arginine, and less so with
histidine, lysine, tyrosine, tryptophan, and phenylalanine that are present in the analyzed
protein. Known concentrations of BSA are used to make a standard curve to determine
the concentration of the L1 protein; therefore, it is advantageous if the L1 has similar
features to BSA. BSA and L1 contain similar percentages of Arg (BSA: 4.3%; L1: 4.7%),
Lys (BSA: 9.9%; L1: 9.8% ), and Trp (BSA: 5.6%; L1: 5.5%) out of total protein;
however, BSA contains ~2-3 times more of the other reactive amino acids. Therefore,
BSA may provide a fairly accurate standard curve for reading of L1 concentration, and, if
anything, underestimates the L1 concentration.

Other measurements also provide

information about the accuracy of the concentration of L1. During reconstitution of a
labeled L1 in to –L1 50S subunits, when analyzed by SDS-PAGE, the L1:50S ratio is 1:1
(Section 2.2.3.3.4) and the label:50S depends solely on the labeling efficiency of the L1.
Therefore, it would appear that the calculation to determine labeling efficiency (using the
L1 concentration from the Bradford Assay) is accurate. Previously, L1 concentration has
been determined by “Folin Phenol Reagent” (Dabbs et al., 1981), but more recent
concentration determinations have not been mentioned.
2.2.3.3 Ribosomal Protein L1 Mutants
2.2.3.3.1 Primer Design For Site-directed Mutagenesis
The Stratagene QuickChange Site-Directed Mutagenesis Kit was utilized to
construct five mutations of L1 (S40C, K54C, V177C, T202C, V221C). According to the
kit’s manual, the following principles were followed when designing primers: 1) Both of
the mutagenic primers must contain the desired mutation and anneal to the same
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sequence on opposite strands of the plasmid. 2) Primers should be between 25 and 45
bases in length, with a melting temperature (Tm) of ! 78 °C. The following calculation
was used to determine Tm for the primers.

Tm = 81.5 + 0.41(%GC) – 675/N

Equation 2.1

, where N is the primer length in bases, and % GC is a whole number. 3) The desired
mutation should be in the middle of the primer with ~10-15 bases of correct sequence on
both sides. 4) The primers optimally should have a minimum GC content of 40% and
should terminate in one or more C or G bases (Figure 2.4).
2.2.3.3.2 Mutagenesis
In a 50 uL reaction volume, 50 ng of double-stranded template L1 DNA, 125 ng of
each plasmid, 1 uL dNTP mix, 5 uL of the 10x reaction buffer, enough DEPC H2O to
reach 50 uL, and lastly 1 uL of 25 U/mL pFu Turbo DNA polymerase were prepared for
PCR. The PCR thermocycler was set up for three segments: 1) 1 cycle at 95 °C for 30
sec; 2) 16 cycles at 95 °C for 30 sec, 55 °C for 1 min, and 68 °C for 7 min; 3) 1 cycle at 4
°C for 10 min; however, the sample can be left at 4 °C up to at least 18 hours. After the
PCR reaction was complete, 1 uL 10 U/µL Dpn I restriction enzyme were added directly
to each amplification reaction, and incubated at 37 °C for one hour in order to digest the
parental DNA.
Transformation was performed by adding 1 uL of the Dpn I digested PCR product
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to 50 uL of XL1-Blue super-competent cells in pre-chilled 14-mL polypropylene roundbottom tubes and incubating on ice for 30 min. The transformation reactions were heat
shocked at 42 °C for 45 sec and then kept on ice for 2 min. 0.9 mL SOC media, preheated to 42 °C, was added to the tube and incubated at 37 °C for one hour. 50 µL of the
transformed cells were added to LB-agar plates containing ampicillin (20 µg/mL) and
tetracycline (10 µg/mL), and allowed to incubate for 24-36 hours. Single colonies were
inoculated into 6 mL of LB broth and grown overnight. 1 mL of the cell cultures were
used to make glycerol stocks, and the remaining 5 mL were prepared for sequence
analysis. Plasmid DNA was extracted and purified from the overnight culture by a
QIAprep Spin Miniprep Kit (Qiagen), and then sent for sequence analysis (Figure 2.5).
2.2.3.3.3 Fluorescent Dye Labeling of Mutated L1
The single mutations of L1 were over-expressed and purified similarly to the wild
type L1, and concentrated to ~ 2 mg/mL in 0.5 mL L1 Storage Buffer. The concentrated
mutant L1 was exchanged into L1 Labeling Buffer by using a NAP-5 (GE-Healthcare)
column, which was pre-washed and pre-equilibrated with 10 mL of the L1 Labeling
Buffer. The protein was eluted with 1 mL of the L1 Labeling buffer. Tris(2carboxyethyl)phosphine (TCEP) was added to the exchanged protein to a final
concentration of 1 mM. A 1-mg package of Amersham Cy3- or Cy5-maleimide monoreactive dye (GE-Healthcare) was resuspended in 50 uL dry dimethylformamide (DMF).
The dye was added to the L1 drop-wise and incubated in a 37 °C shaking water bath for
one hour. Adding !-mercaptoethanol to a final concentration of 43 uM, and shaking at
room temperature for 10 min, stopped the reaction. During the incubation, a 30 mL
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Sephadex G-25 column was pre-washed with 60 mL Milli Q-H2O, and pre-equilibrated
with >75 mL of the L1 Storage Buffer. After the reaction was stopped, the reaction
mixture was added to the G-25 column in order to remove the excess Cy-dye. The labeled
protein elutes out of the column first and the fractions that were high in A552 (Cy3) or
A652 (Cy5) were collected and pooled. The pooled fractions were concentrated in 4-mL
Millipore centrifugal tubes with a molecular weight cutoff of 10,000 in a SLA-1500 rotor
at 7500 rcf, and analyzed by Bradford Assay for protein concentration, and A552 or A652
for the dye concentration. Typical Cy/L1 ratios were 0.6 ± 0.2 (Table 3.1). It was shown
previously that it is possible to separate labeled from unlabeled L11 using FPLC
separation; therefore, several attempts were made in order to separate the labeled L1 from
unlabeled L1 using similar techniques, but all proved to be unsuccessful. Further, the
labeled T202C-L1 (Cy5) was analyzed using MALDI (Section 3.3.2.3, Figure 3.5), and
showed an increase of approximately 750 Da for the labeled sample, which corresponds
nicely with the molecular weight of the Cy5 dye.
2.2.3.3.4 Reconstitution of Cy-Labeled L1 into 50S of –L1 Subunits
Initial attempts to reconstitute the either the wild type, mutated, or labeled L1 into
70S –L1 ribosomes resulted in non-specific binding of the L1 to the ribosome, as seen
through control experiments (Section 3.3.3.1, Figure 3.6). Therefore, reconstitution was
performed using the 50S subunits of the –L1 ribosomes; this change not only doesn’t
show non-specific binding of the L1, but also allows the reconstitution to be observed via
SDS-PAGE analysis. Wild type, mutated, or labeled L1 was added in a 2x excess of the
50S subunits lacking L1 in Reconstitution Buffer to a total of 150 uL, and incubated at 37
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°C for 15 min. The mixture was layered above 400 uL Reconstitution Cushion Buffer,
and centrifuged at 110 K rpm for 40 min (S120-AT2 rotor). The resulting pellet was
resuspended in Buffer A, B, or C, and analyzed by SDS-PAGE. In all cases, except the
S40C mutant, the L1 band in the reconstituted samples revealed ~1:1, 50S to L1
reconstitution, where band density in the SDS-PAGE gels was used to determine
reconstitution efficiency (Table 3.2). Specifically, the ratio of band density from L1/L2
was determined for the reconstituted samples, and compared to the ratio of L1/L2 for the
wild type 70S ribosomes. The ratio of these two numbers determined the reconstitution
efficiency. In the cases where a labeled L1 was used, the Cy5 : 50S ratio was 0.6 ± 0.2
depending solely on the labeling efficiency of the L1 (Figure 2.6).
2.2.3.4 Preparations of crude Yeast and E. Coli Aminoacyl Synthetases
The procedure of Kemkhadze and coworkers was followed to prepare E. coli
aminoacyl-tRNA synthetases (Kemkhadze et al., 1981). The S-100 fraction obtained
from the ribosome preparation in Section 2.2.1.1 was dialyzed against Buffer RS1, and
approximately 375 A280 units were loaded onto a 50 mL DEAE-Cellulose column (2 cm x
20 cm) that was first equilibrated with Buffer RS1. The loaded sample was then eluted
from the column with Buffer RS1. Fractions determined to have a A280/A260 greater than
1.5 were pooled, frozen, and kept at -80 °C in small aliquots. Bradford Assay determined
protein concentrations.
Crude yeast aminoacyl-tRNA synthetases were prepared as described (Lagerkvist
and Waldenstrom, 1964). Approximately 6 g of dry yeast from Saccharomyces
cerevisiae, Type II (Sigma) was added to 40 mL of pre-chilled Buffer RS2, and incubated
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at 4 °C for 20 min. The yeast cells were opened by French press at 10-12 K psi repeated
4 times, and, in an SS34 rotor, were centrifuged at 12 K rpm for 30 min. The supernatant
was re-centrifuged at 12 K rpm for another 30 min (SS34 rotor). At 4 °C, 1/10 volume of
10% streptomycin sulfate in Buffer RS2 was added drop-wise with stirring to the
supernatant in order to precipitate the nucleic acids. The sample was then centrifuged at
12 K rpm for 1.5 hours (SS34 rotor). Ammonium sulfate fractionation was utilized to
partially purify the synthetases by the following procedure. Ceramic mortar and pestle
were used to grind the ammonium sulfate powder, which was then slowly added with
intense stirring to the supernatant to a concentration of 50% (313 g/L). After all the
ammonium sulfate is dissolved, the solution was stirred for 40 min at 4 °C. The solution
was then centrifuged at 12 K for 1.5 hours (SS34 rotor). The pellet was dissolved in 80
mL of Buffer RS3, and dialyzed against 3 L of Buffer RS3 for 3 x 1 hour. The sample
was then quick-frozen and kept at -80 °C in small aliquots.

2.2.4 tRNA Preparations
In Chapters IV and V, I utilize initiator tRNAfMet in a variety of states: 1) highly
charged and highly labeled; 2) highly charged and unlabeled; and 3) uncharged and
highly labeled. The synthesis of the highly charged and highly labeled tRNAfMet can be
thought of as a three-step procedure, involving NaBH4 reduction, labeling with the Cyhydrazide, and aminoacylation using S100 for synthetase. The optimal order of these
reactions was determined by Pan and coworkers, where they found that reductioncharging-labeling gives the best results (Pan et al., 2009). For the highly charged and
"#!
!

unlabeled, only the charging was necessary; for the uncharged and highly labeled,
labeling immediately followed the reduction.

Further, in order to obtain high

stoichiometry of charging or of labeling, HPLC purification was necessary following
either or both of the steps. Elongator tRNAPhe, tRNALys, and tRNAArg are also used in
either charged and labeled, or only charged states as described below (Figure 2.7).
2.2.4.1 NaBH4 Reduction of tRNAs to be Labeled
The tRNAs utilized in this work were either labeled with Rhodamine 110
(Rhd110), Cy3 hydrazide, or Cy5 hydrazide, at the dihydrouridine position(s) in the Dloop of the tRNA. In order for either of these reactions to take place, the
dihydrouridine(s) had to be reduced with NaBH4, to form 3-ureidopropanol, which was
then replaced by the label. This reduction to create tRNA(red) was carried out by
incubating the tRNA (2.5 mg/mL), and NaBH4 (10 mg/mL, added from 100 mg/mL in
0.01 M KOH), in 40 mM Tris-HCl (pH 7.5) at 0 °C for 60 min in a total volume of 400
µL. Three ethanol precipitations then followed in order to remove any unreacted NaBH4.
2.2.4.2 Aminoacylation of tRNAs
Unlabeled tRNAfMet or tRNAfMet(red) was charged and formylated with partially
purified E. coli tRNA synthetase from S100 (described above) which contain MetRS and
formyl-transferase.

The reaction was carried out with 15-20 µM tRNAfMet or

tRNAfMet(red), 720 µM folic acid (as formyl donor), 67 µM [35S]-methionine (~300
cpm/pmol) and between 1/5-1/20th total volume of the crude E. coli tRNA synthetase (as
optimized for each batch) in 100 mM Tris-HCl (pH 7.8), 4 mM ATP, 20 mM MgCl2, 1
mM EDTA, 10 mM KCl, 7 mM !-mercaptoethanol, and 0.005 units/uL of inorganic
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pyrophosphatase (TIPP) for 30 min at 37 °C. The aminoacylation reactions for E. coli
tRNALys and tRNAArg, were similar except 100 µM [3H]-Lys or [3H]-Arg were used,
respectively.
Unlabeled tRNAPhe or tRNAPhe(red) was charged using purified yeast tRNA
synthetase containing PheRS. The reaction was performed with 20-30 µM tRNAPhe or
tRNAPhe(red), 100 µM [3H]-Phe (~200 cpm/pmol) and between 1/5 and 1/20th total
volume of yeast tRNA synthetase (optimized for each batch) in 100 mM Tris-HCl, 10
mM ATP, 50 mM MgCl2, 2.5 mM EDTA, 3 mM !-mercaptoethanol, and 0.005 units/uL
of TIPP for 30 min at 37 °C.
The above charging reactions were quenched with the addition of 1/10 volume of
20% KAc pH 5.0, and extracted with 1 volume of Tris saturated phenol (pH 4.2 +/- 0.2)
to remove proteins, followed by an extraction with 1 volume of chloroform to remove
any remaining phenol. The samples were then ethanol precipitated and the pellets were
resuspended in 800 µL of either Buffer D for HPLC purification or Buffer H for FPLC
purification.
The aminoacylated-tRNAs were further purified from poly-adenine byproducts
through FPLC Mono-Q chromatography starting with a 15 mL wash with 50 mM NaAc
(pH 5.0) followed by a linear gradient of 0-1 mM NaCl in 50 mM NaAc (pH 5.0) (Figure
2.8). As seen in Chapter IV, the ribosome is not blind to the aminoacylation state of the
initiator tRNA. Through the inherent difficulties associated with fully charging tRNA it
was determined that separation of fMet-tRNAfMet from tRNAfMet is necessary, and this is
possible through HPLC purification using C18/15µm column chromatography (Waters)
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with a gradient of 6-21% ethanol in Buffer D (Figure 2.9). The fractions were pooled and
ethanol precipitated based on charging efficiency.
2.2.4.3 Hydrazide Labeling of Reduced tRNA
Labeling of either charged or uncharged tRNA(red) with Cy3- or Cy5-hydrazide
occurs at the now fully reduced dihydrouridine sites in the tRNA (fMet: 20, Phe: 16/17,
Lys: 16/17/20). The pellet of a dried tRNA(red) was resuspended in the smallest volume
possible (typically 5-10 µL) of 0.1 M sodium formate (pH 3.7). Cy3 or Cy5 dye
(resuspended from dry sample to ~200-300 mM in DMSO) was added to a final
concentration of approximately 120-200 mM and incubated at 37 °C for 2 hours,
followed by vacuum drying. The dried sample was resuspended in 400 µL water and
1/10 volume 20% KAc (pH 6.5), and ethanol precipitated three times to remove any
excess dye. Purification of labeled tRNAs from unlabeled tRNAs was accomplished
through HPLC using the same column as above with a gradient of 0-30% ethanol in
Buffer F at 4 °C (Figure 2.10). This separation technique was used for all combinations
of charged and uncharged tRNAfMet, and tRNAPhe.

In each case the fractions were

pooled, and in the case of the charged tRNAs separated based charging efficiency
(typically 0.8-0.9 : 1) and labeling efficiency (fMet-tRNAfMet: ~1:1, Phe-tRNAPhe ~1.5:1).
Or in the case of the uncharged tRNAs, separated based only on labeling efficiency
(tRNAfMet: 1:1) (Table 2.1).
2.2.4.4 Rhodamine 110 Labeling of Reduced tRNA
0.1 mg/mL of either charged or uncharged tRNA(red) was added to 850 µL of 0.1
M sodium formate (pH 3.0). 100 µL of 8 mg/mL rhodamine 110 in methanol was added
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dropwise to the tRNA mixture and incubated at 37 °C for 90 min. The reaction was
stopped by adding 120 µL of 2M Tris-HCl (pH 7-8) and then performing a phenol and
chloroform extraction as seen above.

The labeling reaction was analyzed by

spectrophotometer and typically resulted in labeling efficiencies of Rhd110: Phe-tRNAPhe
of 0.45:1 and Rhd110 : tRNALys of 0.65:1 (Table 2.1).

2.2.5 Complex Formation
All of the following complexes were incubated in a 37 °C water bath.

The

complexes were purified using ultracentrifugation in the Sorvall Discovery M120SE
ultracentrifuge with an S120-AT2-0372 rotor.

The 70SIC, PRE-1, and POST-1

complexes were analyzed by tRNA binding and puromycin reactivity towards each
species, which will be discussed later.
2.2.5.1 70S Initiation Complex (70SIC)
Activated ribosomes were made by preheating mutant-50S or mutant-labeled 50S
(2 µM) with 30S subunits (3 µM) for 10 min in either Buffer A or Buffer B. The
resulting activated ribosomes were incubated with mRNA (8-12 µM, depending on
mRNA batch), IF 1 (3 µM), IF 2 (3 µM), IF 3 (3 µM), GTP (1 mM) and either charged
and labeled, charged and unlabeled, uncharged and labeled, or uncharged and unlabeled,
tRNAfMet (3 µM) and incubated in Buffer A or B for 25 min. Initiation complexes were
purified by ultracentrifugation through 1.1 M sucrose cushion in either Buffer A or B at
450,000 rcf for 40 min at 4 °C. fMet-tRNAfMet binding to the ribosome was determined
through measuring [35S]-fMet-tRNAfMet per ribosome, and/or label per ribosome; when
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using HPLC purified tRNA, stoichiometries of tRNA bound were typically 0.7 : 1 and
0.8 : 1, respectively However, the tRNA binding was strongly influenced by buffer and
aminoacylation of initiator tRNA (Section 4.3.1.2.2, Table 4.3).
2.2.5.2 Ternary Complex
Ternary complex was formed by incubating EF-Tu (6 µM) with unlabeled or
labeled Phe-tRNAPhe, Lys-tRNALys, or Arg-tRNAArg (3 µM), GTP (1 mM), phosphoenoyl
pyruvate (PEP, Roche Diagnostics, 1.5 mM), and pyruvate kinase (Roche Diagnostics,
0.015 mg/mL) in either Buffer A or B for 5 min.
2.2.5.3 PRE Complex
Incubating unpurified initiation complex with ternary complex for 1 min formed
pre-translocation (PRE-1) complexes. The PRE-1 complexes were purified in the same
manner as the 70SIC, and resulted in similar fMet-tRNAfMet binding efficiencies. A-site
binding was measured by the amount of fMet-[3H]-Phe/Lys/Arg-tRNAPhe/Lys/Arg bound to
the ribosome, and typically resulted in ~0.6 – 0.7 [3H]-tRNA / ribosome (Table 4.3).
2.2.5.4 POST Complex
Post-translocation (POST-1) complexes were formed by incubating an unpurified
PRE-1 complex with EF-G (2 : 1 for EF-G : 70S) and GTP (1 mM) for 1 min. The POST
complexes were purified in the same manner as the previous complexes. Further, when
measuring the transition from POST-1 to PRE-2 (Section 5.3.4), it is necessary to ensure
that all EF-G has been removed from the POST-1 sample. To ensure ribosome
purification from EF-G, ~30 pmol of purified POST complex was analyzed on a 12%
SDS-PAGE gel and compared to unpurified POST, and EF-G alone (Figure 2.11). As is
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evident in this figure, the ultracentrifugation of the POST complex through a sucrose
cushion is effective in removing EF-G.

2.2.6 Equilibrium Assays
2.2.6.1 Filter Binding
Filter binding was used to determine the amount of tRNA bound to the ribosome,
to determine initial charging efficiency of reactions in cooperation with TCA
precipitation, and to determine the activity of EF-Tu. To determine the amount of tRNA
bound to the ribosome, the sample was filtered through a nitrocellulose filter (pore size
0.45 µm, from Millipore), followed by 6 washes with 1 mL of either Buffer A or B.
Initial tRNA charging efficiency is determined by first incubating 15 µL of the charging
mixture with 400 µL of pre-chilled 5% TCA on ice for 60 mins. That mixture is then
passed through a nitrocellulose filter (pore size 0.45 µm, from Millipore), and washed six
times with 1 mL of 5% TCA. Determination of the activity of EF-Tu also uses filter
binding and was described above (2.2.3.1).
2.2.6.2 Sucrose Cushion Pull Down
Filter binding to determine the binding of tRNA has its benefit in that it uses very
little sample and is relatively quick; however, the results vary greatly with the technique
used in washing and filtering the sample. In order to obtain a more accurate and precise
measure of tRNA binding, a sucrose cushion pull down is performed. However, it should
be mentioned that some amount of tRNA that is loosely bound to the ribosome is lost
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during sucrose cushioning, which is not lost during filter binding. However, to determine
the amount of [35S]-fMet-tRNAfMet bound to a 70SIC, the 70SIC is made as above with a
final amount of ribosome of approximately 40 pmol. The complex is then layered onto a
1.1 M sucrose cushion in either Buffer A or B, and centrifuged at 450,000 rcf for 40 min
at 4 °C. The pellet is then resuspended in either Buffer A or B, and a small aliquot is
tested for radioactivity in the scintillation counter (Beckman LS6500).
2.2.6.3 Puromycin Reactivity
Puromycin is an A-site-specific antibiotic that forms a peptide bond with
peptidyl-tRNA in the P-site, but has almost no reactivity toward peptidyl-tRNA in the Asite. For the experiments presented here, the puromycin reactivity was only measured at
equilibrium to provide further evidence of the tRNA location in the complexes.

For

example, each of the complexes that were used in my experiments were tested for
puromycin reactivity by incubating 0.1 µM complex with 5 mM puromycin (from 20 mM
stock) for 15 s at 25 °C, the reaction was stopped with 0.3 M sodium formate (pH 5.0),
and extracted with ethyl acetate. The organic phase was analyzed in the scintillation
counter to determine the amount of peptidyl-puromycin formed per ribosome (Table 2.2).
2.2.6.4 FRET Measurements
Equilibrium FRET measurements were made on a photon-counting instrument
(Fluorolog-3 spectrofluorometer, Horiba Jobin Yvon, USA). Typically three fluorescence
traces were averaged for each result. The experiments were performed at 25 °C by
connecting the instrument to a circulating water bath. The majority of the kinetic studies
that were done were first tested at equilibrium because of the small amount of material
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needed for these studies. The results of these equilibrium studies can be seen in Chapter
4.
The complexes that utilized a Cy3/Cy5 FRET pair were excited at 518 nm
(excitation band pass of 2 nm) and the emission spectrum from 550-750 nm was
recorded. For the equilibrium FRET, complexes containing only Cy3 (D*A), only Cy5
(DA*), both dyes (D*A*), and no dyes (DA) were measured. The DA sample was
subtracted from all other traces to correct for light scattering and background
fluorescence, and relative FRET efficiency changes were determined by equation 2.2:
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Where E is the FRET efficiency, DA*’ is the extracted acceptor emission as calculated
by the bottom equation. D*A*(A) is a sample with both donor and acceptor labeled,
measured at the acceptor peak, D*A*(D) is the same complex measured at the donor peak.
The DA* indicates a sample in which only the acceptor is labeled, and a D*A indicates a
sample where only the donor is labeled. The donor efficiency and acceptor efficiency are
measured as the amount of donor/70S and acceptor/70S in the purified complexes.
(Values and a sample calculation can be seen in Table 4.1, Figure 4.1-4.2).
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The complexes that utilized the Rhd110/Cy3 FRET pair were excited at 480 nm
(excitation band pass of 2 nm) and the emission spectrum from 500-750 nm (emission
band pass of 2 nm) was recorded. The complexes containing only Rhd110 (D*A), only
Cy3 (DA*), both dyes (D*A*), and no dyes (DA) were measured, and relative FRET
changes were determined by comparing all three traces after subtraction of DA. The
relative FRET was determined as above for the Cy3 donor experiments, except the
acceptor peak occurs at 566 nm and the donor peak at 532 nm (Table 4.1, Figure 4.7).

2.2.7 Kinetic Assays
Changes in fluorescence and anisotropy after rapid mixing were measured using a
KinTek stopped flow spectrofluorometer model SF-2004 (Figure 2.12 A). In a stopped
flow apparatus, two solutions are rapidly mixed and the reaction times are measured by
fluorescence or anisotropy change. In our instrument, the dead time is ~2 ms, giving us
sufficient time resolution for most of the changes we monitor.
2.2.7.1 Ensemble FRET experiments with Cy3 dye as donor
Experiments were performed in the KinTek stopped flow spectrofluorometer with
an excitation of 530 nm, the donor Cy3 fluorescence was measured in PMT-1 with a 570
+/- 10 nm band pass filter, and the acceptor Cy5 fluorescence was measured in PMT-2
with a 680 +/- 10 nm band pass filter (slit width of 1.56 nm for the excitation). In some
instances complexes were created with only Cy3 (donor alone, D*A) or only Cy5
(acceptor alone, DA*) in order to determine cross talk between the channels (i.e. donor
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excitation being read in the acceptor channel); however, because of the spectroscopic
properties of the FRET pair, the overlap is minimal. In most cases, at least 10 traces were
taken and averaged per experiment.
2.2.7.2 Ensemble FRET experiments with Rhd110 dye as donor
Experiments were performed using the KinTek stopped flow spectrofluorometer
with an excitation of 480 nm.

The donor, in this case Rhd110, fluorescence was

measured in PMT-1 with a 520 +/- 10 nm band pass filter, and the acceptor Cy3
fluorescence was measured in PMT-2 with a 570 nm long-pass filter (slit width of 1.56
nm for the excitation). In all instances the Rhd110 (donor alone D*A) complex was
measured in order to determine the overlap of the Rhd110 emission in the Cy3 channel.
Unlike the Cy3/Cy5 FRET pair, the Rhd110/Cy3 FRET pair has considerable overlap,
and thus the acceptor channel needs to be corrected by looking at the 4 traces utilized in
the bottom half of Equation 2.2: 1) Donor and acceptor labeled, measured at the donor
channel, D*A*(D); 2) Donor and acceptor labeled, measured at the acceptor channel,
D*A*(A); 3) Donor labeled, measured at the donor channel, D*A(D); and 4) Donor
labeled, measured at the acceptor channel, D*A(A). Where D*A*’(A) is the corrected
acceptor channel used to determine FRET efficiency change.
2.2.7.3 Anisotropy Measurements of tRNAfMet (Cy3) Release
In Chapter IV, preliminary fluorescence anisotropy measurements are used in
order to determine the rate at which a deacylated-tRNAfMet (Cy3) is released from the
ribosome. Fluorescence anisotropy is a useful method to study molecular interactions by
monitoring changes in apparent size of fluorescently labeled molecules, in this case the
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interaction between a fluorescent tRNA and the ribosome.

Losses in fluorescence

anisotropy indicate that the fluorescent tRNA has gone from a bound to unbound state,
and provides a direct measurement of tRNA release from the ribosome. The PRE-1
complexes used in Chapter IV were prepared as described above, and the KinTek stopped
flow was equipped with polarizing filters to allow anisotropy measurements (Figure 2.12
B). Anisotropy measurements utilize four fluorescence intensities and the value is
calculated by equation 2.3.

Anisotropy =

G=

I VV ! GI VH
I VV + GI VH

Equation 2.3

I HV
I HH

!

Where, IVV stands for intensity with vertically polarized excitation and vertically
polarized emission, IVH stands for intensity with vertically polarized excitation and
horizontally polarized emission, and so on. G is a measure of the sensitivity difference
between the two PMTs used for obtaining the data.

2.2.8 Rate Constant Estimation
In Chapter IV, the data presented were fit both to triple exponential (Figures 4.44.6, 4.8-4.11) and to the global Scheme 4.1 (Figures 4.12, 4.13) using the program
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Scientist (MicroMath Research, LC). Fitting of the data to a triple exponential (Equation
2.6) yielded apparent rate constants presented in Table 4.1. Whereas fitting to Scheme 4.1,
yielded rate constants presented in Table 4.3.
In Chapter V, the data presented in Figures 5.2A, 5.3, 5.4, and 5.5 were fit to
either a single exponential (Equation 2.4) or a double exponential (Equation 2.5) in
Scientist, and yielded apparent rate constants presented in Table 5.2.

! k ap p1 t

Equation 2.4

y = yO + A1 e

! k ap p1 t

+ A2 e

! k ap p1 t

+ A2 e

y = yO + A1e
y = yO + A1e

! ka pp 2t

! ka pp 2t

Equation 2.5
+ A3 e

! ka pp 3t

Equation 2.6

!
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tRNA

fMet

Phe

Charge

Label

[3H]/[35S]aa :
tRNA

[3H]/[35S]aa :
tRNA

FPLC
Purified

HPLC
Purified

Dye :
tRNA

Dye :
tRNA
HPLC
Purified

Yes

No

0.4±0.1

0.8±0.1

-

-

Yes

Cy3

0.4±0.1

0.8±0.1

0.3±0.1

1.0±0.1

No

Cy3

-

-

0.3±0.1

1.0±0.1

Yes

No

0.3±0.1

0.8±0.1

-

-

Yes

Cy3

0.3±0.1

0.8±0.1

0.4±0.1

1.4±0.1

Yes

Rhd110

0.3±0.1

0.8±0.1

0.4±0.1

-

Yes

No

0.15±0.05

-

-

-

No

Rhd110

-

-

0.6±0.1

1.5±0.1

Yes

No

0.25

-

-

-

Yes

Cy3

0.40

-

0.50

-

Lys

Arg*
*The Arg-tRNAArg was only charged one time, and only charged and labeled one time.
Table 2.1 Charging and labeling efficiencies of tRNAs
Different species of tRNAs were made and purified by either HPLC or FPLC, the
resulting charging efficiencies and labeling efficiencies are shown in this table.

In

general, HPLC purification of charged tRNA and/or labeled tRNA gave efficiencies
greater than FPLC purification due to the higher separation of the HPLC. The >1 labeling
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efficiencies of Phe and Lys can be attributed to the tRNA having more than one
dihydrouridine.

Complex

Buffer

peptidyl-Puro : 70S

A

0.36±0.05

B

0.30±0.05

A

0.03±0.01

B

0.02±0.01

A

0.35±0.05

B

0.32±0.05

A

0.05±0.01

B

0.05±0.01

70SIC

PRE-1

POST-1

PRE-2

Table 2.2 Puromycin Reactivity of Ribosome Complexes
Equilibrium puromycin reactivity was measured for each of the complexes made
to ensure that the correct complex was created. For the 70SIC complex, puromycin
forms a peptide bond with [35S]-fMet to create [35S]-fMet-Puromycin. [35S]-fMetPuromycin per 70S ribosome was measured to determine puromycin reactivity.
Puromycin is unable to react with a PRE-1 or PRE-2 complex and the levels shown in the
table are similar to background. In the POST-1 complex puromycin reacts with the [35S]-
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fMet-[3H]-Phe, to create [35S]-fMet-[3H]-Phe-Puromycin, and either the radioactive fMet
or radioactive Phe is used to measure reactivity.

A.

1.6

Tight Coupled 70S Separation
2+

1.4

(7 mM Mg )
2+

Subunit Separation (2 mM Mg

A260

1.2

)

1.0
0.8
0.6
0.4
0.2

B.

30S

50S

70S

WT -L1
50S 50S L1

MW
37 kD
25 kD

L1

Lane:

1

2

3

4

Figure 2.1 Separation of Purified –L1 Ribosomes
After purification, the –L1 ribosomes were separated to collect either tight coupled 70S
(black triangles) or 50S and 30S subunits (grey crosses). Approximately 30 pmol of the
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50S subunits were then analyzed on a 12% SDS-PAGE gel (B). Lane 1: MRE-600 50S
subunits (~30 pmol); Lane 2: -L1 50S subunits; Lane 3: Purified L1 (~20 pmol); Lane
4: Molecular Weight Marker. Notice that in Lane 2 the band for L1 is missing. The
apparent increase in molecular weight in the L1 band between Lane 1 and Lane 3 is
attributed to the 10x-His-tag and linker associated with the Lane 3 purified L1 protein.
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A.

Lane:

B.

1

2

3

4

5

6

7

8

1.0

fMet/70S

0.8
0.6
022 mRNA
022 MFK mRNA

0.4
0.2
0.0
0

2

4

6
8
10
mRNA/70S

12

14

16

Figure 2.2 mRNA Purity and Activity
A: Transcribed mRNA022 (Lane 1-4, increasing amounts, 0.5, 1, 2, 4 µg) was
loaded on to a 6% SDS-UREA gel, and run against the same amounts of known
mRNA022 (lane 5-8), and stained with a methanol blue stain. B: mRNA promotes the
binding of [35S]-fMet-tRNAfMet that normally reaches a plateau of 0.7 – 0.9 fMet per
ribosome. A number at the plateau that is less than one is a result of either inactive
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ribosomes, or the binding of the non-radioactive tRNAfMet. This assay was used to
determine the correct concentration of mRNA to add in order to reach the optimum fMettRNAfMet binding.

Figure 2.3 EF-Tu Activity Test Results
Increasing amounts of EF-Tu were incubated with a saturating amount of [14C]GDP. The EF-Tu.GDP complex was collected on nitrocellulose filters and the amounts
were determined by radioactive counts.

The active concentration of EF-Tu was

determined by the slope of a linear fitting and was determined to be 64.8% as active as
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the total amount of EF-Tu as determined by Bradford Assay. Typical EF-Tu preparations
yield 60-70% active EF-Tu.

DNA Sequence
1

ATGGCTAAAC TGACCAAGCG CATGCGTGTT ATCCGCGAGA AAGTTGATGC

51

AACCAAACAG TACGACATCA ACGAAGCTAT CGCACTGCTG AAAGAGCTGG

101 CGACTGCTAA ATTCGTAGAA AGCGTGGACG TAGCTGTTAA CCTCGGCATC
151 GACGCTCGTA AATCTGACCA GAACGTACGT GGTGCAACTG TACTGCCGCA
201 CGGTACTGGC CGTTCCGTTC GCGTAGCCGT ATTTACCCAA GGTGCAAACG
251 CTGAAGCTGC TAAAGCTGCA GGCGCAGAAC TGGTAGGTAT GGAAGATCTG
301 GCTGACCAGA TCAAGAAAGG CGAAATGAAC TTTGACGTTG TTATTGCTTC
351 TCCGGATGCA ATGCGCGTTG TTGGCCAGCT GGGCCAGGTT CTGGGTCCGC
401 GCGGCCTGAT GCCAAACCCG AAAGTGGGTA CTGTAACACC GAACGTTGCT
451 GAAGCGGTTA AAAACGCTAA AGCTGGCCAG GTTCGTTACC GTAACGACAA
501 AAACGGCATC ATCCACACCA CCATCGGTAA AGTGGACTTT GACGCTGACA
551 AACTGAAAGA AAACCTGGAA GCTCTGCTGG TTGCGCTGAA AAAAGCAAAA
601 CCGACTCAGG CGAAAGGCGT GTACATCAAG AAAGTTAGCA TCTCCACCAC
651 CATGGGTGCA GGTGTTGCAG TTGACCAGGC TGGCCTGAGC GCTTCTGTAA
701 ACTAA

E. Coli L1 Sequence
1

makltkrmrv irekvdatkq ydineaiall kelatakfve svdvavnlgi darksdqnvr

61

gatvlphgtg rsvrvavftq ganaeaakaa gaelvgmedl adqikkgemn fdvviaspda

121 mrvvgqlgqv lgprglmpnp kvgtvtpnva eavknakagq vryrndkngi ihttigkvdf
181 dadklkenle allvalkkak ptqakgvyik kvsisttmga gvavdqagls asvn
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Primers
S40C (AGC!TGC)
Forward: 5' GCGACTGCTAAATTCGTAGAATGCGTGGACGTAGCTGTTAACC 3'
Reverse: 5' GGTTAACAGCTACGTCCACGCATTCTACGAATTTAGCAGTCGC 3'
GC content: 48.84%
Location: 50-92
Melting temp: 83.9°C
Mismatched bases: 1
Length: 43 bp
Mutation: Substitution
5' flanking region: 21 bp Forward primer MW: 13282.76 Da
3' flanking region: 21 bp Reverse primer MW: 13162.70 Da
K54C (AAA!TGC)
Forward: 5' CTCGGCATCGACGCTCGTTGCTCTGACCAGAACGTACGTG 3'
Reverse: 5' CACGTACGTTCTGGTCAGAGCAACGAGCGTCGATGCCGAG 3'
GC content: 60.00%
Location: 142-181
Melting temp: 81.2°C
Mismatched bases: 3
Length: 40 bp
Mutation: Substitution
5' flanking region: 18 bp Forward primer MW: 12249.07 Da
3' flanking region: 19 bp Reverse primer MW: 12347.13 Da
V177C (GTG!TGC)
Forward: 5' CCACACCACCATCGGTAAATGCGACTTTGACGCTGACAAAC 3'
Reverse: 5' GTTTGTCAGCGTCAAAGTCGCATTTACCGATGGTGGTGTGG 3'
GC content: 51.22%
Location: 113-153
Melting temp: 78.9°C
Mismatched bases: 3
Length: 41 bp
Mutation: Substitution
5' flanking region: 19 bp Forward primer MW: 12492.28 Da
3' flanking region: 19 bp Reverse primer MW: 12718.36 Da
T202C (ACT-->TGC)
Forward: 5'GCTGAAAAAAGCAAAACCGTGCCAGGCGAAAGGCGTGTAC
Reverse: 5'GTACACGCCTTTCGCCTGGCACGGTTTTGCTTTTTTCAGC
GC content: 52.50%
Melting temp: 78.4°C
Length: 40 bp
5' flanking region: 19 bp
3' flanking region: 18 bp

Location: 585-624
Mismatched bases: 3
Mutation: Substitution
Forward primer MW: 12406.20 Da
Reverse primer MW: 12187.03 Da
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V221C (GTT!TGT)
Forward: 5' CACCATGGGTGCAGGTTGTGCAGTTGACCAGGCTG
Reverse: 5' CAGCCTGGTCAACTGCACAACCTGCACCCATGGTG
GC content: 60.00%
Location: 98-132
Melting temp: 80.8°C
Mismatched bases: 2
Length: 35 bp
Mutation: Substitution
5' flanking region: 16 bp Forward primer MW: 10844.13 Da
3' flanking region: 17 bp Reverse primer MW: 10662.05 Da

Figure 2.4 DNA and protein sequences of E. coli ribosomal protein L1 and
sequences of the single mutant primers
Mutants are indicated in the DNA and protein sequence, S40C (blue), K54C
(orange), V177C (red), T202C (pink), V221C (green), and the start codon is underlined
in the DNA sequence. Single mutant primers were designed using the program PrimerX
(http://www.bioinformatics.org/primerx/) under the specifications for the Stratagene
Quickchange site directed mutagenesis kit.
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S40C
AGC!
TGC

!

K54C

!

AAA!
TGC
C

!

V177C
GTG !
TGC
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T202C
ACT!
TGC

!

V221C
GTT !
TGT

Figure 2.5 DNA Sequencing Results of the Single Mutants
The single mutant primers were used to create mutant strains that were sequenced
using the T7 promoter or T7 terminator sequences as a sequencing primer depending on
the location of the mutant within the plasmid. Early mutants in the sequence like S40C
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and K54C utilized the T7 promoter primer, where as the other mutants used the T7
terminator primer.

'$ '(

A

B
1

2

3

4

5

6

'/6,!(

7
37 kD

25 kD

$
%
&
!
)*+,-.+/0!1,2345

Figure 2.6 Reconstitution analyses of L1 and –L1 50S subunits
-L1 50S subunits were reconstituted with T202C-L1 (Lane 1 A, B) and T202C-L1
(Cy5) (Lane 2 A, B). An SDS-PAGE gel was used to analyze the reconstitution by
comparing the reconstituted samples (Lane 1 and 2) to wild type 50S subunits (Lane 4),
50S subunits lacking L1 (Lane 3), T202C-L1 (Lane 5) and T202C-L1 (Cy5) (Lane 6).
Reconstitution with both the T202C-L1 (Cy5) and T202C-L1 samples reached 1:1 when
analyzed by band density. When the labeled T202C-L1 (Cy5) was reconstituted, the
Cy5 : 50S ratio was 0.6 +/- 0.2, depending exclusively on the labeling efficiency of the
L1 protein.
"#!
!

!

A.

!

!

B.

!

!

!

!C.

!

!

!

D.

!

!

Figure 2.7 Secondary Structures of tRNAs
Cloverleaf structures of A) initiator tRNAfMet; B) tRNALys; C) tRNAArg from E.
coli, and D) tRNAPhe from yeast.
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Figure 2.8 FPLC Purification of Charged tRNAs
The above traces are examples for purification of tRNA from the poly-adenine
byproduct (elapsed time ~18-23 min). The FPLC purification does not separate charged
tRNA from uncharged tRNA, thus collection of the tRNA peak (elapsed time ~26-35
min) results in only the inherent charging efficiencies as evidenced by comparison of
tRNA concentration versus amino acid concentration. A) fMet-tRNAfMet: total tRNA
(~0.35:1); B) Phe-tRNAPhe: total tRNA (~0.4:1); C) Lys-tRNALys: total tRNA (~0.2:1);
and C) Arg-tRNAArg: total tRNA (~0.6:1).
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Figure 2.9 HPLC Purification of fMet-tRNAfMet
HPLC purification of tRNAfMet (elapsed time ~18-19 min) from fMet-tRNAfMet
(elapsed time ~25-30 min) resulted in a sample that contained a ratio of [35S]-Met :
tRNAfMet of ~0.8 : 1. The poly-adenosine peak as well as an earlier tRNAfMet peak is not
shown here.
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Figure 2.10 HPLC Purification of Cy3-labeled tRNAs
HPLC purification of Cy3-hydrazide labeled fMet-tRNAfMet (Cy3) (A) or
tRNAfMet (Cy3) (B). In both cases the labeled tRNA (elapsed time A: ~26 min; B: ~24"#!
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25 min) came out after the unlabeled tRNA and resulted in labeling efficiencies of
Cy3:tRNA of 1:1. There is a free dye peak seen in B that is also seen in A, but it is not
shown on the plot.
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Figure 2.11 SDS-PAGE Gel Electrophoresis Result of POST Complex Preparation
Approximately 30 pmol of ribosome complexes were loaded to a 12% SDSPAGE gel. Lane 1: EF-G (39 pmol); Lane 2: 70S; Lane 3: EF-G (39 pmol) and 70S (30
pmol) added together; Lane 4: POST complex after sucrose cushion; Lane 5: Molecular
Weight Marker. The highest molecular weight ribosomal protein S1 is present in lanes 24 indicating the presence of ribosomes. EF-G is present in lanes 1, and 3, but is absent in
lane 2 and 4, which clearly shows that the sucrose cushion has removed most of the EF-G
protein at least beyond the detection limit of the gel.
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Figure 2.12 Schematic for A) Stopped Flow and B) Anisotropy Set-up
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Chapter III: Optimization of Overexpression,
Purification, and Reconstitution of L1 Mutants
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3.1 Abstract
Obtaining pure samples of reconstituted ribosomes with modified L1 in an
efficient manner was required for the success of the following research. It is for this
reason that it was necessary to spend time discovering the optimal conditions for L1
overexpression, L1 purification, and ribosome reconstitution with the mutant and/or
labeled L1. Here we discuss a variety of conditions to increase the protein yield by
overexpression, and optimize the purification of an active, native ribosomal protein L1.
By following suggestions from a review written by Sørensen and Mortensen, it was
determined that the most efficient way to increase yields of native L1 was to lower the
temperature at which overexpression occurred to ~20 °C (Sørensen and Mortensen,
2005). This resulted in yields of purified usable L1 of ~2 mg/L of culture, which, when
overexpressed on a large (15-L) scale provided plenty of pure L1. Once the L1 was
overexpressed, French press or a commercially available Bug Buster® Master Mix was
used to lyse the cells. Both methods proved to be viable means of opening the cells to
obtain soluble protein. Purification was then optimized, and the TALON resin was
determined to provide the highest yield of pure L1.
Once overexpression and purification of the wild type L1 were optimized, the
mutants (S40C, K54C, V177C, T202C, and V221C-L1) were created and either labeled
with a dye functionalized with a maleimide (Cy3, Cy5, or Cy5.5) or left underivatized.
These mutants, either labeled or unlabeled, were then reconstituted into –L1 ribosomes.
By optimizing the previous work of Odom et al., reconstitution into –L1 50S subunits
was determined to be the most efficient method for creating pure reconstituted ribosomes
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(Odom et al., 1990). Further, the reconstituted 50S ribosomes were used to create
ribosomal complexes, and T202C-L1 (Cy5) and K54C-L1 (Cy5) were shown to be useful
probes for P- and E-site tRNA movement.

3.2 Introduction
Much of the work in the biochemical field requires a reliable source for
expression of proteins from a variety of species. In the early 1980s the utilization of
expression vectors containing an IPTG-inducible promoter based on the lac operon
became a popular way to control high-level expression of foreign proteins in E. coli
(Amann et al., 1983; Amann and Brosius, 1985; Sambrook and Russell, 2001). These
vectors use the cell’s own RNA polymerase to express a gene downstream of the lac
promoter; however, this could cause further problems when the RNA polymerase is
needed to express the cell’s own genes, possibly leading to leaky expression. This
problem was solved with the use of expression systems utilizing the bacteriophage T7
promoter (Tabor and Richardson, 1985; Studier and Moffatt, 1986).

These

expression systems use the bacteriophage T7 RNA polymerase, and only recognize the
bacteriophage T7 promoters, therefore limiting the amount of non-specific expression. In
order to use the T7 promoter expression system, two things are required: 1) bacteriophage
T7 RNA polymerase, which is the product of T7 gene 1; and 2) a plasmid vector
containing a bacteriophage T7 promoter upstream of the target gene (Sambrook and
Russell, 2001). The expression system in the following work uses the bacteriophage T7
RNA polymerase from the competent E. coli BL21 (DE3) cells (Stratagene). The BL21
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(DE3) cells contain the T7 gene 1 that is under control of the IPTG-inducible lacUV5
promoter. The plasmid vector utilized for expression of L1 is the pET-16b vector. The
pET series of vectors, originally developed by Studier et al., contains the T7 promoter
region and various cut sites downstream to insert the target gene (Studier et al., 1990).
Specifically, the pET-16b cloning and expression region contains the T7 promoter, a lac
operator, a sequence coding for a 10x His-tag, followed by multiple cloning sites in
which the L1 gene was inserted between the NdeI (5’ end) and BamHI (3’ end), and
finally the T7 terminator (Figure 3.1). Proper expression of the L1 gene, and eventually
the L1 mutants, is necessary in order to successfully put together fluorescently labeled
50S complexes, and therefore, the proper mix of vector and competent cell is critical.
The overexpression of a protein, either foreign or native, to high levels in E. coli
often leads to the formation of insoluble intracellular aggregates of the expressed protein
called inclusion bodies (Williams et al., 1982; for reviews please see Marston, 1986;
Hartley and Kane, 1988; Marston and Hartley, 1990; Georgiou and Valax, 1996;
Sambrook and Russell, 2001). It is unclear what determines whether an overexpressed
protein forms an inclusion body or folds properly and remains soluble. However, the
available evidence suggests that inclusion bodies arise by the aggregation of partially
folded and malfolded polypeptides, and is not a result of insolubility or instability of the
native protein (Sambrook and Russell, 2001). It was previously reported that, when
overexpressed, E. coli L1 forms inclusion bodies, instead of the soluble folded protein
(Köhrer et al., 1998). Therefore, in addition to optimizing the overexpression machinery
for L1, it is also necessary to optimize the conditions of growth to ensure proper folding
of the protein, thus limiting the inclusion bodies. Here, I show that by lowering the
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temperature of the growth, it is possible to limit the amount of L1 in inclusion bodies,
thus increasing the amount of soluble protein.
The next step necessary to obtaining L1-reconstituted ribosomes for use in future
studies is separating L1 from all other soluble proteins. In the case of L1, a 10x-His-tag
on the N-terminus of the protein is employed.

Immobilized-metal affinity

chromatography (IMAC) was first used to purify proteins in 1975, and utilized the
chelating ligand iminodiacetic acid (IDA) charged with metal ions in order to purify
different peptides and proteins (Porath et al., 1975). Since the first IMAC purification
techniques were used, many more have been discovered, including but not limited to NiNTA (Qiagen) and TALON (Clontech). Ni-NTA was first used in the late 1980s and
utilizes nitrilotriacetic acid (NTA) which forms a tetradentate with a metal ion, occupying
four of the six ligand binding sites in the coordination sphere of the Ni, thereby allowing
two sites to coordinate with the His-tag of the protein (Hochuli, 1989; Qiagen Manual).
In 1991, the TALON IMAC resin was introduced and utilizes a special tetradentate metal
chelator that holds the electropositive metal in an electronegative pocket allowing it to
bind metal ions, specifically, cobalt. This binding pocket is an octahedral structure in
which four of the six metal coordination sites are occupied by the TALON resin ligand.
The TALON resin has the advantage of enhancing the accessibility of the bound metal
ion to the polyhistidine-tagged protein. The coordination profile of the TALON Resin
ligand and cobalt is more specific for polyhistidine-tagged proteins than the Ni-NTA
resin, and therefore limits the undesirable tendency to bind unwanted proteins with
histidine residues (Clontech manual). Both of these IMAC resins have their advantages
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and disadvantages, and here it is determined which purification method works best with
L1 and L1 mutants.
The purified mutant proteins were labeled at the new cysteine position by
maleimide functionalized dyes, specifically Cy3 and Cy5. The labeling procedure is very
straightforward and did not necessitate any further optimization resulting in dye:L1 ratios
around 0.6-0.8 (Section 2.2.3.3.3 and Table 3.1). Futile attempts to separate unlabeled
L1 away from labeled L1 using FPLC separation were made, and eventually it was
decided that further attempts would prove unproductive because extremely highly labeled
L1 was not needed for future studies.
Finally, the mutant and/or fluorescently labeled L1 were reconstituted into
ribosomes lacking L1. In 1980, Subramanian and coworkers obtained a spontaneous
mutant ribosome that was found to lack L1. The mutant ribosome was found to have a
reduced level of protein synthesis that is fully restored upon addition of purified L1 to the
mutant (Subramanian and Dabbs, 1980; Dabbs et al., 1981). However, reconstitution
efficiency was difficult to determine, and the reconstituted ribosome was only shown to
be functionally active. Here, the most efficient reconstitution for WT, mutant, and
fluorescently labeled L1 into –L1 ribosomes or subunits was determined to be an
incubation with at least 2x excess L1 to –L1 50S at 37 °C for 15 min.
Initial equilibrium FRET studies were performed using the mutants V177C-L1
(Cy3), or V221C-L1 (Cy3) as the acceptor, and fMet-tRNAfMet (Rhd 110) as the donor.
After multiple attempts it was determined that the Rhd110/Cy3 FRET pair was not
optimal for FRET studies. Even though preliminary data showed FRET efficiency
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changes upon ternary complex addition to 70SIC and translocation, the inherent overlap
between the Cy3 and Rhd110 dye made FRET efficiency calculations more difficult.
However, the Rhd110/Cy3 FRET pair is used later for tRNA/tRNA FRET experiments,
and the signal overlap is addressed. The S40C-L1 (Cy3) mutant studies were dropped
after it became obvious that the reconstitution with this mutant was not readily possible.
Fluorescently labeled T202C-L1 has been shown to be a useful probe for P- and
E-site tRNA in single molecule experiments (Fei et al., 2008). After optimizing the
procedures leading up to the final T202C-L1 (Cy Dye)-50S subunit, it is important to
show that this particular construct is able to work as effectively on an ensemble
experiment

scale.

Steady-state

spectrofluorometer

experiments

(Fluorolog-3

spectrofluorometer, Horiba Jobin Yvon, USA) were conducted to determine the
equilibrium FRET efficiency changes for tRNAs translocating through the ribosome in
both Buffer A and Buffer B. Not only was it determined that the T202C-L1 (Cy Dye) 50S
was an appropriate probe for P- and E-site tRNA, it was also shown that buffer conditions
play an important role in the release of deacylated-tRNA.

3.3 Results
3.3.1 Optimization of L1 Overexpression
Initial overexpression of wild type ribosomal protein L1 was performed at 37 °C
for four hours after induction and resulted in little protein, and almost no soluble protein
after cell lysis. In order to optimize protein recovery from overexpression, an initial time
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course study was performed. A 5-mL culture was grown overnight, and then 1 L of Luria
Bertani media was inoculated with 1:1000th volume of the overnight growth (2.2.3.2.1),
and grown to an OD595= 0.80 at which time, the 1 L culture was induced with IPTG (1
mM). During overexpression, small aliquots were selected at 1, 2, 4, 6, and 20 hours, and
run on a 12% SDS-PAGE gel to determine the level of overexpression (Figure 3.2). As
evidenced by the gel, allowing the protein to express for at least 18-20 hours provides the
optimum level of overexpression.
Although overexpressing for longer periods of time may allow more protein to be
made, the amount of native soluble protein after cell lysis still remains a problem. There
are two approaches that can be taken to redirect the protein from inclusion bodies into
soluble proteins; either the protein can be refolded from inclusion bodies, or the
expression strategy can be modified to obtain expressed protein that is more soluble.
Therefore, a multifaceted approach was taken to solve the problem of aggregated,
misfolded, and, most likely, inactive L1. First, an attempt to simply purify the denatured
protein, and then refold it through a series of dialysis steps (independent communication
with Jingyi Fei) proved to be more difficult and less efficient than previously believed.
Thus, growth conditions, specifically temperature and media type, were varied in order to
limit the amount of protein in inclusion bodies created during overexpression (Review by
Sørensen and Mortensen, 2005). Four different growth media were examined: 1) LB,
2) LB + 0.5% glycerol, 3) Terrific Broth (TB), and 4) TB + 0.5% glucose. Each of these
media were inoculated with the same overnight cell culture and allowed to reach an
OD595= 0.8 before IPTG induction. Immediately after IPTG induction, the temperature
of the overexpression was either left at 37 °C or dropped to 20 °C, resulting in a total of
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eight growth conditions; however, TB growth medium in the absence of 0.5% glucose
resulted in no protein expression, and thus no further analysis was done using this
medium, leaving six conditions.

After an overnight overexpression, the cells were

centrifuged to obtain the cell pellet, which was resuspended and the cells were lysed via
French Press as described in 2.2.3.2.1. The insoluble cellular material was separated from
the soluble protein via centrifugation, and both the insoluble pellet, and the soluble
supernatant were analyzed on an SDS-PAGE gel (Figure 3.3). It is apparent that, aside
from the TB media, the other media (LB, LB + 5% glycerol, or TB + 5% glucose) does
not have a big influence on overexpression; however, the temperature decrease during
overexpression strongly increases the amount of soluble protein produced. All further
overexpressions were performed in LB media simply because other growths in the lab
use LB media, and therefore, sterilized media is readily available. Also the
overexpressions were at 20 °C after addition of IPTG to limit the inclusion bodies.

3.3.2 Optimization of L1 Purification
To facilitate purification, the E. coli L1 construct used in this work is equipped
with a 10x-His-tag on the N-terminus. Initial purification was performed much like the
other His-tag purifications in the lab by utilizing the Ni2+-NTA resin (Qiagen); however,
after optimization, a Co2+ based resin (TALON, Clontech) was determined to provide
better coordination to the polyhistidine tags. Further, along with lysis by French press, a
lysis procedure utilizing a commercially available protein extraction kit called Bug
Buster® Master Mix (Novagen) was tested for opening the cells.
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3.3.2.1 Metal Affinity Resin Optimization
Initially the same amount of harvested L1 overexpressed cells was resuspended
and lysed using the French press, and the soluble proteins were purified by running the
supernatant through either Ni2+-NTA resin, or TALON resin. The His-tagged L1 protein
bound to the resin, and was eluted by an increasing amount of imidazole in a stepwise
gradient using (25, 50, 150 and 300 mM imidazole). The resulting fractions were run on
a 12% SDS-PAGE gel to determine which fractions contain the pure, eluted, His-tagged
L1 (Figure 3.4 A, B). In accordance with the gels, the TALON resin provides a better
purification and separation of the L1 from the other soluble proteins. The TALON resin
inherently provides a better environment for both binding of only the His-tagged protein
and purified elution. The Co2+ core specifically binds only histidines that are neighboring,
essentially eliminating the amount of nonspecific binding of other proteins to the resin.
Since only the His-tagged protein binds the resin, the elution conditions can be less
stringent resulting in a more highly purified sample.
3.3.2.2 Cell Lysis Optimization
In order for the soluble proteins to be harvested, the cell must first be lysed, and
cell debris must be separated from the proteins. There are numerous ways to lyse the
cell; however, I utilize two different methods, French press and Bug Buster® Master Mix,
in order to obtain the soluble protein. Both cell lysis methods result in soluble L1 that is
ready to be purified though the TALON resin. The advantage of the French press is that
it is cost efficient and is able to handle large volumes of cell re-suspension; however,
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sometimes for analytical studies only a small volume is needed, in these cases the Bug
Buster® Master Mix is the best choice because it is quick and does not require use of a
large instrument. In Figure 3.4 B and C, the SDS-PAGE gel clearly shows pure protein
elutions after both French press and Bug Buster® Master Mix treatment.

The

preliminary purifications were done using wild type L1; however, the L1 mutants
described below were all purified in a similar manner, and the pure mutant proteins were
labeled with maleimide dyes without the need for further optimization (Table 3.1).
3.3.2.3 MALDI Analysis of Pure and Labeled Mutant L1 (T202C)
The molecular masses of purified T202C-L1 samples, both labeled with Cy5maleimide and unlabeled were determined by MALDI (Figure 3.5). MALDI of the
unlabeled T202C-L1 resulted in a strong peak at 27,296 Da in strong accordance with the
theoretical molecular weight of the mutant L1 with 10x His-tag and linker. Further, the
Cy5 labeled T202C-L1 resulted in 2 peaks, one indicating the unlabeled portion of the
sample at 27,296 Da, and the other indicating the labeled sample with a molecular weight
of 28,045 Da. The increased molecular weight of ~750 Da corresponds to the molecular
weight of the added Cy5-Maleimide dye (Section 2.1.2).

3.3.3 Optimization of Ribosome Reconstitution with Mutant and Labeled L1
Odom and coworkers first performed the reconstitution of fluorescently labeled
L1 into the ribosome in 1990, when they added a fluorescein-L1 to 50S subunits (Odom
et. al., 1990). Using their protocol as a guide, the optimal conditions of the reconstitution
for the mutant and fluorescently labeled L1 were determined; however, many factors play
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a role in determining the best protocol for reconstitution. For instance, reconstitution into
–L1 70S tight coupled ribosomes has the advantage of saving a week’s worth of time by
not having to separate the ribosome into subunits; however, as mentioned previously,
checking reconstitution efficiency is then not possible with SDS-PAGE because of the
similar molecular weights of L1, S2, S3, and S4, although, this is not a problem when
using fluorescently labeled L1.

As was discovered during the optimization,

reconstituting –L1 70S has the additional problem of non-specific binding of L1 to other
locations on the ribosome, resulting in false positive results for reconstitution.
3.3.3.1 –L1 70S Reconstitution
As seen in section 2.2.3.3.4, ribosome reconstitution involves an incubation of an
excess of either WT, mutant, or fluorescently labeled L1 with –L1 ribosomes, followed
by a sucrose cushion to remove any excess L1 and/or fluorescent dye.

Initial

reconstitution was attempted on –L1 70S with T202C-L1 (Cy5), and the reconstitution
efficiency was measured by A260 (for ribosome) : A652 (for Cy5), allowing the
measurement of the amount of Cy5 per ribosome (~0.7-0.8 : 1). However, as it was
alluded to earlier, reconstitution could not be monitored by SDS-PAGE gel, and therefore,
a direct measurement of L1 : 70S could not be obtained. In order to determine if the L1
protein was indeed being reconstituted, and to rule out that either the Cy5-L1 or the Cy5
alone was binding non-specifically to the ribosome, the reconstituted 70S was separated
into 50S and 30S subunits by decreasing the Mg2+ concentration, and then separating the
subunits via a sucrose gradient. Upon SDS-PAGE analysis of the subunits, it became
apparent that L1 was indeed not being correctly reconstituted into the –L1 70S, and was
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in fact only binding transiently, resulting in a false positive for Cy3:70S, that was not
actually reconstitution (Figure 3.6). Thus, reconstitution into –L1 50S and then subunit
association with 30S is necessary in order to obtain the correctly reconstituted ribosomes.
3.3.3.2 –L1 50S Reconstitution
Reconstituting L1 into –L1 50S has the distinct advantage of allowing monitoring
via SDS-PAGE gel analysis because there are no other 50S subunit proteins that have a
molecular weight close to that of L1; therefore, SDS-PAGE analysis provides a very nice
reporter of the reconstitution efficiency of the reaction. The efficiency can be directly
determined by comparing the band density of the reconstituted L1 to the band density of
L2. This ratio can be compared to the L1:L2 ratio in a wild type 50S subunit, and the
closer these two numbers become, the better the reconstitution (Table 3.2). With this in
mind, the optimal conditions necessary for reconstitution were determined, specifically,
incubation time, L1 : -L1-50S ratio, and incubation temperature.
T202C-L1 mutants were reconstituted into –L1 50S subunits in a ratio of 2:1 and
incubated at 37° C for 5, 10, 15, and 30 min, before being purified through a sucrose
cushion, and analyzed on a 12% SDS-PAGE gel (Figure 3.7). As evidenced from the gel,
the reconstitution efficiency reached a maximum at 15 min; therefore, all future
reconstitutions were incubated for 15 min (Table 3.2).
Because the –L1 50S can be made on a larger scale, pure mutant L1 or pure
mutant fluorescently labeled L1 is a limiting reagent when determining how much
reconstituted ribosomes can be made. Thus, in order to limit waste, it was important to
determine the most efficient ratio of L1 to –L1-50S for reconstitution. T202C-L1 and –
"#!
!

L1-50S were combined in ratios of: 1:0 (control), 1:1, 2:1, 3:1, and 5:1, and incubated for
15 min at 37 °C before being purified by centrifugation through a sucrose cushion, and
analyzed on a 12% SDS-PAGE gel (Figure 3.8). As expected, the control that only
contained T202C-L1 did not pellet through the cushion, ensuring that all the L1 seen in
the gel is indeed reconstituted in the ribosome. Further, the reconstitution efficiency
reached approximately 90-100% when starting with a two times excess of L1 over –L1
50S. The efficiency only increased a little bit when adding three times excess, and then
plateaued (Table 3.2).
Even though a reconstitution efficiency of approximately 100% was reached
using an incubation with a 3 times excess of L1 at 37 °C for 15 min, it would be useful to
obtain a similarly highly reconstituted sample using less L1. Therefore, a 1:1 ratio of
T202C-L1 to –L1 50S was used and incubated for 15 min at 25 °C, 37 °C, and 45 °C,
followed by purification through a sucrose cushion.

The resulting reconstituted

ribosomes were analyzed on a 12% SDS-PAGE gel, and it was determined that changing
the incubation temperature does not result in further reconstitution; therefore, it is
necessary to use a 2-3 fold excess of L1 (depending on availability of L1) in order to
obtain approximately 100% reconstitution (Figure 3.9, Table 3.2).
In addition to using the mutant T202C-L1 and T202C-L1 (Cy5), reconstitutions of
S40C-L1 (Cy3), K54C-L1 (Cy5), V177C-L1 (Cy3), V221C-L1 (Cy3) were all done with
a 2 times excess of L1 : 50S and incubated for 15 min at 37 °C (Figure 3.10). These
samples were all analyzed by SDS-PAGE for reconstitution efficiency, and
spectrophotometrically for label per 50S (Table 3.1). All the labeled mutants besides the
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S40C-L1 (Cy3) were able to be adequately reconstituted into the –L1 50S, and were used
for further equilibrium FRET experiments (See Appendix).
Previously, it had been shown the ribosomes lacking L1 resulted in lower binding
of initiator tRNA. In order to test the functional activity of the reconstituted ribosomes,
an assay was designed to determine the binding of [35S]-fMet-tRNAfMet to the
reconstituted ribosomes.

As seen in Figure 3.11, initiator tRNA binding to –L1

ribosomes was very low, but binding was recovered to near wild-type efficiency when
using the fully reconstituted ribosomes.

As expected, the complexes made with

ribosomes supposedly reconstituted with S40C (Cy3), did not regain binding efficiency.

3.4 Discussion
The ability to effectively and efficiently reconstitute a site-specifically labeled L1
into a ribosome is a very useful tool for the future investigation of tRNA progression
through the ribosome. Fluorescently labeled L1 on the ribosome has been previously
used for single molecule work in other labs; however, their methods of expression,
purification, and reconstitution proved to be too inefficient for use on the much larger
scale that is necessary for ensemble work. By optimizing all the steps to work in our
facilities, creating a probe to monitor tRNA near the exit site of the ribosome is now a
very simple task. Fluorescently labeled L1 is currently being used for both ensemble
FRET studies (Cy5), as well as single molecule studies (Cy3).

Further, work is

progressing using the fluorescent ribosomes to monitor translation in a cell free
transcription/translation system.
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The overexpression of L1 was initially tested on the wild type L1 obtained from
Dr. Robert Zimmermann; however, after expression was optimized, the single site
directed mutant L1 (S40C, K54C, V177C, T202C, V221C), was overexpressed with
similar results as the wild type. The overexpression of the wild type L1 along with all 5
mutants initially resulted in very high levels of inclusion body formation, which was also
noted in Fei et al., 2008. Fei and coworkers were able to overcome this by purifying the
denatured insoluble L1 and then refolding after purification; however, for our needs, this
process was deemed inefficient. By simply lowering the temperature of the growth after
induction with IPTG, the amount of soluble L1 was increased dramatically, allowing the
purification of active, soluble L1 for use in future studies. As mentioned above, inclusion
bodies typically result from misfolded proteins, not necessarily unstable proteins;
therefore, by lowering the growth temperature and essentially slowing down the
overexpression, we were able to limit the amount of misfolded proteins, resulting in more
soluble L1.
Purification of the wild type, S40C, V177C, and V221C was attempted using the
Ni-NTA resin, but the purification using this procedure was very poor.

Therefore,

purification was moved to the TALON resin system for all five mutant L1 samples. The
use of the TALON cobalt resin resulted in much cleaner purification, and therefore, a
higher yield of usable protein. The better purification with the TALON resin is most
likely attributed to the inherently better coordination of the cobalt metal ion to the resin,
resulting in more specific binding of polyhistidine residues, and limiting the nonspecific
binding of proteins or peptides containing native histidines.
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Initial studies were performed using the S40C, V177C, and V221C mutants (see
Appendix); however, it became obvious that the most viable mutant for my studies was
the T202C-L1 mutant. The S40C-L1 mutant did not reconstitute into –L1 50S to a high
enough extent (Table 3.1, Figure 3.11); and the V177C-L1 (Cy3) and V221C-L1 (Cy3)
mutants showed limited FRET efficiency changes when analyzed with fMet-tRNAfMet
(Rhd110). However it is very possible that, using what we currently have learned with
the T202C-L1 (Cy5) mutant, the V177C and V221C mutants could still be very viable
options for P- and E-site probes in the future. Further, very promising preliminary results
have been seen with the K54C-L1 (Cy5) mutant, in which it can be easily labeled and
reconstituted into –L1 50S, and has also shown the ability to act as a probe for P- and Esite tRNAs, possibly in a different manner than the T202C-L1 mutant.
Nonetheless, throughout this thesis the T202C-L1 (Cy5) ribosome is utilized to
measure FRET changes from Cy3 labeled initiator tRNA. In separate single molecule
work, T202C-L1 (Cy3) ribosomes are used with Cy5 and Cy5.5 labeled tRNAs. In both
cases, the reconstitution of T202C-L1 (Dye) to ribosomes is very close to 1:1 and the
label to ribosomes is solely dependent on the labeling efficiency of the dye to L1
(typically 0.6-0.8).

Further, a functional assay in which the binding of [35S]-fMet-

tRNAfMet to –L1 ribosomes, MRE-600 wild type ribosomes, or reconstituted ribosomes
was measured, and proved that the reconstitution described above results in a ribosome
that actively binds initiator tRNA to an extent similar to the wild type ribosome. tRNA
binding per ribosome appears to be less than one because of the low (~30%) charging
efficiency of the [35S]-fMet-tRNAfMet in addition to the notion that the undetectable
tRNAfMet also binds to the P-site.
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3.5 Conclusion
We have developed a method to efficiently overexpress, purify, label, and
reconstitute ribosomal protein L1 into a –L1 strand of ribosomes, allowing us to use the
labeled L1 as a probe for measuring tRNA movement on the ribosome as it approaches
the exit site. The labeled ribosomes are currently being used in ensemble as well as
single molecule two and three color FRET experiments. By optimizing the steps leading
to the site specifically labeled L1 in the ribosome, we were able to obtain a large amount
of L1-labeled ribosome in order to do multiple ensemble studies without having to go
through the process of overexpressing and purifying the L1 on a regular basis. The
method for limiting inclusion bodies during expression is dependent of the protein being
studied; however, the use of TALON resin for purification is most likely universally
better and has been applied to the purification of other His-tagged proteins in the lab
including EF-Tu, L11, and the initiation factors.
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L1

Purification
Efficiency
(mg/L)

Cy:L1 Labeling
Efficiency

Cy:50S
Reconstitution
Efficiency

Approximate
L1:50S
Reconstitution
Efficiency

Wild Type

2.3 ± 0.2

N/A

N/A

1:1

S40C

1.3 ± 0.7

Cy3: 0.7 ± 0.2

0.5 ± 0.1

0:1

K54C

2.3*

Cy5: 0.5 ± 0.1

0.5 ± 0.2

1:1

V177C

1.3 ± 0.3

Cy3: 0.60 ± 0.05

0.6 ± 0.1

1:1

T202C

1.5 ± 0.5

Cy5: 0.6 ± 0.2

0.6 ± 0.2

1:1

V221C

0.7 ± 0.3

Cy3: 0.6 ± 0.2

0.6 ± 0.1

1:1

$%&'()*+!,-./0.!1/2!3045!6-7898:;!30:!.8,:<!

Table 3.1 Purification, Labeling, and Reconstitution Efficiency for L1
Preparations
The wild-type L1 and L1 mutants were overexpressed for 18 hours in LB media at
25 °C. The cells were opened with French Press and purified using TALON (Co2+) resin
yielding the above efficiencies of pure protein to amount of overexpression media. The
mutant L1 samples were labeled with Cy maleimide dye and efficiency was measured
spectrophotometrically. The mutant, labeled L1 samples were then reconstituted into –
L1 50S subunits by incubation with a 2x excess of L1 at 37 °C for 15 min.
Reconstitution was measured spectrophotometrically to obtain the Cy:50S ratio, and by
SDS-PAGE analysis to obtain the approximate L1:50S efficiency. All but the S40C-L1
mutant reconstituted to almost 100% when measured by L1:50S, and the Cy:50S
efficiencies were typically limited by the labeling efficiency of the L1.
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Incubation Time
Reconstituted L1:L2
Reconstitution
(min)
Band Density Ratio
Efficiency*
5
0.33
0.44
10
0.34
0.44
37 °C
2:1 (L1:50S)
15
0.51
0.68
30
0.22
0.29
Incubation L1 : 50S
Ratio
1:1
0.23
0.36
2:1
0.49
0.76
37 °C
15 min
3:1
0.65
1.0
5:1
0.68
1.0
Incubation
Temperature (°C)
25
0.21
0.28
1:1 (L1:50S)
37
0.20
0.26
15 min
45
0.28
0.38
$%&'()*+,+-+,()!.//,',&)'0!12*!3&+&45,)&3!60!%&'()*+,+-+&3!7#879!42+,(!3,:,3&3!60!
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Table 3.2 Band Density Analysis for the Various Reconstitution
Conditions.
The gels seen in Figures 3.7-3.9 were analyzed using the software Image J to
obtain the density of the bands corresponding to L1 and L2.
normalizing agent for ribosome concentration.
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L2 was used as a

A.

$%

B.
L1
!

!

Figure 3.1 pET-16b Cloning Vector for L1 Expression
L1 was cloned into the pET-16b E. coli vector using the 5’ Nde I and 3’ BamHI
cut sites to incorporate the L1 gene. The vector (A) contains an N-terminal 10x-His-tag
and the T7 promoter/terminator sequence for efficient overexpression. B) The expression
sequence highlights the important aspects of the vector, as well as indicates positions for
sequencing primers when determining accuracy of the mutations.
Figure is adapted from Novagen pET-16b vector manual.
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Figure 3.2 SDS-PAGE Analysis of Wild Type L1 During
Overexpression
An aliquot of 10 µL of growth media were collected and loaded onto a 12% SDSPAGE gel after IPTG induction. Lane 1: Purified wild type L1 (~20 pmol); Lane 2:
Aliquot of the growth media at OD595= 0.8, immediately prior to addition of IPTG; Lane
3-7: aliquots of the protein overexpression media after 1, 2, 4, 6 and 20 hours following
the addition of IPTG.

The band corresponding to L1 (approximately 27,000 Da)

increases as the overexpression time increases, leading to a maximum amount of protein
after overexpression for at least 20 hours. Protein amounts for overexpression times
longer than 20 hours were not determined.
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Figure 3.3 SDS-PAGE Analysis of Soluble L1 Created by Growth at
Different Buffer Conditions
Overexpression of L1 results in soluble active L1 and/or denatured inclusion
bodies of L1. Multiple growth media (A: Luria Bertani (LB); B: LB + 5% Glycerol, C:
Terrific Broth + 5% Glucose) and temperatures (20 °C and 37 °C) were tested to
determine the optimum conditions for limiting inclusion bodies, and thus increasing the
amount of useful protein. After 18 hours of induction, the cells were harvested, opened,
and the soluble protein (Super) was separated from the cell debris and inclusion bodies
(Pellet) by centrifugation. A 10 µL aliquot of the supernatant was loaded to a 12% SDSPAGE gels (Lanes 2 and 4).

The pellet was resuspended in a denaturing buffer

containing 8 M Urea, and a 10 µL aliquot was taken and loaded onto the gels (Lanes 3
and 5). In addition to a protein standard (A: Lane 6), a previously purified wild type L1
sample was added as a marker for L1 (Lane 1). As evidenced in all three growth media,
the amount of soluble L1 is increased when the protein is overexpressed at 20 °C. It
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should be mentioned that a fourth growth media, Terrific Broth, was tested but resulted in
no protein overexpression, and thus is left out of this comparison.
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Figure 3.4 SDS-PAGE Analysis L1 Purification Techniques
After overexpression, the cells were opened by French Press (A and B) or Bug
Buster® Master Mix (C). Either a TALON Co2+ column (B and C) or Ni2+-NTA column
(A) was used to bind the His-tag of the overexpressed L1. A stepwise gradient of 25 mM
to 300 mM imidazole (25, 50, 150, 300 mM) was used to elute the L1 from the column,
1-mL fractions were collected and 10 µL aliquots were loaded to a 12% SDS-PAGE gel
for analysis. A previously purified L1 sample was used as a marker (Lane 1), and a
protein standard was also used in B: Lane 8, and C: Lane 15. As is evidenced by the
gels, the TALON resin (B and C) provided a more pure L1 sample, and both French
Press and Bug Buster ® Master Mix were viable options for opening the cells.
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Figure 3.5 MALDI Analysis of T202C-L1 and T202C-L1 (Cy5)
MALDI analysis was performed on T202C-L1 (Peak 1) and T202C-L1 (Cy5)
(Peak 2) using sinapic acid as the matrix on a Bruker Daltonics MALDI TOF MS.
Approximately 4-8 pmol of protein was combined with excess sinapic acid in order to
obtain the peaks. Peak 1 corresponds to the unlabeled T202C-L1 with a molecular
weight of 27296, and the shaded region represents the unlabeled portion of T202C-L1
(Cy5). Peak 2 represents the labeled portion of T202C-L1 (Cy5) with a corresponding

"#!
!

molecular weight of 28045, approximately 750 Da higher than the unlabeled peak.
Corresponding directly to the molecular weight of the Cy5 maleimide dye.
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Figure 3.6 SDS-PAGE Analysis of Reconstituted 70S Ribosomes and
Subunits
Approximately 20 pmol of ribosomes were loaded onto a 12% SDS-PAGE gel to
analyze the presence or absence of L1 after a reconstitution into –L1 70S and subsequent
subunit separation. T202C-L1 (Cy5) was reconstituted into –L1 70S and purified by
centrifugation through a sucrose cushion. The ribosome pellet was resuspended in buffer
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containing 1 mM Mg2+ in order to separate the subunits, and then the subunits were each
purified through a sucrose gradient in order to obtain pure 30S and pure 50S. The
purified 50S (Lane 4) was shown to not contain L1, and therefore to not have actually
been reconstituted. Lane 1: wild type 70S; Lane 2: -L1 70S, take note that it is difficult
to see that L1 is missing due to the presence of either S2, S3 and/or S4 which have
similar molecular weights as L1; Lane 3: T202C-L1 (Cy5); Lane 4: Purified 50S
subunits from the reconstitution of T202C-L1 (Cy5) and –L1 70S, notice that there is no
band corresponding to L1; Lane 5: Purified wild type 50S subunits from wild type 70S;
Lane 6: Protein standard.
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Figure 3.7 SDS-PAGE Analysis of Incubation Time During T202C-L1: L1 50S Reconstitution.
Approximately 20 pmol (unless otherwise noted) of 50S subunits were loaded to a
12% SDS-PAGE gel. T202C-L1 was added in excess to –L1 50S subunits and incubated
for 5, 10, 15, or 30 min at 37 °C, followed by purification through sucrose cushion
centrifugation (Lanes 1-4). Lane 5: MRE-600 50S (~50 pmol); Lane 6: MRE-600 50S;
Lane 7: -L1 50S incubated without L1 for 15 min. The apparent density around where L1
appears is caused by contaminating 30S ribosomal protein either S3 or S4 (the presence
of contaminating S30 is confirmed by the presence of a slight amount of S1 at
approximately 65 kDa, not shown); Lane 8: T202C-L1 incubated without ribosomes or
subunits for 15 min, but not centrifuged; Lane 9: Protein standard. It should be noted
that the L1 band in Lanes 1-4 and 7 has a higher molecular weight than that of the MRE600 50S because the purified mutant L1 contains a 10x-His-tag in addition to a linker
between the tag and the protein. Band density analysis of the L1 band was normalized to
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the density of the L2 band to determine reconstitution efficiency. The ratio of L1:L2
band density was used as a measure of reconstitution efficiency, and normalized to the
L1:L2 ratio of the wild type 50S (see Table 3.2).
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Figure 3.8 SDS-PAGE Analysis of Reconstitution Ratio of T202C-L1
and –L1 50S Subunits
Approximately 20 pmol of 50S subunits were loaded onto a 12% SDS-PAGE gel,
and the reconstitution or T202C-L1 into –L1 50S was analyzed based on the L1:L2 band
density ratio, normalizing to the MRE-600 50S L1:L2 band density. T202C-L1 was
incubated with –L1 50S for 15 min at 37 °C at increasing ratios of T202C-L1 : -L1 50S,
and purified through a sucrose cushion centrifugation. Lane 1: 40 pmol of T202C-L1
was incubated without 50S subunits, and centrifuged through the sucrose cushion as a
control to ensure that L1 does not pellet on its own; Lanes 2-5: Increasing ratios of
T202C-L1 to –L1 50S; Lane 6: T202C-L1; Lane 7: -L1 50S; Lane 8: MRE-600 50S;
Lane 9: Rainbow Molecular Weight Marker; Lane 10: Protein standard. Although the
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L1 band may appear darkest for the 5:1 reconstitution, the ratio of L1:L2 is the same for
the 3:1 reconstitution, and only slightly lower for 2:1; therefore, further reconstitutions
were performed at either 2:1 or 3:1.
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Figure 3.9 SDS-PAGE Analysis of Incubation Temperature on the
Reconstitution of T202C-L1 with –L1 50S
T202C-L1 was incubated with –L1 50S at a ratio of 1:1 for 15 min at various
temperatures in order to determine if complete reconstitution could be achieved while
using less L1. After reconstitution, the samples were purified through sucrose cushion
centrifugation and loaded (~20 pmol) onto a 12% SDS-PAGE gel.

Although

reconstitution occurred, the ratio of L1:L2 was not increased by varying temperature;
therefore, a beginning ratio of T202C-L1 : -L1 50S of ! 2:1 must be used to achieve 1:1
reconstitution.
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Figure 3.10 SDS-PAGE Reconstitution Analysis of Wild Type L1 and
Cy-Labeled Mutant L1
Wild type, S40C (Cy3), K54C (Cy5), V177C (Cy3), T202C (Cy5), and V221C
(Cy3) L1 was reconstituted into –L1 50S subunits by incubating a 2x excess of L1 with –
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L1 50S for 15 min at 37 °C. Approximately 30 pmol of reconstituted ribosomes were
added to a 12% SDS-PAGE gel for analysis. A) Ribosomes reconstituted with wild type
L1 (Lane 1), Cy3-S40C L1 (Lane 3), and Cy3-V221C (Lane 4) were run on a 12% gel,
notice that the S40C-L1 (Cy3) does not reconstitute into the –L1 50S subunits; therefore,
this mutant was no longer used. The wild type, and V221C-L1 (Cy3) reconstituted to
approximately 1:1. B) Ribosomes reconstituted with V177C-L1 (Cy3) (Lane 1) were
loaded to a 12% gel, and compared to MRE-600 50S (Lane 2 and 4), -L1 50S (Lane 3),
and V177C-L1 (Lane 5). The L1 band in the reconstituted sample runs higher than in the
MRE-600 50S sample because of the increased molecular weight due to the 10x His-tag,
linker, and dye in the L1 that is reconstituted, this trend is seen in all of the reconstituted
samples. C) Ribosomes reconstituted with Cy5-T202C-L1 (Lane 1) were loaded to a
12% gel, and compared to MRE-600 50S (Lane 4), -L1 50S (Lane 3), and T202C-L1
(Lane 2). D) Ribosomes reconstituted with K54C-L1 (Cy5) (Lane 1) were loaded to a
12% gel, and compared to MRE-600 50S (Lane 2), -L1 50S (Lane 3), and K54C-L1
(Lane 4).
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Figure 3.11 [35S]-fMet-tRNAfMet Binding to Ribosomes to Measure
Activity
30S subunits were incubated with an excess of 50S subunits, mRNA, and [35S]fMet-tRNAfMet for 5 min at 37 °C, followed by a filter binding to remove any unbound
tRNA, and analysis by radioactive counting. As seen here, ribosomes lacking L1, and
30S subunits without 50S have reduced tRNA binding efficiencies; however, upon
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reconstitution of V177C-L1 (Cy3), T202C-L1, T202C-L1 (Cy5), or V221C-L1 (Cy3)
with –L1 50S, the binding efficiency increases to almost wild type levels. However, as
indicated in the SDS-PAGE gel analysis, the S40C-L1 (Cy3) did not reconstitute in the –
L1 50S. Further, for the wild type subunits, binding is not 1:1 because of the low aminoacylation efficiency of the fMet-tRNAfMet, and the fact that initiator tRNA binds the Psite independent of its acylation state. Therefore, it is probable that the undetectable
tRNAfMet is also binding to P-site.
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Chapter IV: The Conditions that Affect
Deacylated-tRNA Movement After Translocation
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4.1 Abstract
The occupancy of the E-site has previously been postulated to be linked to fidelity
of cognate tRNA selection at the ribosomal decoding site, preserving the reading frame,
regulating programmed frameshifting, and determining the preference of the ribosome for
binding either EF-Tu or EF-G. Therefore, it is important to better understand how tRNA
behaves while in the E-site. Three experimental procedures were utilized in order to
determine how deacylated-tRNAfMet leaves the E-site of the ribosome. 1) The FRET
efficiency changes between T202C-L1 (Cy5) ribosomes and tRNAfMet (Cy3); 2) The
FRET efficiency changes between tRNAfMet (Cy3) and tRNAPhe (Rhd110); and to a lesser
extent, 3) The anisotropy loss from the translocated tRNAfMet (Cy3) as it dissociates from
the ribosome. When using 70SICs created with fMet-tRNAfMet (Cy3) in the P-site and
T202C-L1 (Cy5) ribosomes, the addition of ternary complex results in an increase in
FRET efficiency because of both the tRNAfMet (Cy3) adoption of a P/E-hybrid, and the
L1-stalk movement towards the body of the ribosome into a closed conformation. This
FRET efficiency is eventually lost when either the L1-stalk moves away, or the
deacylated-tRNA dissociates. Three different pathways were demonstrated that allow the
deacylated-tRNAfMet to dissociate from the E-site; 1) the L1-stalk moves away from the
body of the ribosome into an “out” conformation before the deacylated-tRNAfMet
dissociates; 2) the L1-stalk moves away at a similar time as the deacylated-tRNAfMet
dissociation; or, 3) the deacylated-tRNAfMet moves along with the L1-stalk into an
apparent E2-site as the L1 moves to the “out” conformation. In all the cases, the release
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of deacylated-tRNAfMet from the E-site proceeds at similar rates; however, the rates of
dissociation from E-site and E2 site are quite different.

4.2 Introduction
Ribosomal protein L1 was first observed as a biochemically relevant protein in
the early 1980s when Subramanian and coworkers discovered that ribosomes lacking L1
displayed a 40-60% reduced capacity for in vitro protein synthesis (Subramanian et al.,
1980). Later in the 1980s, it was discovered that L1 was important for the binding of
tRNA to the ribosomal P-site (Sander, 1982). A long period passed before Nikonov and
coworkers finally crystallized an isolated E. coli L1 in 1996, and it wasn’t until the early
2000’s that the structure of L1 on the ribosome really came into focus (Nikonov et al.,
1996; Valle et al., 2003; Yusupov et al., 2001; Selmer et al., 2006). With the known
structure came more biochemical work, specifically in the single molecule field when Fei
and coworkers used a labeled T202C-L1 to help determine the motions of a ratcheting
ribosome (Fei et al., 2008). In the present work, we determine how L1 movement relates
to the mechanism of deacylated-tRNAfMet dissociation from the E-site of the ribosome.
The L1-stalk, comprised of ribosomal protein L1 and helices 76-78 from the 23S
rRNA, is a highly mobile region of the 50S subunit. Previous X-ray crystallography and
cryo-EM work has shown that the movement of the L1-stalk is highly linked to both the
positions and acylation state of tRNAs on the ribosome. The L1-stalk occupies an “out”
state when the ribosomes have vacant E-sites or in isolated 50S subunits (Korostelev et
al., 2008; Harms et al., 2001). When deacylated-tRNA is bound in the E-site the L1"""!
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stalk moves inward by ~30-40 Å to the “in” conformation (Korostelev et al., 2006;
Selmer et al., 2006). A third position for the L1-stalk, the “overly closed,” determined by
Cornish and coworkers, occurs when the tRNA adopts a P/E-hybrid conformation, and
requires a further movement of ~15-20 Å towards the body of the ribosome. (Cornish et
al., 2009; Valle et al., 2003; Gao et al., 2003). It has been hypothesized that the L1stalk moves with the deacylated-tRNA as it moves from P/E to E/E-sites, and then has to
move to an “out” conformation in order for the deacylated-tRNA to release. The behavior
of deacylated-tRNA as it reaches the E-site is important because E-site occupancy has
been linked to accuracy at the decoding site (Nierhaus, 2006; Zaher and Green, 2009),
regulation of programmed frameshifting (Leger, M. et al., 2007; Liao, et al., 2008), and
determination of the preference for the ribosome to bind either EF-Tu or EF-G (Wilson
and Nierhaus, 2006). In the following work, I demonstrate that deacylated-tRNAfMet
leaves the E-site of the ribosome via at least three distinct pathways, each one favored by
different buffer conditions and peptidyl-state of P-site tRNA.
Results presented in Chapters II and III demonstrate that it is possible to prepare
reconstituted 50S ribosomes containing either labeled or unlabeled T202C-L1. Here, we
use these ribosomes, along with highly labeled tRNAs, to measure the FRET efficiency
and anisotropy changes associated with tRNA release from the E-site of the translocated
ribosome.
The highly mobile nature of the L1-stalk and the mobile nature of the deacylatedtRNA after translocation make it difficult to determine which physical movement the
FRET efficiency change is associated with; therefore, two different FRET efficiency
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measurements were taken: 1) FRET between the deacylated-tRNAfMet (Cy3) donor and
the T202C-L1 (Cy5) acceptor (L/t FRET); and, 2) FRET between the (fMet)-PhetRNAPhe (Rhd110) acceptor (which may or may not be present as a dipeptide depending
on the set up of the experiment) and the deacylated-tRNAfMet (Cy3). In a translocated
ribosome the (fMet)-Phe-tRNAPhe (Rhd110) is in the P-site and the deacylated-tRNAfMet
(Cy3) is, at least initially, in the E-site. The L/t FRET experiments provide information
about the movement of the L1-stalk relative to the deacylated-tRNAfMet; the t/t
experiment uses a relatively rigidly bound P-site tRNA ((fMet)-Phe-tRNAPhe) as a marker
for when deacylated-tRNAfMet leaves the E-site (loss of FRET efficiency) (See Section
4.3.2.1).
Preliminary fluorescence anisotropy measurements were utilized to monitor the
release of deacylated-tRNA from the ribosome, exploiting the decrease in anisotropy that
accompanies tRNA dissociation from the ribosome. Here, we were able to relate the
apparent rate constant for tRNA dissociation with values associated for the FRET
efficiency losses in order determine a distinct kinetic pathway for each set of conditions
(Buffer A, peptidyl-tRNA in the P-site after translocation from PRE-1 to POST-1; Buffer
B, peptidyl-tRNA in the P-site; and, Buffer B, aminoacyl-tRNA in the P-site). Our
results provide clear, biochemical evidence for a second E-site, the E’- or E2- site, that
may have initially been described by Robertson and colleagues in early biochemical data,
and incorrectly named the E-site (Robertson et al., 1986; reviewed by Burkhardt et al.,
1998). Later, cryo-EM work characterized the additional exit binding position as the E’or E2-site (Agrawal et al., 1999, Fischer et al., 2010).
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4.3 Results
4.3.1 L1 Interaction with tRNAfMet (L/t FRET)
FRET efficiency between T202C-L1 on the 50S subunit and either fMet-tRNAfMet
or tRNAfMet (depending on the progression of the elongation cycle) was measured using
T202C-L1 (Cy5) and (fMet)-tRNAfMet (Cy3). 70S initiation complexes (70SIC, 4.3.1.1),
pre-translocation complexes (PRE-1), and post-translocation complexes (POST-1,
Chapter 5), were made and utilized in the following work in order to better understand
what affects the release of deacylated-tRNAfMet after the first round of translocation. In
this chapter, except where noted, PRE-1 complexes were created and purified via sucrose
cushion centrifugation.
In order to establish preliminary FRET efficiency values between T202C-L1
(Cy5) ribosomes and fMet-tRNAfMet (Cy3), equilibrium FRET experiments were
performed on 70SICs, PRE-1, and POST-1 complexes (Figure 4.1, 4.2). 70SICs were
prepared in either Buffer A or Buffer B with D*A*: T202C-L1 (Cy5) ribosomes and
highly charged fMet-tRNAfMet (Cy3) initiator tRNA; D*A: T202C-L1 ribosomes and
fMet-tRNAfMet (Cy3) initiator tRNA; DA*: T202C-L1 (Cy5) ribosomes and fMettRNAfMet initiator tRNA; and, DA: T202C-L1 ribosomes and fMet-tRNAfMet initiator
tRNA and purified via sucrose cushion centrifugation; PRE-1 complexes were made by
adding excess ternary complex to the 70SICs, and POST-1 complexes were made by
adding excess ternary complex and EF-G to the 70SICs. Measurements were made in
parallel on the D*A*, D*A, DA*, and DA samples for each ribosome complex. The
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signal for the corresponding blank sample (DA) was subtracted from each D*A*, D*A,
and DA* to correct for light scattering and background fluorescence. The efficiency of
energy transfer was determined through acceptor fluorescence enhancement at 667 nm,
and calculated by equation 2.2, as seen in Table 4.1. Traces corresponding to D*A*,
D*A, and DA*, as well as, the fitted donor contribution, and the extracted acceptor
emission are seen in Figure 4.1 for Buffer A, and Figure 4.2 for Buffer B. Fitted donor
contribution is determined by multiplying the D*A fluorescence by the ratio of D*A* and
D*A at 567 nm, and the extracted acceptor was determined by subtracting the fitted
donor from the D*A* fluorescence. As evidenced in Figure 4.2, the apparent FRET
efficiency decreases approximately 2-fold upon addition of EF-G.GTP to a PRE-1
complex in Buffer B. According to previous single-molecule FRET efficiency studies
between tRNA and L1, there is no FRET efficiency change associated with translocation
(Fei et al., 2008). Therefore, I interpret the retention of FRET signal after translocation
as indicating that tRNA is not fully released from the POST-1 state. This is not seen in
Buffer A because the deacylated-tRNA is not stably bound in the E-site under these
conditions. Although equilibrium FRET experiments were not performed starting with
uncharged-tRNAfMet, Appendix 2 contains other examples for FRET efficiency changes
in Buffer A and Buffer B starting with 70SICs containing ~25% charged fMet-tRNAfMet.
Unlike the time-resolved studies seen later in this chapter (Section 4.3.1), apparent FRET
efficiency does not depend on initiator tRNA charging efficiency in Buffer B for
equilibrium experiments.
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4.3.1.1 FRET Increase Upon Addition of Ternary Complex to 70SIC (70SIC !
PRE-1)
In both Buffer A and Buffer B, a significant increase in FRET efficiency is seen
when a Phe-tRNAPhe.EF-Tu.GTP ternary complex (0.5 µM) is added to a 70SIC (0.1 µM)
containing fMet-tRNAfMet (Cy3) and T202C-L1-50S (Cy5). This is not only obvious in
the equilibrium FRET experiments (Figure 4.1 D, 4.2 D), but also in a time-resolved
stopped flow experiment where ternary complex (0.5 or 1.0 µM; Buffer A and Buffer B,
respectively) was added to the sucrose purified 70SIC (0.25 µM) (Figure 4.3). In the
equilibrium FRET experiments, the FRET efficiency calculated for the PRE-1 complex in
Buffer A and Buffer B was 0.73 and 0.90, respectively (Table 4.1, Equation 2.2). These
values are similar to the 0.8 that was shown for a PRE complex in previous single
molecule work. This work also showed that a deacylated-tRNAfMet in the PRE complex
would fluctuate between hybrid (FRET= 0.8) and classical states (Fei et. al., 2008).
Population of a high FRET state is observed in ensemble studies as a net FRET efficiency
increase between L1 and deacylated-tRNA on PRE-1 complex formation that is caused
by L1 movement towards the body of the ribosome and deacylated-tRNA adopting a P/E
hybrid conformational state.
4.3.1.2 FRET Efficiency Change Following Translocation (PRE-1 ! POST-1)
PRE-1 complexes were created and purified to remove any excess tRNA and
factors that are unbound to the ribosome. Previous single molecule work has shown that
the FRET efficiency between deacylated-tRNA in a P/E hybrid state and T202C-L1 does
not change during translocation because the L1 moves along with the elbow region of the
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tRNA (Fet al., 2008). In the L/t FRET experiments, the addition of EF-G.GTP (1.0 µM
unless otherwise noted) to purified PRE complexes (0.25 µM), results in a lag that can be
attributed to the rate-limiting translocation step in the majority of the experiments (k1app,
Table 4.2). In all experiments the rate constant for the lag associated with translocation is
between 3.3 s-1 for complexes in Buffer B, and 8 s-1 for complexes in Buffer A. For the
complexes in Buffer A, the translocation rate is in agreement with the previously
measured translocation rates upon addition of 1 µM EF-G.GTP, of ~7.8 s-1 (Pan et al.,
2007). Although, the translocation of mRNA has previously been shown to be similar in
both buffer conditions (Liu et al., 2010), a decrease in translocation rate by a factor of ~2
has been shown here for Buffer B and will be explained in the Discussion. Following the
lag, the rate and amplitude of L/t FRET efficiency loss are highly dependent on both
buffer conditions and the aminoacylation state of the tRNA occupying the P-site as seen
in Table 4.2.
The L/t FRET traces (as well as the t/t FRET traces seen in Section 4.3.2, and
anisotropy change traces seen in Section 4.4.3) were all initially fit to a triple exponential
curve using Scientist (MicroMath):

" kapp 1 t

y = y o + A1e

!

" kapp 2 t

+ A2 e

+ A3e

" k app 3 t

(Equation 4.1)

As mentioned earlier, the kapp1 in the L/t FRET experiments was attributed to the lag
between the L1 and the deacylated-tRNAfMet before separation occurs. Depending on the
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conditions, the major change in the FRET efficiency is represented by either kapp2 or kapp3
as seen below and in Table 4.2.
4.3.1.2.1 Buffer Conditions Affect Deacylated-tRNA-L1 Movement
Figure 4.4 directly compares the tRNA-L1 FRET efficiency loss between Buffers
A and B upon addition of EF-G.GTP (1.0 µM) to a PRE-1 complex (0.25 µM) containing
tRNAfMet (Cy3) and T202C-L1 (Cy5) that was made from a 70SIC using highly charged
fMet-tRNAfMet (Cy3). After a lag (kapp1), the fluorescence loss of the acceptor was
measured to determine the L/t FRET efficiency loss, after ~10 s the full FRET efficiency
is lost in Buffer A, as is evidenced by the D*A* sample reaching the same level as the
DA* sample (Figure 4.1, 4.4). The amplitude difference of the FRET efficiency change
between the two buffer conditions can be attributed to deacylated-tRNA binding to E-site
more tightly in Buffer B (Semenkov et al., 1996), so that, following translocation, it is
not fully released. Indeed, retention of FRET signal in Buffer B reflects the establishment
of an equilibrium between tRNA release (giving rise to a FRET efficiency loss) and
deacylated-tRNA rebinding (refer to section 5.3.2).
Buffer A contains 7.5 mM Mg2+ and no polyamines, and the lag phase
corresponding to translocation is k1app= 7.6 s-1; further, the major loss of FRET efficiency,
as indicated by the loss of acceptor fluorescence, has an apparent rate constant of kapp2=
4.71 s-1. In Buffer B, containing 4.5 mM Mg2+ and polyamines, the translocation rate is
slower (k1app= 3.6 s-1) and the major loss of FRET efficiency is also slower, with an
apparent rate constant of kapp2= 1.6 s-1. The loss of FRET efficiency can be accounted for
in two ways: 1) L1 movement away from the E-site tRNA and/or, 2) tRNA release from
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the ribosome. Because both labeled species, L1 and tRNA, are mobile, further
experiments need to be conducted to determine which is indeed causing the loss of FRET
efficiency. Distinguishing between these two possibilities is addressed later in this
chapter (Section 4.3.2).
4.3.1.2.2 Peptidyl State of P-site tRNA Affects Deacylated-tRNA-L1 Movement
The ability to aminoacylate a tRNAfMet to a very high level requires meticulous
work and HPLC separation to attempt to remove the uncharged tRNAfMet. To this date,
the best charging efficiency achieved for fMet-tRNAfMet was 70-80%. Non HPLCpurified samples reached ~30-40% charging.
In Buffer A, the charging efficiency of fMet-tRNAfMet, and thus occupancy of
peptidyl-tRNA in the P-site upon translocation, does not make a difference in rate of the
L1-tRNA FRET efficiency decrease (Figure 4.5, Table 4.2). However, it does make a
difference in the amplitude of the acceptor fluorescence change (Table 4.2).

The

amplitude of the fluorescence change increases approximately proportionally as the
charging efficiency increases (25% charging: 0.33, 70% charging: 0.65, 78% charging:
0.70).
A possible explanation is that the uncharged tRNAfMet does not bind to the P-site
as tightly, and thus does not survive the sucrose cushion purification of the PRE-1 state.
Direct evidence for this is seen when preparing the PRE-1 complexes from 70SIC
containing deacylated-tRNAfMet (Cy3). When the 70SIC complexes were prepared, half
were purified via centrifugation through a sucrose cushion, and the other half were
treated with ternary complex to make PRE-1 complexes, and then subjected to sucrose
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cushion purification. In both cases the ribosome pellets were resuspended in Buffer A,
and tRNAfMet (Cy3) in the 70SIC remained bound to the ribosome through the sucrose
cushion (~0.60 Cy3 / ribosome), whereas very little tRNAfMet (Cy3) was bound in the
PRE-1 complex (~0.06 Cy3 / ribosome) (Table 4.3, 70S IC: Row 1; PRE: Row 4),
indicating that the binding of deacylated-tRNAfMet to a P-site in a PRE-1 complex is less
stable than in a 70SIC.

Initially this result was surprising because previous single

molecule work has shown that FRET efficiency is retained between P-site deacylatedtRNAfMet and A-site Phe-tRNAPhe after purification through size exclusion spin columns
at varying concentrations of Mg2+ and no polyamines (Kim et al., 2007); however, the
above experiment has been repeated multiple times and deacylated-tRNAfMet continues to
be unstably bound. It is possible that sucrose cushion purification is more stringent than
size exclusion spin columns, and therefore, less stably bound tRNA is removed via
sucrose cushion, but not size exclusion columns.
In Buffer B both highly charged and completely uncharged initiator tRNAs
remain bound to PRE complexes at similar levels (~0.4-0.7 Cy3/70S, Table 4.3). It is
possible that the binding of a deacylated-tRNAfMet to the P-site in a PRE-1 complex is
stronger in Buffer B versus Buffer A, allowing the purification of a PRE-1 complex with
aminoacyl-Phe-tRNAPhe in the A-site in Buffer B, but not in Buffer A.
Using a PRE complex formed from a 70SIC containing uncharged tRNAfMet
(Cy3), in Buffer B, results in a P-site that is filled with aminoacyl-tRNA upon
translocation, and a biphasic change in the FRET efficiency between T202C-L1 (Cy5)
and tRNAfMet (Cy3). After the initial lag (kapp1) phase that follows EF-G.GTP addition,
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only a small fraction of the FRET efficiency loss is attributed to rapid tRNA release (kapp2
=1.17 s-1), and the major change is the second phase that occurs with an apparent rate
constant of kapp3 =0.022 s-1. Using a PRE complex formed with highly charged fMettRNAfMet (Cy3) results in a P-site that is filled with a peptidyl-tRNA upon translocation,
and after the initial lag (k1app), the first phase is the major change with an apparent rate
constant approximately 75 times faster (kapp2 = 1.6 s-1) than the major change seen when
aminoacyl-tRNA is in the P-site (kapp2 = 0.022 s-1) (Figure 4.6, Table 4.2).
In all three conditions: 1) Buffer A, 2) Buffer B, peptidyl-tRNA in the P-site, and
3) Buffer B, aminoacyl-tRNA in the P-site, the L/t FRET efficiency loss occurs in three
phases. For all three conditions, the first phase is a lag phase with a k1app similar to the
translocation rate. For conditions 1 and 2, the second phase is the major change in which
the L/t FRET efficiency decreases at a rate depending on the buffer (kapp2), and the third
phase is a smaller, slower loss of FRET efficiency that is attributed to slow tRNA release
(kapp3). However, in condition 3, the second phase is a small change where only a fraction
of the L/t FRET signal is lost, and the slower third phase is the much larger FRET
efficiency change.

4.3.2 tRNAfMet Interaction with Phe-tRNAPhe (t/t FRET)
The changes in L/t FRET efficiency, although interesting, do not provide enough
information in order to fully understand the tRNA movement and subsequent release of
deacylated-tRNAfMet after translocation. Definitive statements for the tRNA movement
in L/t experiments is difficult due to the inherent movements of both labels; therefore, a
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complex with a relatively stably-bound FRET donor in the P-site of a POST complex
(Phe-tRNAPhe (Rhd110)) was used to monitor movement of acceptor tRNAfMet (Cy3)
away from the P-site of the ribosome. Preliminary equilibrium FRET efficiency
measurements seen in Figure 4.7, were taken for purified PRE-1 complexes, and purified
PRE-1 complexes with EF-G.GTP (1 µM ), where the acceptor was limiting. The FRET
efficiency value was determined as above for the L/t experiments, except using
Cy3/Rhd110 as the FRET pair. The PRE-1 complex has a FRET efficiency of ~0.53 as
determined by equation 2.2 (Table 4.1), which is in agreement with previous single
molecule work (Chen et al., 2011).

For the kinetic experiments, PRE-1 complexes

were isolated using sucrose cushion centrifugation, and the t/t movement was measured
upon addition of EF-G.GTP (1.0 µM unless otherwise noted), and fit to equation 4.1. In
addition to monitoring the donor channel increase and acceptor channel decrease during
FRET efficiency loss, calculations were performed in order to eliminate contributions to
acceptor intensity due to acceptor fluorescence resulting from direct excitation from the
laser and donor fluorescence leakage into the acceptor channel (Equation 2.2, Section
2.2.7.2).
4.3.2.1 In Buffer A, L1 Moves Away From Deacylated-tRNAfMet Prior to tRNA
Release
A tRNA translocated from the A- to P- site remains in the P/P-site, and maintains
a fairly stable conformation, as seen in the X-ray crystallographic structure of a POST-1
complex with deacylated-tRNA in the P-site (B-factor = 86 Å2, indicating a rms
displacement of ~1 Å) (Gao et al., 2009). Also, Fischer and coworkers use cryo-EM to
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see three different POST complexes and there is no indication of movement in the P-site
tRNA between the complexes (Fischer et al., 2010). For these reasons, any loss in FRET
efficiency between tRNAfMet (Cy3) and fMet-Phe-tRNAPhe (Rhd110) should reflect
movement of tRNAfMet (Cy3) away from the P-site of the ribosome. 70SICs containing
fMet-tRNAfMet (Cy3) and T202C-L1 50S were incubated with ternary complex
containing Phe-tRNAPhe (Rhd110) to create PRE-1 complexes, which were subsequently
purified through sucrose cushion centrifugation. EF-G.GTP (1 µM) was stopped flow
added to the purified PRE-1 complexes (0.25 µM) in Buffer A; the resulting FRET
efficiency losses were monitored as acceptor fluorescence losses and were fit to a triple
exponential curve (Equation 4.1).

As seen in Figure 4.8, there is a brief initial lag in

which the FRET efficiency does not change which corresponds to kapp1, followed by the
major FRET efficiency decrease that occurs with an apparent rate constant of kapp2 = 1.4
s-1, approximately 3.5 times slower than the loss of L/t FRET efficiency under the same
conditions (Table 4.2). Therefore, when considering the major FRET efficiency changes
for the t/t and L/t experiments, it is reasonable to assume that the L1-stalk is moving
away from the deacylated-tRNAfMet prior to its release from the ribosome (see Discussion,
Scheme 4.1).
4.3.2.2 In Buffer B, the tRNA Release Pathway is Dependent on P-site Peptidyl-state
As seen before, the L/t FRET efficiency change in Buffer B depends heavily on
whether the P-site is occupied with fMet-Phe-tRNAPhe or Phe-tRNAPhe (Figure 4.6). In
contrast, Figure 4.9 shows that the t/t FRET efficiency change shows only weak
dependence on the P-site tRNA peptidyl state. The t/t FRET efficiency changes can be
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compared to the L/t FRET efficiency changes under the same conditions in order to better
understand the movement of the deacylated-tRNAfMet after translocation.
When EF-G.GTP is added to PRE-1 complexes containing tRNAfMet (Cy3) and
fMet-Phe-tRNAPhe (Figure 4.10 A), only a fraction of the t/t FRET signal is rapidly lost
(kapp1 = ~28 s-1), with the major loss of FRET efficiency having an apparent rate constant
of kapp2 = 1.6 s-1, approximately the same apparent rate constant as the major L/t FRET
efficiency loss seen under the same conditions (Table 4.2). Also, similar to the L/t FRET
efficiency loss, a slower minor FRET efficiency loss is seen with an apparent rate
constant of kapp3 = 0.20 s-1. The simplest model for understanding the major FRET
efficiency changes seen in the t/t and L/t experiments is that the deacylated-tRNAfMet loss
in FRET efficiency from L1 and from P-site peptidyl-tRNA is concomitant with the
release of deacylated-tRNA from the ribosome (Scheme 4.1, see discussion).
When EF-G.GTP is added to PRE-1 complexes containing tRNAfMet (Cy3) and
Phe-tRNAPhe (Figure 4.10 B,C), the t/t FRET efficiency changes are basically similar to
what is seen in Figure 4.10 A. They can still be fit to a triple exponential curve (Equation
4.1) with only a fraction of the t/t FRET signal is lost in the first rapid change (kapp1= ~17
s-1) and the major loss occurring in the second phase kapp2= 1.3 s-1, that is followed by a
slower (kapp3= 0.24 s-1) smaller loss. However, the L/t FRET efficiency changes are quite
different from what is seen in Figure 4.10 A, with the major L/t FRET efficiency loss
occurring >50 times slower than the major FRET efficiency loss associated with the t/t
FRET. Thus, the movement of deacylated-tRNA away from the P-site is at a rate that is
similar to the movement away in other conditions, but much faster than the loss in FRET
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efficiency from L/t. This indicates that the tRNA is remaining bound to the L1 stalk and
moving away from the E-site, possibly into a secondary E2-site that retains FRET
efficiency with T202C-L1, but loses FRET efficiency with P-site tRNA (Fischer et al.,
2010; Agrawal et al., 1999).

4.3.3 Fluorescence Anisotropy Change of tRNAfMet (Cy3) After Translocation
Fluorescence anisotropy is a useful tool for measuring of the apparent size of a
fluorescently labeled molecule. By using Cy3 labeled initiator tRNA, it was possible to
monitor the koff rates of the deacylated-tRNAfMet upon translocation in Buffer B. The
bound and free states of the tRNA each have an intrinsic polarization value: a higher
value for the bound state and a lower value for the free state; thus, by looking at the
decrease in anisotropy of the labeled tRNA it is possible to have a direct measurement of
tRNA release. Anisotropy measurements utilize four fluorescence intensities, and the
value is calculated by equation 4.2.

Anisotropy =

G=
!

I VV " GI VH
IVV + GI VH

Equation 4.2

I HV
!
I HH

!

Where, IVV stands for intensity with vertically polarized excitation and vertically
polarized emission, IVH stands for intensity with vertically polarized excitation and
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horizontally polarized emission, and so on. G is a measure of the sensitivity difference
between the two PMTs used for obtaining the data.
Initial equilibrium anisotropy measurements were taken on PRE-1 complexes
(bound), and POST-1 complexes (unbound) to determine the maximum loss of anisotropy
for the translocation and release, these experiments were performed in Buffer A to ensure
release, and the anisotropy loss was approximately 0.05±0.01, from 0.31 to 0.26
(Yuanwei Chen, work in progress). PRE-1 complexes were created using 70SICs that
were made with unlabeled T202C-L1 ribosomes and either deacylated-tRNAfMet (Cy3),
or highly charged fMet-tRNAfMet (Cy3) in Buffer B, and the anisotropy changes were
monitored upon stopped flow addition of EF-G.GTP (1.5 µM). As expected, the
anisotropy change for both complexes made with tRNAfMet (Cy3) and fMet-tRNAfMet
(Cy3) was significantly less than that seen in Buffer A due to the inherent equilibrium of
binding and release of deacylated-tRNA in the E-site in Buffer B as seen in the FRET
studies. Unfortunately, this led to difficulty in analyzing the overall anisotropy changes,
and this analysis is still ongoing. However, preliminary results show that in Figure 4.11,
the anisotropy change resulting from a POST-1 complex containing P-site Phe-tRNAPhe
mimics the major L/t FRET efficiency loss, with kapp3= ~0.052 s-1 (B) (Table 4.2).

4.3.4 Fitting of All Data to a Global Kinetic Scheme (EF-G Binding !
Translocation)
A major goal in this research was to find a general kinetic scheme for the release
of deacylated-tRNAfMet that would fit all the data obtained quantitatively. In order for the
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scheme to be valid, not only did the data collected here need to fit properly, but also the
results of previous work needed to be accommodated. Rates of EF-G.GTP binding,
hydrolysis, and conformational change were all first performed by Savelsbergh and
coworkers at 37 °C (Savelsbergh et al., 2003); however, since the work shown here is at
25 °C, the following results have been used (Pan et al., 2006). At 25 °C in Buffer A with
coumarin labeled EF-G, EF-G.GTP binding and dissociation occur at rates of 30 µM-1 s-1
and 25 s-1, respectively, and binding is followed almost immediately by hydrolysis at
~100 s-1 (Seo et al., 2006; Pan et al., 2006; Pan et al., 2007). Conformational change
within the EF-G.GDP.Pi complex follows hydrolysis and occurs at ~30 s-1. This
conformational change is indistinguishable from a tRNA movement creating a P/E
complex, as both steps are inhibited by thiostrepton (ThS) and occur at similar rates (Seo
et al., 2006, Pan et al., 2007). A very fast conversion from the P/E complex to an INT
complex directly precedes translocation.
4.3.4.1 Varying EF-G Concentration
In order to better understand the early steps of EF-G.GTP addition to a PRE-1
complex, increasing concentrations of EF-G.GTP were added to the PRE-1 complexes
discussed above, and the FRET efficiency changes were monitored. In all cases (A, B,
and C), the curves were fit to the global Scheme 4.1, where the hydrolysis and
conformational change steps leading up to translocation described above were combined
into k3. When fitting the concentration dependent data to Scheme 4.1, k4 through k9 were
held constant and the data for k1 though k3 were fit to the Scheme. In Buffer A (A), at
higher concentrations of EF-G (2.0-5.0 µM) a very rapid (~ 29 µM-1 s-1) increase in
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FRET efficiency is seen (Figure 4.12 A) upon binding of EF-G.GTP. At lower EF-G
concentrations (0.5-1 µM) this increase is only seen as a lag because the higher FRET
intermediate does not have time to build up before L1 movement. Further, the GTP
hydrolysis and conformational change steps are combined into (k3), and result in a rate
constant of ~25 s-1 (Tables 4.4, 4.5).
In Buffer B, using PRE-1 complexes created with 70SICs containing highly
charged fMet-tRNAfMet (Cy3) and T202C-L1 (Cy5) ribosomes, only two EF-G
concentrations were examined, but both were fit to Scheme 4.1 as above (Figure 4.12 B).
Under these conditions, addition of 5 µM EF-G results in a small increase in FRET
efficiency. The rate constant for the binding was determined to be ~44 µM-1 s-1, and k3 =
25 s-1 (Tables 4.4, 4.5).
In Buffer B, using PRE-1 complexes created with 70SICs containing deacylatedtRNAfMet (Cy3) and T202C-L1 (Cy5) ribosomes, increasing concentrations of EF-G were
added to the PRE-1 complex (Figure 4.12 C). The curves were all fit to the global
Scheme 4.1, as above, where k4-k9 were all held constant. Like in Buffer A, the binding
of EF-G resulted in an increase in FRET efficiency (k1= ~26 µM-1 s-1) at higher
concentrations, and a k3 of ~25 s-1 (Tables 4.4, 4.5).

4.3.5 Fitting of All Data to a Global Kinetic Scheme (Translocation Through
Deacylated-tRNA Release)
The results obtained by the EF-G concentration dependence studies for the early
steps after EF-G addition were set into Scheme 4.1, and the remaining steps k4-k9 were
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determined by fitting the L/t and t/t FRET traces from Figure 4.8 and Figure 4.10 to the
global Scheme 4.1. The results from these fittings are seen in Tables 4.4, 4.5, and
summarized below.
4.3.5.1 Global Fitting of Deacylated-tRNA Release in Buffer A
Scheme 4.1 represents the steps leading up to deacylated-tRNA release from the
ribosome after addition of EF-G.GTP. From what we know about the triple exponential
fits of the L/t and t/t FRET efficiency data in Buffer A, tRNA release should follow
pathway 1 with the rate constants k6 and k8 dominating the L/t and t/t FRET efficiency
changes, respectively. As seen in Figure 4.13 A and Table 4.4, initial translocation
occurs with a rate constant of k4= 8.2 s-1, and after reaching a POST-1 state, the rate
constant k6= 5.10 s-1 corresponds to the movement of the L1-stalk into an out position,
followed by deacylated-tRNAfMet release via a rate constant k8= 1.07 s-1. Additionally, in
both t/t and L/t FRET experiments, a slower release follows pathway 2, and is seen as k5
= 0.65 s-1. It can be said that the deacylated-tRNA release follows a dominant pathway 1,
but there is also a minor pathway 2, in which less deacylated-tRNA is released with a
slower rate.

4.3.5.2 Global Fitting of Deacylated-tRNA Release in Buffer B (Peptidyl-tRNA in
the P-site)
Using what was learned by fitting the L/t and t/t FRET experiments to a triple
exponential curve above (Figure 4.10 A), both sets of data were fit to Scheme 4.1,
holding k1 – k3 constant with values observed above (4.3.4.1). After translocation (k4 =
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3.34 s-1), the majority of the release of deacylated-tRNAfMet followed pathway 2, and was
dominated by the rate constant k5= 1.60 s-1, with very little release following any of the
other pathways as seen in Figure 4.13 B, and Table 4.4. It should be noted, that since the
initial charging efficiency of the fMet-tRNAfMet was 78%, approximately 22% of the
ribosomes still contain aminoacyl-tRNA in the P-site after translocation; therefore, it is
possible that a small fraction, undetectable in this Scheme, is following pathway 3, as
described below.
4.3.5.3 Global Fitting of Deacylated-tRNA Release in Buffer B (Aminoacyl-tRNA in
the P-site)
The rate constants obtained by fitting the L/t and t/t FRET traces to triple
exponential curves above (Figure 4.10 B, C), shows that in global Scheme 4.1 the
majority of the release of deacylated-tRNAfMet follows pathway 3, in which the
deacylated-tRNA moves out along with the L1-stalk and is then slowly released (k7 and
k9). Indeed, when the L/t and t/t FRET traces were fit to Scheme 4.1, the major release
was seen by k7= 1.30 s-1 and k9= 0.020 s-1, with a minor release being seen via pathway 2,
k5= 0.74 s-1 (Figure 4.13 C, Table 4.4).

4.4 Discussion
Both the Cy5-labeled and unlabeled T202C-L1 ribosomes have been shown to be
readily accessible and able to bind initiator tRNA to near wild type efficiency (Chapter
3). Further, this particular mutant has been shown to be a very good indicator of tRNA
movement between the P/P and E/E-tRNA binding sites as seen in both single molecule
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work (Fei et al., 2008, Ben Stevens manuscript in progress), equilibrium FRET, and
the stopped flow kinetic FRET. Further, the ability to prepare tRNAs that are highly
labeled with either hydrazide dyes, or rhodamine 110 and highly aminoacylated was
essential to being able to discover different pathways by which tRNA can leave the E-site
of the ribosome.
The L1 stalk has been shown to occupy at least two (Fei et al., 2008) or three
(Cornish et al., 2009) distinct conformations depending on the positions and acylationstate of the tRNAs bound to the ribosome. The L1-stalk occupies an “open” (out) state
when the ribosomes have vacant E-sites or in isolated 50S subunits (Korostelev et al.,
2008; Harms et al., 2001) and this is most likely the position for the sucrose-purified
70SIC ribosomes used here. When deacylated-tRNAfMet is bound in the E-site, the L1stalk moves inward by ~30-40 Å (Korostelev et al., 2006; Selmer et al., 2006) and this
is the most likely position of the stalk directly after translocation when the E-site is
occupied with the translocated deacylated-tRNAfMet. A third position for the L1-stalk,
the “overly closed,” determined by Cornish and coworkers, requires a further movement
of ~15-20 Å towards the body of the ribosome and occurs when a tRNA adopts the P/Ehybrid conformation (Cornish et al., 2009; Valle et al., 2003; Gao et al., 2003). This is
most likely the position of the stalk directly after addition of ternary complex to a 70SIC
resulting in the increase in FRET efficiency described above.
In a 70SIC complex, the L1 stalk remains in an “out” conformation at least until
peptide bond formation, at which point the now deacylated-tRNAfMet can adopt a hybrid
P/E conformation. It is this movement of deacylated-tRNAfMet, along with the movement
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of the L1 into an “overly-closed” conformation, which results in the increase in FRET
efficiency seen in Figures 4.1-4.3. During translocation, the L1/tRNA interaction from
P/E-hybrid to E/E-site does not change, as first seen in single molecule work by Fei et al.,
2008, and as shown here by a L/t FRET efficiency lag. The FRET efficiency for the PRE1 complex has been calculated from equilibrium FRET and stopped flow FRET
experiments and is approximately 0.8 ± 0.1 in Buffer A, and ~0.90 ± 0.03 in Buffer B.
This FRET efficiency, first seen in the PRE-1 state, remains relatively unchanged until
either deacylated-tRNA dissociation or conformational change, at which time the POST1 FRET efficiency either goes to 0 as in Buffer A, or decreases to approximately 0.5 in
Buffer B. As mentioned before, the remaining FRET efficiency in the POST-1 complex
in Buffer B is caused by rebinding of deacylated-tRNA to the E-site. The measured
values for the PRE-1 complex are similar to FRET efficiency values seen previously in
single molecule work (Table 4.6).
EF-G.GTP Binding ! Translocation
Two different variables, buffer conditions and P-site peptidyl-state, with two
possibilities were tested above; however, for one of the buffer conditions (A) we could
only study the peptidyl-tRNA because the aminoacyl-tRNA did not remain bound to the
PRE-1 complex through sucrose cushioning. Therefore, three different complexes were
used to determine the possible pathways in which deacylated-tRNA can dissociate from
the ribosome. In all three pathways, the steps leading up to translocation did not change,
and were in accordance with previous literature (Pan et al., 2007).
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L/t FRET

experiments with addition of multiple concentrations of EF-G to PRE-1 complexes were
used in order to better understand the early stages of POST-1 formation.
As seen in Figure 4.12, the addition of EF-G.GTP at high concentrations (2.0 µM5.0 µM, in most cases) resulted in a net FRET efficiency increase between L1 and
deacylated-tRNA at a rate constant of ~30 µM-1 s-1. Interestingly, this increase in FRET
efficiency is associated with the binding of EF-G rather than with conformational change
step (k3) (Table 4.5). For samples with peptidyl-tRNA (A and B), the FRET efficiency
increase in Buffer A is greater than it is in Buffer B. For the PRE-1 complex, the FRET
efficiency value in Buffer A is 0.8 (Figure 4.1) and in Buffer B it is 0.9 (Figure 4.12 A, B,
Table 4.6). It is possible that more deacylated-tRNA samples the higher FRET state in
Buffer B prior to addition of EF-G.GTP, and therefore, less of an increase is observed
after addition of EF-G.GTP. Prior to EF-G.GTP addition, the L1-stalk fluctuates between
“in” and “out” conformations, while the now deacylated-tRNA fluctuates between classic
(P/P) and hybrid (P/E) conformations. A deacylated-tRNA in the P/E hybrid state will
show a FRET signal with the L1-stalk that moves into the “in” conformation. Upon
addition of EF-G.GTP, the equilibrium between classic and hybrid states shifts towards
the hybrid, resulting in a net increase in average FRET efficiency between the L1 and
deacylated-tRNA, as seen in Figure 4.12. Indeed, in Buffer A, the increase in FRET
efficiency leads to a FRET efficiency value of ~1, similar to the FRET efficiency value
seen for the PRE-1 state in Buffer B. At lower concentrations of EF-G.GTP, the
intermediate in which an increased fraction of the complexes is hybrid does not have a
chance to build up, thus the binding is observed as a lag (as is seen in all other L/t
experiments presented here). After EF-G.GTP binding, GTP hydrolysis occurs, followed
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by a series of conformational changes (which were all fit to a single rate constant, k3),
and translocation, none of which affect the L/t FRET signal (Table 4.5) because the
distance between the L1-stalk and the deacylated-tRNA in the P/E state does not change
when the tRNA is translocated to the E/E state.
Translocation ! Deacylated-tRNA Release
By using the L/t and t/t FRET efficiency changes, three different pathways for
deacylated-tRNAfMet release from the E-site have been discovered. As seen above, during
the steps leading up to translocation and the steps immediately after translocation, the
conformation of the ribosome is the same for each pathway; the L1-stalk is in towards the
body of the ribosome (Li) and the deacylated-tRNA is in the E-site (E). After release, the
tRNA is off of the ribosome (Eo) and the L1-stalk has moved out (Lo). Pathway 1) the
L1-stalk moves to the open conformation first (Lo E), and then deacylated-tRNAfMet is
released from the ribosome (Lo Eo); 2) the L1/tRNA interaction is lost at a similar time as
tRNA release occurs (Lo Eo); and 3) the L1-stalk moves to an open conformation (Lo) and
remains in contact with the deacylated-tRNAfMet that has now moved into an apparent
E2-site (E2) and is then released very slowly (Eo) (Scheme 4.1).
The first pathway, in which the L1-stalk moves out prior to deacylated-tRNAfMet,
was discovered by monitoring translocation and release in Buffer A. Buffer A has
previously been shown to cause tRNA in the E-site to be released rapidly. However, the
timing of the release was never determined (Semenkov et al., 1996). In the PRE-1
complex, the FRET efficiency between deacylated-tRNAfMet (Cy3) and T202C-L1 (Cy5)
is approximately 0.73, as measured by L/t equilibrium FRET (Figure 4.1).
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translocation, this FRET efficiency value does not change; therefore, under these
conditions, in which EF-G.GTP (1 µM) is added to the PRE-1 complex, the only change
in FRET efficiency is when either the L1-stalk moves away, or the tRNA is released.
Prior to the major FRET efficiency loss, a lag phase is indeed seen in the L/t FRET; this
lag corresponds to the events leading up to and including the rate limiting translocation
and has an apparent rate constant of 8.2 s-1, which is in accordance with translocation
rates of ~7.8 s-1 measured in similar conditions by Pan and coworkers (Pan et al., 2007).
Two-thirds of the release of deacylated-tRNA in Buffer A follows pathway 1, in which
the L1-stalk moves away prior to the release of deacylated-tRNA. Therefore, the loss in
FRET efficiency seen in the L/t FRET traces is due to the movement of the L1-stalk to an
out conformation. The movement from an in conformation to an out conformation is
approximately 30-40 Å, which increases the distance between the dyes from ~40 Å to
~70-80 Å. With a Förster Ro of approximately 50 Å (Fei et al., 2008) for the Cy3/Cy5
FRET pair, this increase in distance takes a theoretical FRET efficiency from ~0.80 to
~0.05 (Distance= Ro*(1/E-1)1/6) , values that correspond very nicely with the values
observed (Table 4.6). After the L1-stalk moves out, deacylated-tRNA dissociation is
seen by the loss of t/t FRET efficiency with a rate constant of ~1.6 s-1.
The second pathway, is one in which the L1 moves away from the tRNA at a
similar apparent rate constant as the tRNA releases off of the ribosome, and was
discovered by monitoring translocation and deacylated-tRNAfMet release in Buffer B. In
order to obtain complexes which release deacylated-tRNAfMet via this pathway, PRE-1
complexes had to be prepared using 70SICs which contained highly charged (>75%)
fMet-tRNAfMet, because ribosomes that bind deacylated-tRNAfMet in the 70SIC favor
"#$!
!

release from pathway 3, as discussed later. The only definitive statement that can be
made about ribosomes that follow this pathway of deacylated-tRNAfMet release from the
E-site is that the deacylated-tRNAfMet dissociates from the ribosome at an apparent rate
constant of ~1.6 s-1, as seen by the global fitting to Scheme 4.1 of the L/t and t/t FRET
traces. There are four sets of circumstances that could occur to cause all of these rate
constants to be similar, and none of them can be positively ruled out using this set of
experiments: 1) The L1-stalk outward movement, and the dissociation of the deacylatedtRNAfMet are concerted movements; 2) The deacylated-tRNAfMet loss occurs while the
L1-stalk is “in” and the dissociation of tRNA causes the decrease in L/t and t/t FRET
efficiency; 3) The L1-stalk and the deacylated-tRNAfMet move out together in a ratedetermining step that is followed by rapid deacylated-tRNAfMet release from the E2-site,
so that L/t and t/t FRET efficiency decrease at indistinguishable rates; or 4) The L1-stalk
moves out first in a rate-determining step that is followed by rapid deacylated-tRNAfMet
dissociation from the E-site. It is very unlikely that the two events occur concertedly, and
from the evidence seen in the crystal structures when the E-site is unoccupied (L1-stalk in
an open conformation), and from the other pathways presented here, it is unlikely that the
L1-stalk remains in an in conformation while tRNA releases; therefore, the first two
options are improbable. This leaves options 3) and 4), which we are unable to distinguish
between to the precision of the rate constants measured here. Fei and coworkers used
single molecule FRET to monitor a similar release of deacylated-tRNA after
translocation, with a dipeptide in the P-site. Their results indicate that the L1-stalk moves
out, prior to the release of deacylated-tRNA, similar to pathway 1; however, their buffer
conditions (with polyamines, 15 mM Mg2+) cause the translocation reaction as well as the
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release to slow down drastically at roughly 0.1 s-1, and 0.06 s-1, respectively based on
lifetimes. (Fei et al., 2008). It is possible that the pathway 2 seen here, is indeed similar
to what they observe, but here it is on a much faster time scale, and thus tRNA
dissociation and L1-stalk movement appear as concerted movements.
The third pathway, in which the tRNA moves away from the body of the
ribosome with the L1-stalk, was discovered by monitoring translocation and deacylatedtRNAfMet release in Buffer B. This pathway is favored by ribosomes that initiate protein
synthesis using a deacylated-tRNAfMet, so that, upon translocation, the P-site contains
only an aminoacyl-tRNA. For ribosomes that follow this pathway, after the deacylatedtRNAfMet loses contact with the P-site tRNA, it remains in contact with the L1-stalk as
the stalk moves from a closed (Li) to an open (Lo) position. This movement of tRNA
with the L1-stalk is believed to put the deacylated-tRNA into a position similar to the E2site (E2) seen in recent cryo-EM images (Fischer et al., 2010). The distance between the
dihydrouridine (and therefore Cy3) at position 20 of the tRNAfMet in the E/E-site, and the
dihydrouridines at position 16/17 (Rhd110) of tRNAPhe in the P/P-site is ~45 Å. If the
deacylated-tRNAfMet were indeed moving to the E2-site, the anticodon stem loop and the
elbow region would move away from the P-site tRNA. Although it is currently not
possible to obtain distance calculations because the coordinates are not available, it is
likely that this movement would cause the loss of FRET efficiency that is seen in the t/t
FRET measurements. The loss in t/t FRET efficiency observed in the ribosomes that
follow this pathway occurs at a rate constant that is very similar to that seen for the loss
in t/t FRET efficiency for the other pathways (~1.6 s-1); therefore, the release of
deacylated-tRNAfMet from the E-site is the same for all three pathways. The L1-stalk
"#$!
!

movement, and the interaction of the tRNA with the L1-stalk is dependent on (in these
cases) the buffer conditions and the peptidyl-state of the P-site tRNA after translocation.
In this pathway, the deacylated-tRNAfMet remains in contact with the L1 stalk as it moves
to an open conformation, and occupies the E2-site. The E2-site, according to cryo-EM
images, does not have any codon/anticodon interactions between the tRNA and mRNA;
therefore, under these conditions the tRNA in the E2-site may be very easily displaced by
any deacylated-tRNA in solution (as seen in Chapter 5).

However, under these

conditions in which there are no excess deacylated-tRNAs, it is possible for the tRNA to
remain bound to the E2-site for a long time, as seen with the slow loss of L/t FRET
efficiency and the major fluorescence anisotropy change that is seen on the same time
scale (~0.02 s-1).
Although it has been shown that the three different conditions favor three
different major pathways of deacylated-tRNA release, it should be mentioned that a
minor, less significant pathway is also followed in each case. The probability of a
deacylated-tRNA releasing via any of the three specific pathways varies based on the
conditions.
As previously mentioned in Section 1.6, the function and occupancy of the E-site
has been highly debated in the literature. In one case the E-site acts as a stable binding
site in which a translocated deacylated-tRNA can remain bound to the E-site in Buffer B
even after sucrose centrifugation (Gnirke et al., 1989). In light of the findings that
peptidyl-state of the P-site tRNA affects the release of deacylated-tRNAfMet from the Esite (or E2-site) in Buffer B, the stable binding of E-site tRNA described above was
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explored.

The current results indicate that when peptidyl-tRNA is in the P-site,

deacylated-tRNAfMet dissociates from the ribosome relatively rapidly, whereas, when
aminoacyl-tRNA is in the P-site, deacylated-tRNAfMet dissociates from the ribosome
much more slowly. The complexes used by Nierhaus and colleagues utilize a POST
translocation state that has an N-acetyl-acyl-tRNA in the P-site, and show that this
particular complex has a stable binding of E-site tRNA. It is possible that N-acetyl-acyltRNA in the P-site favors release of deacylated-tRNA via pathway 3 in Scheme 4.1,
which would allow the stable binding of the deacylated-tRNA after translocation.
The second role of the E-site, proposed by Wintermeyer and colleagues, is that it
acts as a transient intermediate (Lill and Wintermeyer, 1987; Lill et al., 1988;
Semenkov et al., 1996). This work, performed mostly in Buffer A, shows in a non-time
resolved manner, that approximately 85% of the deacylated-tRNA is released
“instantaneously” upon translocation (Semenkov et al., 1996). Our results agree in
showing release of deacylated-tRNAfMet via pathway 1 (Scheme 4.1).
As mentioned previously, it is important to better understand the function of the
E-site because its occupancy has been implicated in preventing amino acid
misincorporation and random frameshifting (Nierhaus, 2006; Devaraj et al., 2009;
Sergiev et al., 2005), as well as assisting in programmed frameshifting (Leger et al.,
2007, Liao et al., 2008). To this end, it is possible that all three pathways observed here
are viable options for deacylated-tRNA release, and the probability of release via any one
pathway is dependent on conditions that may favor or disfavor changes in protein
synthesis, such as frameshifting.
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4.5 Conclusions
By utilizing a site specifically labeled L1 mutant, and reconstituting it into –L1
50S subunits, I was able to create a probe for EF-G.GTP binding and deacylated-tRNA
release from the ribosome.

Using this labeled ribosome along with t/t FRET and

preliminary fluorescence anisotropy, three possible pathways for deacylated-tRNAfMet
release from the E-site (or E2-site) were discovered. 1) The L1 stalk moves from a closed
to an open position prior to release of deacylated-tRNAfMet; 2) The L1 stalk moves from a
closed to an open position with a rate constant similar to that for the release of
deacylated-tRNAfMet; and, 3) The deacylated-tRNAfMet moves with the L1-stalk as it
moves away from the body of the ribosome into an E2-site and is then released very
slowly. All three of these pathways are viable options for deacylated-tRNA release and
the probability of release via any one pathway is dependent on experimental conditions.
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Table 4.1 Equilibrium FRET Efficiency Measurements
70SICs were made for L/t FRET analysis using fMet-tRNAfMet (Cy3) as the donor
and T202C-L1-50S (Cy5) as the acceptor. Equilibrium FRET measurements were taken
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using a Spectrofluorometer to determine the FRET efficiency at different stages of
translocation. The samples were excited at 518 nm and FRET efficiency was measured as
acceptor fluorescence change at 667 nm. D*A*, D*A, DA*, and DA samples were
prepared for each complex, and the DA background was subtracted for all samples prior
to analysis. The t/t sample was prepared similarly, using Phe-tRNAPhe (Rhd110) as the
donor and fMet-tRNAfMet (Cy3) as the acceptor, exciting at 480 nm, and measuring
acceptor fluorescence at 567 nm.

The efficiency of energy transfer was calculated via

Equation 2.2, reshown here as a sample calculation for FRET efficiency in the PRE-1
complex in Buffers A and B (B). Where E is the FRET efficiency, DA*’ is the extracted
acceptor emission as calculated by the bottom equation. D*A*(A) is a sample with both
donor and acceptor labeled, measured at the acceptor peak, D*A*(D) is the same complex
measured at the donor peak. The DA* indicates a sample in which only the acceptor is
labeled, and a D*A indicates a sample where only the donor is labeled. The donor
efficiency and acceptor efficiency are measured as the amount of donor/70S and
acceptor/70S in the purified complexes.
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Exp.

Buffer

Charging
Efficiency
of fMettRNAfMet in
70S IC

1 (L/t)

A

25%

13.2 ± 0.4
(lag)

4.7 ±0.1
(0.33)

0.71±0.02
(0.29)

34 (L/t)

A

70%

7.7 ±0.1 (lag)

4.67 ± 0.08
(0.65)

0.544±0.006
(0.30)

41 (L/t)

A

78%

7.6 ± 0.1
(lag)

4.7 ± 0.1
(0.70)

0.54 ±0.01
(0.30)

32 (t/t)

A

70%

13.3 ± 0.4
(lag)

1.38 ± 0.01
(0.53)

0.293 ± 0.003
(0.27)

44 (t/t)

A

78%

14.5 ± 0.4
(lag)

1.44 ± 0.03
(0.52)

0.27 ± 0.02
(0.29)

13 (L/t)

B

0%

1.7 ± 0.3
(lag)

1.8 ± 0.3
(0.26)

0.018 ± 0.001
(0.74)

30 (L/t)

B

0%

1.28 ± 0.07
(lag)

1.17 ± 0.06
(0.20)

0.022 ± 0.004
(0.70)

39 (L/t)

B

0%

2.5 ± 0.2
(lag)

0.5 ± 0.1
(0.28)

0.030 ± 0.008
(0.69)

28 (t/t)

B

0%

17 ± 1 (0.10)

1.24 ± 0.06
(0.51)

0.238 ± 0.007
(0.31)

38 (t/t)

B

0%

17 ± 2 (0.12)

1.24 ± 0.02
(0.37)

0.238 ± 0.006
(0.13)

12 (L/t)

B

78%

2.5 ± 0.1
(lag)

1.57 ± 0.08
(0.62)

0.11 ± 0.03
(0.14)

26 (L/t)

B

70%

3.6 ± 0.3
(lag)

1.6 ± 0.1
(0.61)

0.26 ± 0.03
(0.11)

k1app

k2app

k3app
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40 (L/t)

B

78%

5.5 ± 0.1
(lag)

1.6 ± 0.3
(0.61)

0.27 ± 0.07
(0.14)

24 (t/t)

B

70%

28 ± 3 (0.10)

1.69 ± 0.06
(0.55)

0.20 ± 0.01
(0.11)

42 (t/t)

B

78%

25 ± 2 (0.17)

1.04 ± 0.02
(0.59)

0.22 ± 0.03
(0.12)

64
(Anis.)

B

0%

1.2+/- 0.4
(lag)

0.48 +/- 0.06
(0.20)

0.052 +/- 0.002
(0.70)

*Amplitude changes appear in parenthesis, major change appears in bold
Table 4.2 Rate Constants Associated with PRE-1 to POST-1 Translocation and
tRNA Dissociation
PRE-1 complexes were made by incubating 70SIC containing (fMet)-tRNAfMet
(Cy3) at varying aminoacylation efficiencies, and either T202C-L1 50S (t/t) or T202C-L1
(Cy5) 50S (L/t) with ternary complexes containing either Phe-tRNAPhe (Rhd110) (t/t) or
Phe-tRNAPhe (L/t). The PRE-1 complex used for the anisotropy study were created from
70ICS containing uncharged tRNAfMet (Cy3) and unlabeled T202C-L1 ribosomes. The
FRET efficiency and anisotropy changes were all fit to a triple exponential curve using
Scientist (MicroMath) with the major change for each experiment appearing in bold.
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Buffer

Initial
fMet
Charging

fMet/
PRE

Phe/
PRE

Cy3/PRE
(tRNAfMet)

Rhd/PRE
(tRNAPhe)

70SIC

A

0

0

--

0.58*

--

4.3

70SIC

A

25

0.52

--

0.42

--

4.3

70SIC

B

78

0.45

--

0.36

--

PRE-1

A

0

0

0.19

0.06*

--

4.5

PRE-1

A

25

0.39

0.70

0.39

--

4.4, 4.5

PRE-1

A

70

0.45

0.67

0.53*

--

4.5,
4.8,
4.12A,
4.13A

PRE-1

A

78

0.58

0.61

0.62*

--

4.6,
4.10B/
C,
4.12C,
4.13C

PRE-1

B

0

0

0.35

0.57*

--

PRE-1

B

25

0.34

0.31

0.46

--

PRE-1

B

78

0.52

0.37

0.70*

--

PRE-1

A

0

0

0.20

0.06*

0.16

PRE-1

A

70

0.47

0.76

0.63*

0.54

PRE-1

A

78

0.57

0.73

0.65*

0.50

Fig.

4.4,
4.6,
4.10A,
4.12B,
4.13B

4.8,

Purified
Complex
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4.13A
4.9,
4.10B/
C,
4.11,
4.13C

4.9,
4.10A,
4.13B

PRE-1

B

0

0

0.41

0.52*

0.35

PRE-1

B

70

0.48

0.47

0.43*

0.45

PRE-1

B

78

0.50

0.51

0.46*

0.53

*HPLC purified, highly labeled tRNAfMet
Table 4.3 Binding Efficiencies of tRNA to Purified Ribosome Complexes
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Table 4.4 Rate Constants for Global Scheme 4.1!
L/t and t/t FRET traces were fit to the global Scheme 4.1 using Scientist. A) PRE1 complexes made in Buffer A; B) PRE-1 complexes made in Buffer B with peptidyltRNA in the P-site (after translocation); and C) PRE-1 complexes made in Buffer B with
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aminoacyl-tRNA in the P-site (after translocation). Rate constants for the steps leading
up to translocation (k4) were fit to scheme 4.1 using EF-G concentration dependent data
seen in Figure 4.12, and previous literature values, while holding k4-k9 constant. Then,
the L/t and t/t FRET traces were all fit to the global Scheme 4.1 while holding the early
steps constant (k1-k3). For each complex tested (A, B, and C) the L/t and t/t data fit to the
scheme showed that the majority of deacylated-tRNA was released via 1 of 3 different
pathways (bold), with a slower release resulting from heterogeneity in the sample (red).

Fig

Exp.

FA

FC

FD

FE

FF

FG

FH

4.12

L/t

4.0*

3.9 ±

2.2 ±

2.3 ±

n.d.

n.d.

n.d.

"#$!
!

A

4.12
B

4.12
C

4.13
A

4.13
B

4.13
C

0.5 µM

0.4

0.3

0.4

1.0 µM

4.0*

5.7 ±
0.2

2.3 ±
0.2

2.4 ±
0.2

n.d.

n.d.

n.d.

2.0 µM

4.0*

6.0 ±
0.2

3.2 ±
0.2

2.8 ±
0.2

n.d.

n.d.

n.d.

5.0 µM

4.0*

5.7 ±
0.1

3.7 ±
0.1

3.0 ±
0.1

n.d.

n.d.

n.d.

L/t
1.0 µM

4.0*

4.01 ±
0.02

4.02 ±
0.01

3.76 ±
0.01

n.d.

n.d.

2.17 ±
0.01

5.0 µM

4.0*

4.08 ±
0.01

4.03 ±
0.01

3.85 ±
0.01

n.d.

n.d.

2.62 ±
0.01

L/t
0.5 µM

4.0*

4.03 ±
0.05

4.09 ±
0.01

4.11 ±
0.02

n.d.

n.d.

10 ±
0.3

1.0 µM

4.0*

4.03 ±
0.03

3.97 ±
0.01

4.16 ±
0.01

n.d.

n.d.

12 ±
0.3

2.0 µM

4.0*

3.96 ±
0.02

4.01 ±
0.01

4.17 ±
0.02

n.d.

n.d.

14 ±
0.3

5.0 µM

4.0*

4.28 ±
0.02

3.98 ±
0.01

4.01 ±
0.01

n.d.

n.d.

7.5 ±
0.3

L/t

4.0*

4.0*

4.0*

4.0*

2.95 ±
0.03

n.d.

2.6 ±
0.1

t/t

4.07 ±
0.02

3.74 ±
0.06

4.09 ±
0.03

3.76 ±
0.03

3.48 ±
0.03

n.d.

3.1 ±
0.1

L/t

4.0*

4.0*

4.0*

4.0*

n.d.

n.d.

n.d.

t/t

4.00 ±
0.01

3.93 ±
0.03

3.88 ±
0.01

3.78 ±
0.01

n.d.

n.d.

n.d.

L/t

4.0*

4.0*

4.0*

4.0*

n.d.

3.93 ±
0.01

3.32 ±
0.02

t/t

4.00 ±
0.01

4.01 ±
0.01

3.89 ±
0.01

3.75 ±
0.01

n.d.

n.d.

n.d.

*Fixed values
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Table 4.5 Fluorescence Values for Global Fits
Fluorescence values of traces fit to global Scheme 4.1. In the table above, the
complexes that are n.d. (not determined) are complexes that don’t build up during the
course of the reaction.
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Figure

Experiment

Buffer

PRE FRET
Efficiency
Value (t0)

Apparent
POST FRET
Efficiency
Value (t10s)

4.1

Equil; HC; L/t

A

0.7

0

4.2

Equil; HC; L/t

B

0.9

0.5

4.4, 4.8

SF; HC; L/t

A

1.0

0

4.4, 4.6, 4.10

SF; HC; L/t

B

0.95

0.53

4.6, 4.10

SF; UC; L/t

B

0.93

0.55*

4.7

Equil; HC; t/t

B

0.53

0

4.9, 4.10A

SF; HC; t/t

B

0.52

0.15

4.9, 4.10B,C

SF; UC; t/t

B

0.91

0.07

4.12 A

SF; HC; L/t
(5 uM EF.G)

A

0.80/1.0**

0.12

4.12 B

SF; HC; L/t
(5 uM EF.G)

B

0.95/0.96**

0.46

4.12 C

SF; UC; L/t
(5 uM EF.G)

B

0.93/0.97**

0.6***

Chen et al,
(submitted)

sm FRET t/t

-

0.5

Fei et al.,
(2008)

sm FRET L/t

PA

0.8

0.8

Stevens et al.,
(submitted)

sm FRET L/t

TAM15

0.5

0.75

Abbreviations: Equil: Equilibrium FRET; SF: Stopped Flow FRET; HC: Starting with
highly charged fMet-tRNAfMet; UC: Starting with uncharged tRNAfMet; smFRET: Single
Molecule FRET; PA: Polyamine Buffer (polyamines, and 15 mM Mg2+); TAM15: 20
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mM Tris-HCl (pH 7.5), 15 mM Mg(OAc)2, 30 mM NH4Cl, 70 mM KCl, 0.75 mM EDTA,
1 mM DTT, 0.2% (w/v) Tween 20.
*POST fluorescence value for FRET calculation was taken at t= 90s.
** X/Y, where X is the FRET at t=0 and Y is the FRET at the peak of the increase, in B,
the change in FRET value may not be significant.
***POST fluorescence value for FRET calculation was taken at t= 30s
Table 4.6 FRET Efficiency Measurements for Equilibrium FRET and Stopped
Flow FRET in PRE-1 and POST-1 States.
It is possible to obtain FRET efficiency measurements the experiments presented
here. The equilibrium FRET calculation is done as shown in Table 4.1. To obtain FRET
efficiency measurements from stopped flow data, the PRE-1 state is defined at t = 0s,
before EF-G.GTP is added:

PRE _ FRET =

&
D * A *(t 0) !DA *(t 0) #
1
"%
(
DA *(t 0)
$ DonorEfficiency '

POST _ FRET =

&
D * A *(tx ) !DA *(tx ) #
1
"%
(
DA *(tx )
$ DonorEfficiency '

Where, D*A* is a sample containing both donor and acceptor dyes, and DA* is a sample
containing only the acceptor dye. The POST FRET efficiency is calculated similarly,
using times after the translocation has occurred.
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A.

k6

A+B

B.

tRNA: P/P A/A
PRE-1 +
EF-G.GTP

k1
k2

k1

C

D

k4

P/P A/A

k3

PRE-1.G.GTP

E

E/E P/P
POST-1
Li, E1

E/E P/P
POST-1
Lo, E1

POST-1
Lo, E2

"#$!

k9

P/E A/A
PRE-1.G.GDP.Pi

k8

k4
Translocation
Pi Release

!"#$%"&
'
P/P
POST-1
Lo, Eo

k5

E2 P/P

H

G

Hydrolysis/
Conformational
Change

k2

k7

!

F
k5

k7

k6

k4

k3

k8

k9

(
)

Scheme 4.1 Global Scheme for Deacylated-tRNA Release From a Translocated
Ribosome
A) The L/t and t/t FRET data that was originally fit to triple exponential curves
(Figures 4.8 and 4.10), was fit to this global scheme using Scientist. Further, EF-G
concentration dependent L/t FRET data was used to help find the rate constants
associated with EF-G binding (k1 and k2) and hydrolysis/conformational change k3. With
these rate constants known, k4 through k9 were determined by fitting the L/t and t/t FRET
traces for each complex to the scheme, and the pathway for deacylated-tRNA release was
elucidated from these fits. B) The same scheme as A, but with the corresponding states
of the ribosome and tRNA. Li: L1-stalk “in”; Lo: L1-stalk “out”; E1: deacylated-tRNA in
the E site; E2: deacylated-tRNA in the E2 site; and Eo: deacylated-tRNA off the ribosome.
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Figure 4.1 Equilibrium FRET Efficiency Changes in Buffer A
70SICs were made for FRET analysis using fMet-tRNAfMet (Cy3) as the donor
and T202C-L1-50S (Cy5) as the acceptor, and purified through a sucrose cushion.
Equilibrium FRET measurements were taken using a spectrofluorometer to determine the
FRET efficiency at different stages of translocation (A: 70SIC (0.1 µM), B: PRE-1
(70SIC + Phe-tRNAPhe.EF-Tu.GTP (0.25 µM)), C: POST-1 (70SIC + Phe-tRNAPhe.EFTu.GTP (0.25 µM) + EF-G.GTP (0.25 µM))) . The samples were excited at 518 nm and
FRET efficiency was measured as acceptor fluorescence change at 667 nm. D*A*, D*A,
DA*, and DA samples were prepared for each complex, and the DA background was
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subtracted for all samples prior to analysis.

Fitted D contribution and extracted A

emission were determined for each stage, and the efficiency of energy transfer was
determined by equation 2.2. The DA samples are plotted together for each ribosome
complex in D.
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Figure 4.2 Equilibrium FRET Efficiency Changes in Buffer B
Complexes were made and analyzed in the same way as Figure 4.1, except they
were made in Buffer B. Notice in C and D that the FRET efficiency is not completely
lost due to the rebinding of deacylated-tRNA to the E-site in Buffer B.
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Figure 4.3 FRET Efficiency Increase Associated with PRE-1 Formation
70SIC was created in either Buffer A or Buffer B with highly charged fMettRNAfMet (Cy3) and T202C-L1 (Cy5) ribosomes.

Phe-tRNAPhe.EF-Tu.GTP ternary

complex (0.5 µM for Buffer A, and 1.0 µM for Buffer B) was stopped flow added to the
70S IC (0.25 µM). tRNAfMet (Cy3) in the PRE-1 complex was excited at 540 nm and the
emission of the Cy5 acceptor was monitored at 680 ± 10 nm to determine FRET
efficiency change, and is seen here.

"#$!
!

Buffer A (D*A*)
Buffer B (D*A*)
Triple Exponential Fit
Buffer A (DA*)
Buffer B (DA*)

Acceptor Fluorescence

1.0

0.9

0.8

0.7

0.6
0

2

4
6
Time (sec)

8

10

Figure 4.4 L/t FRET Efficiency Change Upon Translocation in Buffer A and Buffer
B
1.0 µM EF-G.GTP was rapidly mixed in a stopped flow spectrophotometer with a
PRE-1 complex (0.25 µM) that was created from a 70SIC containing highly charged
fMet-tRNAfMet (Cy3) and T202C-L1 (Cy5) ribosomes in Buffer A or B. tRNAfMet (Cy3)
in the PRE-1 complex was excited at 540 nm and the emission of the Cy5 acceptor was
monitored at 680 ± 10 nm to determine FRET efficiency change. D*A* samples contain
both Cy5 and Cy3 labels, whereas DA* samples contain only Cy5. Background (DA)
traces were subtracted from all samples, and the D*A* samples were normalized to 1.0.
The DA* samples were compensated for the normalization by dividing by the D*A*
fluorescence at time 0. After ~10 s in Buffer A, tRNA is completely released from the
"#$!
!

ribosome resulting in no FRET; however, in Buffer B, FRET remains due to the
equilibrium established between release and rebinding of deacylated-tRNA. The D*A*

Normalized Acceptor Fluorescence

traces were both fit to a triple exponential curve using Scientist.
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Figure 4.5 L/t FRET Efficiency Change Upon Translocation in Buffer A
1.0 µM EF-G.GTP was rapidly mixed in a stopped flow spectrophotometer with a
PRE-1 complex (0.25 µM) that was made from 70SIC complexes containing fMettRNAfMet (Cy3) charged to different levels, and ribosomes containing T202C-L1 (Cy5)
50S in Buffer A. tRNAfMet (Cy3) in the PRE-1 complex was excited at 540 nm and the
emission of the Cy5 acceptor was monitored at 680 ± 10 nm to determine FRET
efficiency change. The FRET efficiency changes were fit to a triple exponential curve
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using Scientist. Unlike Buffer B, the level of charging efficiency of the initiator tRNA
does not affect the apparent rate constant of the major FRET change in Buffer A.
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Figure 4.6 L/t FRET Efficiency Change Upon Translocation in Buffer B
1.0 µM EF-G.GTP was rapidly mixed in a stopped flow spectrophotometer with a
PRE-1 complex (0.25 µM) that was made from 70SIC complexes containing either
highly charged fMet-tRNAfMet (Cy3) or deacylated-tRNAfMet (Cy3), and ribosomes
containing T202C-L1 (Cy5) 50S in Buffer B. tRNAfMet (Cy3) in the PRE-1 complex was
excited at 540 nm and emission was measured at 570 ± 10 nm. The emission of the Cy5
acceptor was monitored at 680 ± 10 nm and is shown here fitted to a triple exponential
curve using Scientist. Acceptor alone (DA*) samples are also shown to indicate the
FRET Efficiency = 0 fluorescence.
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Figure 4.7 t/t Equilibrium FRET Change in Buffer B
PRE-1 complexes were made for FRET analysis using Phe-tRNAPhe (Rhd110) as
the donor and fMet-tRNAfMet (Cy3) as the acceptor, and purified through a sucrose
cushion. Equilibrium FRET measurements were taken using a spectrofluorometer to
determine the FRET efficiency at different stages of translocation (A: PRE-1 (0.1 µM),
B: POST-1 (PRE-1 + EF-G.GTP (0.25 µM)). The samples were excited at 480 nm and
FRET efficiency was measured as acceptor fluorescence change at 567 nm. D*A*, D*A,
DA*, and DA samples were prepared for each complex, and the DA background was
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subtracted for all samples prior to analysis.

Fitted D contribution and extracted A

emission were determined for each stage, and the efficiency of energy transfer was
determined by equation 2.2. The DA samples are plotted together for each ribosome
complex in C.
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Figure 4.8 L/t and t/t FRET Efficiency Change in Buffer A
The L/t FRET efficiency change is monitored as described in Figure 4.2. For the
t/t FRET experiments, 1.0 µM EF-G.GTP was rapidly mixed with 0.25 µM PRE-1
complex that was made from a 70SIC complex containing highly charged fMet-tRNAfMet
(Cy3), Phe-tRNAPhe (Rhd110), and T202C-L1 50S ribosomes. The donor fMet-PhetRNAPhe (Rhd110) was excited at 480 nm and emission was measured at 525 ± 10 nm,
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the acceptor emission was monitored at 570 ± 10 nm and is shown here. The L/t FRET
was fit to a triple exponential curve as seen in Figure 4.2, and the t/t was also fit to a
triple exponential using Scientist.
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Figure 4.9 t/t FRET Efficiency Change Upon Translocation in Buffer B
For the t/t FRET experiments, 0.25 µM PRE-1 complex made from a 70SIC
containing either highly charged fMet-tRNAfMet (Cy3) or deacylated-tRNAfMet (Cy3),
Phe-tRNAPhe (Rhd110), and T202C-L1-50S ribosomes. The PRE-1 complex was rapidly
mixed with 1.0 µM EF-G.GTP in a stopped flow experiment. The donor (fMet)-PhetRNAPhe (Rhd110) was excited at 480 nm and emission was measured at 525 ± 10 nm,
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the acceptor emission was monitored at 570 ± 10 nm and is shown here. The t/t FRET
efficiency changes were both fit to a triple exponential curve using Scientist.
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Figure 4.10 L/t and t/t FRET Efficiency Change in Buffer B
The complexes used in the L/t FRET experiments are made, and the efficiency
change is monitored as described in Figure 4.6. For the t/t FRET experiments, 1.0 µM
EF-G.GTP was rapidly mixed with 0.25 µM PRE-1 complex made from a 70SIC
containing highly charged fMet-tRNAfMet (Cy3) (A) or deacylated-tRNAfMet (Cy3) (B
and C), and T202C-L1-50S ribosomes. The donor (fMet)-Phe-tRNAPhe was excited at
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480 nm and emission was measured at 525 ± 10 nm, the acceptor emission was
monitored at 570 ± 10 nm and is shown here. Acceptor alone (DA*) samples are also
shown to indicate the FRET Efficiency = 0 fluorescence. The L/t FRET efficiency
changes were fit to a triple exponential curve as in Figure 4.4, and the t/t FRET efficiency
changes were also fit to a triple exponential curve using Scientist.
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Figure 4.11 tRNA Release Measured by L/t FRET and Anisotropy Change
To measure the L/t FRET efficiency change, 1.0 µM EF-G.GTP was rapidly
mixed in a stopped flow spectrophotometer with a PRE-1 complex (0.25 µM) that was
made from 70SIC complexes containing deacylated-tRNAfMet (Cy3), and ribosomes
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containing T202C-L1 (Cy5) 50S in Buffer B. The resulting trace was fit to a triple
exponential using Scientist. For anisotropy change experiments, 1.5 µM EF-G.GTP was
rapidly mixed with 0.25 µM PRE-1 complex made from a 70SIC containing deacylatedtRNAfMet (Cy3), and unlabeled T202C-L1-50S ribosomes in Buffer B.

Anisotropy

change was measured using a polarizing excitation at 540 nm, and monitored with
polarizers on the PMT at 570 ± 10 nM; the changes were fit to a triple exponential curve.
It should be noted that the L/t FRET efficiency change was monitored when 1.0 µM EFG.GTP was added to 0.25 µM PRE-1 complex, whereas 1.5 µM EF-G.GTP was added to
the PRE-1 complex for the anisotropy experiments. However, as seen in (Figure 4.12)
EF-G concentration does not significantly affect the release of deacylated-tRNA.
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Figure 4.12 EF-G Concentration Dependent L/t FRET Efficiency Change
The L/t FRET efficiency change is monitored for PRE-1 complexes that were
made from 70SIC complexes containing either highly charged fMet-tRNAfMet (Cy3) (A
and B), or deacylated-tRNAfMet (Cy3) (C), and T202C-L1 (Cy5) ribosomes in either
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Buffer A (A) or Buffer B (B and C). Acceptor alone (DA*) samples are also shown to
indicate the FRET Efficiency = 0 fluorescence. In all three conditions, the FRET
efficiency changes were fit to global Scheme 4.1, where k4 through k9 were held constant,
while k1 though k3 were fit under these conditions.
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Figure 4.13 Global Fitting of L/t and t/t FRET Traces and Anisotropy
The traces shown in kinetic FRET experiments above were initially fit to triple
exponential curves with the apparent rate constants seen in Table 4.2. Here, those traces
were fit to the global Scheme 4.1 and followed different pathways for deacylated tRNA
release depending on the ribosome complex and buffer conditions. A) 1.0 µM EF-G.GTP
was added to 0.25 µM PRE-1 complexes in Buffer A as described in Figure 4.8; B) 1.0
µM EF-G.GTP was added to 0.25 µM PRE-1 complexes as described in Figures 4.10 A;
C) 1.0 µM EF-G.GTP was added to 0.25 µM PRE-1 complexes as described in Figures
4.10 B/C. Both the L/t and t/t FRET traces for each complex were fit to the Scheme to
elucidate the major pathway for deacylated-tRNA release. The fluorescence anistropy
trace was created as in Figure 4.11, and also fit to the Scheme. Complexes from A mostly
followed pathway 1, with a less significant and slower release via pathway 2. Complexes
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from B followed pathway 2, and complexes from C mostly followed pathway 3, with a
less significant release via pathway 2 as well.
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Chapter V: Addition of Deacylated-tRNA in Solution
Enhances the Slow Release of Translocated DeacylatedtRNAfMet
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5.1 Abstract
The ribosomes which follow pathway 3 described in Chapter IV have an
apparent problem to overcome in that the deacylated-tRNA remains bound to the E2site for too long to be viable in vivo. However, the above experiments were done in
conditions in which there were no outside factors competing for the tRNA binding
site, or ternary complexes binding to the A-site. It is possible that deacylated-tRNA
in solution can compete for the E2-site, and/or ternary complex binding to the A-site
could allosterically affect the release of tRNA from the E/E2-site. Here, it is shown
that there is indeed a competition between deacylated-tRNAs for binding to the
ribosome that affects the release of tRNA. Further, this competition, rather than an
allosteric interaction between A- and E-sites, seems to provide the major affect on
deacylated-tRNA release.

5.2 Introduction
In Chapter IV it was shown that tRNA could leave the E-site of the ribosome
via three different pathways, each one distinct in the movement of the L1-stalk in
relation to the deacylated-tRNA.

The first two pathways show that deacylated-

tRNAfMet can dissociate from the ribosome at a reasonable rate (~1-2 s-1); however,
the third pathway holds the deacylated-tRNAfMet in what is presumed to be the E2-site
as seen in cryo-EM images (Agrawal et al., 1999; Fischer et al., 2010). Although it
would be troublesome for a translating ribosome to only slowly release a translocated
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tRNA, one must remember that in the above experiments, there were no deacylatedtRNAs, and no additional ternary complexes present. In vivo there is on the order of
200 µM tRNA (Dong et al., 1996), and available ternary complex ready to continue
translation.

Therefore, it is possible that, even though the ribosomes following

pathway 3 (Chapter 4) appear to hold onto the deacylated-tRNA for an excessively
long time, in vivo the deacylated-tRNAfMet is in an equilibrium between bound and
unbound states, and this equilibrium can be affected by competition between other
deacylated-tRNAs present in the cell.
In order to test whether or not the dissociation of deacylated-tRNAfMet from
ribosomes following pathway 3 is affected by the presence of deacylated-tRNA in the
solution, POST-1 complexes were prepared in conditions that favor pathway 3. Such
complexes were rapidly mixed with various concentrations of deacylated-tRNALys or
tRNATyr, and the changes in fluorescence were recorded in a stopped flow
spectrofluorometer.

Both the loss of FRET between T202C-L1 (Cy5) and

translocated tRNAfMet (Cy3), and the gain of FRET between T202C-L1 (Cy5) and
added tRNALys (Cy3) were measured in order to determine if there were indeed a
competition for the apparent E2-site.

According to the cryo-EM images, there

should be no codon-anticodon interaction with tRNAs in the E2-site. Therefore, we
tested the codon dependence of the competition between the deacylated-tRNAfMet
(Cy3) and the added deacylated-tRNAs.
Further, the supposed allosteric interaction between the A-site and the E-site
as first proposed by Nierhaus and colleagues (Rheinberger and Nierhaus, 1986),
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and as later seen in single molecule work by Chen and colleagues (Chen et al.,
submitted manuscript) was tested under these conditions.

The presence of an

allosteric interaction between an A-site and E-site by way of negative cooperativity
would allow better accuracy of selection of aminoacyl-tRNAs while preventing
binding of non-cognate codons in the decoding process. Further, by constantly
maintaining 2 codon-anticodon interactions, it may help keep the messenger RNA in
frame during translation (Nierhaus, 1990; Rheinberger, 1991).

The criticism

against interpreting the results of Rheinberger and Nierhaus as reflecting an allosteric
interaction was that the release of translocated E-site tRNA was coming from a
competition with deacylated-tRNA in the solution (Robertson and Wintermeyer,
1987). Here, we find that deacylated-tRNA in solution does indeed provide the major
affect on the release of tRNA; however, there is possibly a small additional affect
when ternary complex is also added, presumably via binding to the A-site.
In the preliminary work presented here, it appears that there is a competition
between deacylated-tRNA for a site near the labeled L1 that is not codon dependent.
However, the data here have yet to be incorporated into a general kinetic scheme, and
further work needs to be completed in order to determine the exact mechanism for
this competition.
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5.3 Results
5.3.1 Preparation of a POST-1 Complex
Unless otherwise specified, T202C-L1 (Cy5) POST-1 complexes were made
in Buffer B for the following experiments, starting with 70SICs containing
deacylated-tRNAfMet (Cy3). Addition of EF-Tu.GTP.Phe-tRNAPhe and EF-G.GTP
resulted in POST-1 complexes that were purified through sucrose to remove any
excess factors and tRNA (Section 2.2.5.4). Table 5.1 presents the binding efficiencies
for the tRNAfMet (Cy3) to the ribosome, in what is assumed to be the E2-site, and
Phe-tRNAPhe to the P-site in the purified complexes; further, to ensure the complexes
are indeed POST-1, puromycin reactivity was tested. The untranslocated PRE-1
complex does not react with puromycin (~0.02 aminoacyl-puro/70S); however, upon
addition of EF-G.GTP the resulting POST-1 complex regains reactivity to a level
similar to that seen in 70SIC (~0.3 aminoacyl-puro/70S), indicating that the A-site is
indeed unoccupied (Table 2.2). A complex created under these conditions should
result in the release of deacylated-tRNA following a pathway like pathway 3 in
Scheme 4.1 (Refer to 4.3.5.3), where the deacylated-tRNAfMet moves away from the
body of the ribosome with the L1-stalk before being released. This release from the
E2-site, can be affected by the presence of deacylated-tRNAs in the solution. Figure
5.1 presents the binding curve for deacylated-tRNAfMet (Cy3) as measured by an
increase in T202C-L1 (Cy5) FRET efficiency fluorescence upon addition of
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increasing amounts of deacylated-tRNAfMet (Cy3) in an equilibrium FRET
experiment. The initial amount of fluorescence without any tRNAfMet (Cy3) added
back (0.0 µM) accounts for the fluorescence seen from the translocated-tRNAfMet
(Cy3). This experiment allowed the estimation of a KD = 0.123 µM. To ensure E2site occupancy in the following experiments, the equilibrium was shifted by
preincubating the POST-1 complexes with 0.5 µM deacylated-tRNAfMet (Cy3, unless
otherwise specified).

5.3.2 The Extent of Competition Depends on the Concentration of the Added
Deacylated-tRNA
The FRET efficiency between T202C-L1 (Cy5) on the 50S subunit and
deacylated-tRNAfMet (Cy3) in the E2-site of a POST-1 complex (0.25 µM) was
measured as a result of stopped-flow addition of increasing concentrations of tRNALys
(0.0, 0.1, 0.5, 0.75, 1.5, and 3.0 µM; Figure 5.2A). The curves were fit to either a
single or double exponential curve and, Table 5.2 shows that the apparent rate
constant of the major FRET efficiency decrease remains constant at ~1.5 s-1,
independent of the concentration of deacylated-tRNALys added to the complex;
however, the amplitude of the major FRET efficiency decrease is dependent on the
concentration of the added deacylated-tRNALys. An apparent KD of ~0.15 µM can be
obtained by plotting the amplitude change after 30 sec versus the concentration of
added deacylated-tRNALys (Figure 5.2 B, in agreement with the KD obtained earlier
by different methods using tRNAfMet). Further, although the rate constant of the
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major change (kapp1= ~1.5 s-1) is not affected by concentration (and is even present
without addition of tRNALys), at concentrations above 0.75 µM the overall change
becomes biphasic and introduces a slower

(kapp2= ~0.13 s-1) change of lesser

magnitude.
In order to measure the binding of deacylated-tRNA to the ribosome, a
T202C-L1 (Cy5) POST-1 complex was made from 70SICs with unlabeled
deacylated-tRNAfMet, and purified as previously. In the POST-1 complex, the
unlabeled deacylated-tRNAfMet is in the E2-site, and to ensure E2-site occupancy 0.5
µM unlabeled-tRNAfMet was added to the complex. tRNALys (Cy3) was then added to
the T202C-L1 (Cy5) POST-1 complex via stopped flow, and an increase in FRET
efficiency was measured when the tRNALys (Cy3) bound to the ribosome near L1
(Figure 5.3 A). This FRET efficiency increase was fit to a double exponential curve,
with the major change occurring with an apparent rate constant of kapp1 = 0.81 s-1, and
a slower, lesser change occurring with an apparent rate constant of kapp2= 0.10 s-1 for
deacylated-tRNALys (Cy3) concentrations higher than 0.75 µM (Table 5.2). The rate
constants for binding of deacylated-tRNALys (Cy3) are similar to the rate constants for
the release of deacylated-tRNAfMet (Cy3) (Table 5.2, Figure 5.3 A versus Figure 5.3
B). It is difficult to obtain the actual FRET efficiencies because the amount of Cy3tRNA bound to the ribosome is unknown. In the complexes containing labeled
tRNAfMet (Cy3), it is not known how much remains bound to the E/E2-site after
preincubation; further, it is unknown the amount of tRNALys (Cy3) that binds to the
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ribosome in that experiment. By not knowing the amounts of deacylated-tRNA
bound, it is impossible to measure accurate FRET efficiencies.

5.3.3 Competition is Not Codon Specific
Previous cryo-EM data has shown that tRNA in an E2-site has no contacts
with the mRNA codon in the E-site (Fischer et al., 2010). In the POST-1 complexes
used above, the mRNA codon in the E-site is AUG, and tRNALys has an anticodon
that corresponds to a codon of AAA or AAG where there is at least one base pair
possible. Therefore, in order to measure whether or not the competition is codon
specific, a tRNATyr that has no bases in common with the mRNA in the E-site was
used (codon: UAU or UAC). T202C-L1 (Cy5) POST-1 complexes (0.25 µM) were
preincubated with 0.5 µM tRNAfMet (Cy3) as before, and then deacylated-tRNATyr
(0.75 or 1.5 µM) was added in a stopped flow. As seen in Figure 5.4, the release of
E2-site tRNAfMet (Cy3) as measured by FRET efficiency loss upon addition of
tRNATyr, is similar to the release upon addition of tRNALys in both rate constant and
amplitude.

5.3.4 Addition of Ternary Complex Does Not Dramatically Enhance DeacylatedtRNAfMet Release
As alluded to in the introduction, an A- to E-site allosteric interaction has been
shown in previous work (Rheinberger and Nierhaus, 1986; Rheinberger et al.,
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1986; Gnirke et al., 1989, Nierhaus, 1990; Rheinberger, 1991; Chen et al.,
submitted manuscript); further, this allostery has also been held under scrutiny for
the possibility that deacylated-tRNA inherent in the ternary complex is causing E-site
competition resulting in release of E-site tRNA (Robertson and Wintermeyer,
1987).

Above, it has been shown that deacylated-tRNA does indeed create a

competition for the ribosome that is codon independent. Here, I explore whether the
addition of a ternary complex has any additional effect on the release of tRNA.
Because of the limits of artificial tRNA charging, any ternary complex added has an
inherent amount of deacylated-tRNA that will create a competition for the E2-site.
Lys-tRNALys charging efficiency has been optimized to ~35-40% resulting in
deacylated-tRNALys concentrations of 0.5 µM and 1.5 µM for ternary complex
concentrations of 0.39 µM and 1.0 µM, respectively. As seen in Figure 5.5 A/B, the
addition of these ternary complexes to a POST-1 complex (made as above) only
minor further deacylated-tRNAfMet (Cy3) release as compared to the release seen
upon addition of 0.5 µM (Figure 5.5 A) or 1.5 µM (Figure 5.5 B) deacylated-tRNALys.
Due to the low charging efficiency of tRNALys, creation of a ternary complex
resulted in an approximate 2-fold excess of deacylated-tRNA : ternary complex. In
order to increase the ratio of ternary complex : deacylated-tRNA, a more highly
charged Phe-tRNAPhe (~72% charged) was used. A POST-1 complex had to be made
using an mRNA sequence of MRFK, instead of MFKR, in order to put the codon for
tRNAPhe in the open A-site of the complex. Using the MRFK mRNA sequence, a
70SIC complex was made with deacylated-tRNAfMet (Cy3), and to it EF"#$!
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Tu.GTP.Arg-tRNAArg and EF-G.GTP was added to create the POST-1 complex,
which was then purified through sucrose, and preincubated with 0.5 µM tRNAfMet
(Cy3). Addition of EF-Tu.GTP.Phe-tRNAPhe (1.0 µM, as measured by Phe-tRNAPhe
concentration) to a POST-1 complex also resulted in 0.39 µM deacylated-tRNAPhe
being added. Therefore, if the addition of ternary complex to the POST-1 complex is
a major contributor to the loss of tRNAfMet (Cy3) from the ribosome, the FRET
efficiency loss from addition of ternary complex should be much greater than from
the addition of 0.39 µM deacylated-tRNAPhe alone. However, as seen in Figure 5.5 C,
the FRET efficiency loss is similar in both instances, meaning that the addition of
ternary complex does not provide great enhancement of deacylated-tRNAfMet (Cy3)
release from the ribosome. However, there is a slightly larger amplitude change for
the complexes in which there is a ternary complex added; therefore, it is possible that
ternary complex has some effect on the release of deacylated-tRNAfMet. Another
possibility is that since there is no direct measurement of the amount of deacylatedtRNA present in the ternary complex solution, we may be imprecise in the amount of
deacylated-tRNA leading to skewed amplitudes. Further experiments must be
performed to better understand the exact scheme by which the release occurs.
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5.4 Discussion
The slow rate of deacylated-tRNA release from the ribosomes that
predominantly follow pathway 3 described above, would drastically hinder in vivo
protein synthesis. However, in in vivo conditions, the cell has deacylated-tRNA and
ternary complexes present in the solution; therefore, it is possible that this pathway is
indeed followed, but the tRNA in the E2-site is subsequently released because of an
equilibrium reached between bound and unbound deacylated-tRNA.
The equilibrium between bound and unbound deacylated-tRNAfMet was
measured by both deacylated-tRNAfMet (Cy3) binding (Figure 5.1) and deacylatedtRNAfMet (Cy3) dissociation caused by competition with tRNALys (Figure 5.2 B), and
allowed for an estimation of the dissociation constant of ~0.12-0.15 µM. Further, as
Figure 5.3 shows, the deacylated-tRNALys (Cy3) in solution binds to the ribosome in
a position that allows FRET between it and the T202C-L1 (Cy5) ribosomes. As
mentioned before, it is difficult to measure accurate FRET efficiencies for each
complex.
As seen in Figure 5.2 A and Table 5.2, the major apparent rate constant for
dissociation is not affected by the concentration of tRNALys added to the solution.
Furthermore, even complexes without tRNALys added, have a small loss in FRET
efficiency associated with release of tRNAfMet (Cy3). This apparent rate constant for
release is similar to the smaller magnitude apparent rate constant for release seen in
Chapter IV (Table 4.1, Exp. 30, kapp2) and indicates that there is an inherent amount
of deacylated-tRNA released at this rate that increases as a function of increasing
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amounts of added deacylated-tRNA in solution. The data have been attempted to be
fit into multiple general schemes but to this date have been unsuccessful. Therefore,
unfortunately, at this time, it is not completely clear how the deacylated-tRNA from
solution affects the release of deacylated-tRNA on the ribosome. Further t/t FRET
and anisotropy experiments need to be completed in order to gain a better
understanding of the mechanism.
Although the equilibrium between binding and dissociation cannot be
specifically linked to the E2-site, it does occur at a position that is codon independent.
In a translocated POST-1 ribosome, the mRNA codon in the E-site is AUG. The
codon that is cognate for tRNALys is either AAA or AAG; therefore, there is at least
near cognate coordination between the added tRNALys and the codon in the E-site.
As seen in the cryo-EM images, when tRNA occupies the E2-site there is no longer
any codon specificity, and thus, if the competition were for this site, there should not
be a dependence on the identity of the deacylated-tRNA. Indeed this is what is seen
when tRNALys is replaced with the completely non-cognate tRNATyr (codon: UAU or
UAC). The competition for the site does not depend on the codon of the deacylatedtRNA because near cognate (tRNALys), and non-cognate (tRNATyr) compete at a
similar level as seen in Figure 5.4.
The idea of an A- and E-site allosteric interaction has been suggested
numerous times; for example, the loss of codon-anticodon interaction at the E-site
provokes high-efficiency frameshifting (Trimble et al., 2004; Marquez et al., 2004),
the antibiotic ediene binds to the E-site on the 30S and induces misreading at the A"#$!
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site (Dinos et al., 2004), and weakening of E-site tRNA binding by mutations on the
S7-S11 interface cause misincorporation and readthrough at the A-site (Robert and
Brakier-Gingras, 2003; Dinos et al., 2005), however, it is not universally accepted.
The major argument against one experiment that has been used as evidence for the
allosteric interaction, that added ternary complex induces tRNA release from the Esite, is that the deacylated-tRNA inherent in the ternary complex is causing the E-site
tRNA to release. In previous experiments by Nierhaus and coworkers, they dispute
this criticism by suggesting that the deacylated-tRNA in the system cannot compete
with the E-site tRNA because they do not share the same codon, and therefore do not
text the addition of non-cognate deacylated-tRNA (Gnirke et al., 1989). Above, I
prove that this competition is not codon specific and any deacylated-tRNA can
compete for the binding site. However, the question remained, as to whether or not
the addition of a ternary complex can cause an allosteric release from the E-site, or
E2-site in this case. As seen in Figure 5.5, the addition of ternary complexes with
varying amounts of deacylated-tRNA in the mixture does not drastically change the
amount of tRNA released from the ribosome. However, it cannot be overlooked that
there is a slightly larger amplitude of FRET efficiency change associated with the
complexes that have ternary complex added to them. It is possible that this increase
in amplitude is only apparent because the concentration of deacylated-tRNA in the
ternary complex solution cannot be accurately measured, or that the addition of
ternary complex does indeed have a slight affect on release of E/E2-site tRNA.
Further experiments need to be performed in order to obtain a full kinetic scheme for
the competition between deacylated-tRNAs before any conclusions can be drawn
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about the allosteric interactions. However, the drastic effects on deacylated-tRNA
release from the E2-site seem to be the results of competition between binding of
deacylated-tRNA from solution, and not from any allosteric interaction between the
A- and E-sites.
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Experiment

Figure

Cy3/POST-1

[3H]Phe/POST-1

--

5.1

0.22*

0.34

52,55,56,61

5.2 A

0.49

0.43

58

5.3 A

--

0.45

52

5.3 B

0.49

0.43

52, 57

5.4

0.49

0.43

49,52

5.5 A

0.49

0.43

60, 61

5.5 B

0.65

0.47

62, 63

5.5 C

0.74

0.41**

*POST-1 complex was made with tRNAfMet (Cy3) labeled to only 0.33: 1, Cy3: tRNAfMet
**[3H]-Arg/POST-1

Table 5.1 tRNA Binding to POST-1 Complexes
T202C-L1 (Cy5) POST-1 complexes were made in Buffer B, starting with 70SICs
(2 µM) containing highly labeled deacylated-tRNAfMet (Cy3, ~1:1). Addition of 3.0 µM
ternary complex with Phe-tRNAPhe (unless otherwise specified) and EF-G.GTP (3.0 µM)
resulted in a POST-1 complex that was purified through sucrose. Cy3/POST-1 indicates
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the amount of tRNAfMet (Cy3) remaining bound to the POST-1 complex, and Phe/POST1 indicates the amount of Phe-tRNAPhe remaining bound as measured by radioactive Phe,
unless otherwise mentioned. These binding efficiencies were measured before the
preincubation with excess deacylated-tRNAs.

Exp

DeacylatedtRNA

Ternary
Complex

tRNAfMet

kapp1

kapp2

5.1

--

tRNAfMet
(Cy3), (0.1,
0.2, 0.4, 1.0
µM)

NO

Cy3

N/A

N/A

5.2

55

NO

NO

Cy3

1.88 ± 0.07
(0.13)

--

5.2

56

tRNALys,
0.10 µM

NO

Cy3

1.45 ± 0.02
(0.18)

--

5.2,
5.5A

61

tRNALys,
0.50 µM

NO

Cy3

1.61 ± 0.04
(0.36)

--

52

tRNALys,
0.75 µM

Cy3

1.71 ± 0.05
(0.35)

0.190 ±
0.008
(0.08)

5.2,
5.5B

52

tRNALys,
1.50 µM

NO

Cy3

1.21 ± 0.01
(0.38)

0.134 ±
0.002
(0.09)

5.2

52

tRNALys,
3.00 µM

NO

Cy3

1.59 ± 0.05
(0.35)

0.130 ±
0.004
(0.09)

58

tRNALys
(Cy3) 0.75
µM

NO

Unlabeled

0.73+/0.02
(-0.36)!

0.090 +/0.001
(-0.06)!

5.4

57

tRNATyr,
0.75 µM

NO

Cy3

1.37 ± 0.02
(0.38)

0.164 ±
0.006
(0.08)

5.5 A

60

tRNALys,

0.27 µM

Cy3

1.65 ± 0.03

0.21 ± 0.01

Figure

5.2,
5.3B,
5.4

5.3A

NO
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0.50 µM*

(0.40)

(0.043)

5.5 B

49

tRNALys,
1.50 µM**

1.0 µM

Cy3

1.92 ± 0.04
(0.40)

0.317 ±
0.008
(0.12)

5.5 C

62

tRNAPhe,
0.39 µM

NO

Cy3

1.1 ± 0.1
(0.09)

--

5.5 C

63

tRNAPhe,
0.39 µM***

1.0 µM

Cy3

1.79 ± 0.05
(0.10)

0.080 ±
0.002
(0.086)

! Rate constants for binding of tRNALys (Cy3)
* based on using a Lys-tRNALys preparation that was 37% charged
** based on using a Lys-tRNALys preparation that was 40% charged
*** based on using a Phe-tRNAPhe preparation that was 72%? charged

Table 5.2 Apparent Rate Constants of tRNAfMet (Cy3) Release Upon Addition of
Deacylated-tRNA and/or Ternary Complex
T202C-L1 (Cy5) POST-1 complexes were created in Buffer B, starting with
70SICs containing highly labeled deacylated-tRNAfMet (Cy3) unless otherwise mentioned.
0.50 µM tRNAfMet (Cy3) or tRNAfMet (exp. 58) was added to the purified POST-1
complex (0.25 µM) in order to ensure E2-site occupancy.

Labeled or unlabeled

deacylated-tRNA or ternary complex was added to the POST-1 complexes as indicated in
the text and the resulting traces were fit to either a single or double exponential curve
using Scientist (Micromath).
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Figure 5.1 tRNAfMet (Cy3) Binding to a POST-1 Complex
T202C-L1 (Cy5) POST-1 complexes were made in Buffer B starting with 70SICs
containing deacylated-tRNAfMet (Cy3). The resulting POST-1 complexes were purified
through sucrose and increasing concentrations of deacylated-tRNAfMet (Cy3) were titrated
in an equilibrium FRET experiment. A) The increase in acceptor fluorescence signal
upon addition of tRNAfMet (Cy3) at increasing concentrations. B) The binding curve for
the increase in acceptor emission. The Cy3 donor was excited at 518 nm and the Cy5
acceptor emission was monitored at 667 nm. An increase in acceptor emission indicative
of E/E2-site binding and a KD value of 0.123 µM was obtained.
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Figure 5.2 Release of Deacylated-tRNAfMet (Cy3) from the E2-site as a Function of
Added Deacylated-tRNALys Concentration
T202C-L1 (Cy5) POST-1 complexes were made in Buffer B, starting with 70SICs
containing highly labeled deacylated-tRNAfMet (Cy3). 0.50 µM tRNAfMet (Cy3) was
added to the purified POST-1 complex (0.25 µM) in order to ensure E2-site occupancy
with the labeled tRNAfMet (Cy3).

In a stopped-flow experiment, increasing

concentrations of tRNALys was added to POST-1 complexes, and the acceptor
fluorescence was monitored as a measure of tRNAfMet (Cy3) release. The rate constants,
as found by fitting to either single or double exponential equations in Scientist, for the
major FRET efficiency decreases do not vary with concentration; however, the amplitude
of the change does. Even at high concentrations of tRNALys, some amount of
fluorescence remains because the binding and dissociation is indeed an equilibrium
process, and there is still some tRNAfMet (Cy3) competing for the E2-site. By plotting the
change in acceptor fluorescence versus tRNALys concentration (B) an apparent KD for
tRNALys binding can be obtained and is = 0.157 µM. As determined by an Eadie-Hofstee
plot (inset).
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Figure 5.3 Deacylated-tRNA Binding to and Release From the E2-Site
T202C-L1 (Cy5) POST-1 complexes were made from a 70SICs containing either
highly-labeled tRNAfMet (Cy3) (0.49 Cy3/POST-1) (A, ii) or unlabeled tRNAfMet (B,i). A,
ii: 0.75 µM tRNALys as seen in Figure 5.2. B, i: 0.75 µM tRNALys (Cy3) (0.52
Cy3/tRNALys) was added to 0.25 µM POST-1 unlabeled tRNAfMet complexes that were
preincubated with 0.5 µM tRNAfMet, and FRET efficiency was monitored as acceptor
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increase from the acceptor alone baseline upon tRNALys (Cy3) binding to ribosome near
the L1-stalk. Apparent rate constants for the release and the binding were found by
fitting both curves to double exponential equations as seen in Table 5.2.
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Figure 5.4 Competition for the E2-site is Not Codon Specific
T202C-L1 (Cy5) POST-1 complexes were made in Buffer B, starting with 70SICs
containing highly labeled deacylated-tRNAfMet (Cy3). 0.50 µM tRNAfMet (Cy3) was
added to the purified POST-1 complex (0.25 µM) in order to ensure E2-site occupancy
with the labeled tRNAfMet (Cy3). In a stopped-flow experiment, 0.75 µM or 1.5 µM (A
and B, respectively) of either tRNALys or tRNATyr was added to the POST-1 complex and
the release of tRNAfMet from the E2-site of the ribosome was monitored by loss of
acceptor FRET efficiency. The apparent rate constants for the loss of FRET efficiency
were determined by fitting the curves to a double exponential equation as seen in Table
5.2.
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Figure 5.5 Addition of Ternary Complex Does Not Significantly Promote Additional
Deacylated-tRNA Release
T202C-L1 (Cy5) complexes were made starting with deacylated-tRNAfMet (Cy3)
in the 70SICs, and adding either EF-Tu.GTP.Phe-tRNAPhe (A and B; mRNA: MFKR) or
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EF-Tu.GTP.Arg-tRNAArg (C; mRNA: MRFK) plus EF-G.GTP in order to make the
POST-1 complex.

The POST-1 complexes were purified through sucrose cushion

centrifugation and additional deacylated-tRNAfMet (Cy3) was added to ensure E2-site
occupancy, as seen above. A) Either addition of 0.5 µM deacylated tRNALys or 0.27 µM
EF-Tu.GTP.Lys-tRNALys (as measured by Lys-tRNALys concentration), where the
concentration of deacylated-tRNALys in the mixture is 0.5 µM due to the low charging
efficiency (37%) of the tRNALys, was added to a preincubated POST-1 complex. B)
Either addition of 1.5 µM deacylated tRNALys or 1.0 µM EF-Tu.GTP.Lys-tRNALys (as
measured by Lys-tRNALys concentration), where the concentration of deacylated-tRNALys
in the mixture is 1.5 µM due to the low charging efficiency (40%) of the tRNALys, was
added to a preincubated POST-1 complex. C) POST-1 complexes were made using an
MRFK message, putting the deacylated-tRNAfMet (Cy3) in the E2-site, Arg-tRNAArg in
the P-site, and an open A-site coding for tRNAPhe. Either addition of 0.39 µM deacylated
tRNAPhe or 1.0 µM EF-Tu.GTP.Phe-tRNAPhe (as measured by Phe-tRNAPhe
concentration), where the concentration of deacylated-tRNAPhe in the mixture is 0.39 µM
due to the higher charging efficiency (72%) of the tRNAPhe, was added to a purified,
preincubated POST-1 complex.
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Appendix 1: Fluorescent Studies of V177C-L1 (Cy3), V221C-L1 (Cy3), and K54CL1 (Cy5)
V177C-L1 (Cy3), V221C-L1 (Cy3)
Fluorescently labeled mutant L1 50S were able to be prepared in an efficient
manner. In order to probe the P- and E-site tRNA, steady-state spectrofluorometer
experiments were used to determine the equilibrium FRET efficiency between the dye
labeled mutant L1 50S and labeled fMet-tRNAfMet upon 70SIC to PRE-1 conversion, and
PRE-1 to POST-1 conversion of the ribosome complex. Initially V177C-L1 (Cy3) 50S
or V221C-L1 (Cy3) 50S were used as FRET acceptors with fMet-tRNAfMet (Rhd110) as
the FRET donor. In these experiments, the donor was the limiting reagent, and therefore,
the loss in donor signal was the main focus of the FRET efficiency measurements. In
Buffer B, the purified 70SIC was incubated with ternary complex to create a PRE-1
complex in which the tRNAfMet (Rhd110) was free to sample the P/E hybrid state, and
this resulted in an overall FRET efficiency increase between the deacylated-tRNAfMet and
the labeled L1 as measured by decrease in donor fluorescence (Figure A1.1). Further,
upon addition of EF-G.GTP to the PRE-1 complex, the donor fluorescence does not
change, indicating a similar FRET efficiency for when deacylated-tRNAfMet occupies a
P/E hybrid and a E/E translocated state, as expected from previous single molecule
results (Fei et al., 2008). Although, initially these results were promising, we later
decided that the Cy3 / Rhd110 FRET pair was not ideal for these L1 to tRNA (L/t)
equilibrium FRET experiments, and by using a Cy5 / Cy3 pair, analysis by measuring
acceptor fluorescence would also be possible due to decreased overlap of signals with
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this dye pair. Further, during optimization of the L/t FRET experiments, the mutant
T202C-L1, utilized by Fei and coworkers, was discovered and we decided to use this
mutant because it was already shown to work well as an indicator for tRNA movement.
However, we should not be hasty in ruling out the possibility that these other mutants
would work just as well, and/or provide further information about the movements near
the E-site.
K54C-L1 (Cy5)
Munro and coworkers initially used the mutant S55C as an indicator of L1-tRNA
FRET in single molecule experiments, and therefore, we decided to design the mutants
K54C and S55C (Munro et al, 2009; Munro et al., 2010). Undergraduate (Adrianne
Remiker) and rotation students (Chris Bryan, Cheryl McCullough, and Yanxin Wang)
performed the majority of the experiments done with these mutants under my supervision.
Primers for both mutants were designed, and Adrianne overexpressed the subsequent
mutant protein.

Chris and Cheryl labeled the K54C-L1 with Cy5-maleimide, and

reconstituted the labeled L1 into the –L1 50S, and Yanxin performed the majority of the
equilibrium FRET and stopped flow FRET experiments seen below. Equilibrium FRET
studies were performed on two different complexes: 1) 70SICs created with highly
charged fMet-tRNAfMet (Cy3); and 2) 70SICs created with deacylated-tRNAfMet (Cy3).
The complexes were not purified through sucrose cushion, and either ternary complex
(PRE-1) or ternary complex and EF-G.GTP (POST-1) were added to the 70SICs. The
complexes created with highly charged fMet-tRNAfMet (Cy3) show very little change in
the FRET efficiencies between all three complexes (Figure A1.2 A). The complexes
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created with deacylated-tRNAfMet (Cy3) show a steady decrease in FRET efficiency from
70SIC to PRE-1 to POST-1. It is possible that this is due to deacylated-tRNA (not
removed by sucrose cushion) non-specifically binding to the E-site creating high FRET
efficiency in the 70SIC that is lost upon addition of ternary complex and/or EF-G.GTP
(Figure A1.2 B). This decrease in FRET efficiency between the 3 complexes is also seen
in time resolved stopped flow experiments seen below.
A 70SIC was created using deacylated-tRNAfMet (Cy3) and K54C-L1 (Cy5) (0.25
µM) and a ternary complex with Phe-tRNAPhe.EF-Tu.GTP (1.0 µM) was added in a
stopped flow experiment. The resulting acceptor fluorescence change can be seen in
Figure A1.3 A and can be fit to a double exponential curve with an initial rapid increase
(kapp1= 25 s-1) followed by a slower decrease (kapp2= 0.37 s-1). The rapid FRET efficiency
increase may be attributed to the ternary complex binding, whereas, the slow decrease
(most likely what is seen in the equilibrium FRET) can be attributed to the loss of any
deacylated-tRNAfMet (Cy3) from the E-site of the ribosome. Further, the donor channel
signal (Figure A1.3 B) can be fit to a triple exponential, where the first phase is a
mathematically induced donor decrease to accompany the acceptor increase described
above. Analysis of the donor channel reveals a fluorescence change associated with
inherent fluorescence change of the tRNAfMet (Cy3) upon tRNA accommodation, and
occurs with an apparent rate constant of ~10 s-1. The final phase seen in the donor
channel is a slow increase that is similar to the decrease seen in the acceptor channel and
is most likely attributed to the loss of any tRNA that was initially bound to the E-site in
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the 70SIC complex. Further studies with the K54C-L1 mutant must be performed in
order to determine its true effectiveness as a probe for P- and E-site tRNA movement.
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Figure A1.1 Equilibrium FRET Traces of PRE and POST
Translocation Ribosomes Using the Rhd110/Cy3 FRET Pair (V177C-L1,
V221C-L1)
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70S initiation complexes were made for FRET analysis using fMet-tRNAfMet
(Rhd110) as the donor and A) V177C-L1-50S (Cy3) or B) V221C-L1-50S (Cy3) as the
acceptor. Equilibrium FRET measurements were taken using a Spectrofluorometer to
determine the FRET at different stages of translocation. P-site / L1 FRET was measured
in two ways; 1: using a P-site bound initiator tRNA (70SIC, 0.1 uM, green trace); and 2:
by adding ternary complex containing Phe-tRNAPhe.EF-Tu.GTP (0.25 uM) to create a
deacylated initiator tRNA that is free to sample the P/E hybrid state (PRE-1, red trace).
The PRE-1 complexes were translocated by addition of EF-G.GTP (0.50 uM) and the
FRET efficiency was measured by change in Donor wavelength fluorescence.

The

complexes were created using limiting donor (fMet-tRNAfMet (Rhd110)); therefore, the
change in donor is used to determine FRET efficiency change. Because excess acceptor
is used, it is possible that an acceptor molecule does not interact with a donor molecule;
thus, the signal at the acceptor emission does not necessarily increase upon donor
decrease since this is a bulk experiment. Further, the background caused by direct
excitation of Cy3 in the experiment makes it very difficult to analyze the traces at the
acceptor wavelength. Therefore, in all later experiments using T202C-L1 and K54C-L1
mutants, Cy3/Cy5 FRET efficiency is measured.
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Figure A1.2 Equilibrium FRET Traces of K54C-L1 (Cy5) Ribosomes
A and B: 70S initiation complexes not purified through sucrose were made for
FRET analysis using A: fMet-tRNAfMet (Cy3) or B: deacylated-tRNAfMet (Cy3) as the
donor and K54C-L1-50S (Cy5) as the acceptor. Equilibrium FRET measurements were
taken using a Spectrofluorometer to determine the FRET efficiency at different stages of
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translocation. P-site / L1 FRET was measured in two ways; 1: using a P-site bound
initiator tRNA (70SIC, 0.1 uM, green trace); and 2: by adding ternary complex
containing Phe-tRNAPhe.EF-Tu.GTP (0.25 uM) to create a deacylated initiator tRNA that
is free to sample the P/E hybrid state (PRE-1, red trace). The PRE-1 complexes were
translocated by addition of EF-G.GTP (0.50 uM) and the FRET efficiency change was
observed. The use of deacylated-tRNAfMet (Cy3) in the 70SIC resulted in a decrease in
FRET efficiency as measured by the acceptor decrease, and could be attributed to
contaminating E-site deacylated tRNAfMet (Cy3) leaving the E-site.
The complexes were created using limiting acceptor (Cy5-50S); therefore, the
change in acceptor is used to determine FRET efficiency change. Because excess donor
is used, it is possible that a donor molecule does not interact with an acceptor molecule;
thus, it is possible that the signal at the donor emission does not necessarily decrease
upon acceptor increase when FRET is seen since this is a bulk experiment.
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Figure A1.3 FRET Efficiency Changes Associated With 70SIC to PRE-1
Complex as Viewed by Labeled K54C-L1
70SIC complexes were made containing deacylated-tRNAfMet (Cy3) and K54CL1 (Cy5) and not purified through sucrose cushion centrifugation. Ternary complex
(Phe-tRNAPhe.EF-Tu.GTP, 1.0 µM) was stopped flow added to the 70SIC (0.25 µM) in
order to create a PRE-1 complex. The donor Cy3 was excited at 540 nm, the acceptor
channel emission (A) was observed at 680 ± 10 nm, and the donor channel emission (B)
was observed at 570 ± 10 nm.
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Buffer

D*A*
(A)
x105

D*A*
(D)
x106

D*A
(A)
x104

D*A
(D)
x106

Ext.
A (A)
x105

DA*
(A)
x105

FRET

1.95

1.54

4.85

1.51

1.45

1.62

~0

2.66

1.41

4.85

1.51

2.21

1.62

0.73

POST-1

1.79

1.54

4.85

1.51

1.29

1.62

~0

70SIC

1.72

1.47

4.71

1.46

1.25

1.64

~0

2.73

1.44

4.71

1.46

2.26

1.64

0.77

POST-1

1.62

1.46

4.71

1.46

1.15

1.64

~0

70SIC

1.66

1.46

4.84

1.50

1.90

1.53

~0

2.68

1.45

4.84

1.50

2.21

1.53

0.90

POST-1

2.35

1.43

4.84

1.50

1.89

1.53

0.48

70SIC

1.56

1.39

4.97

1.40

1.07

1.46

~0

2.60

1.37

4.97

1.40

2.12

1.46

0.94

POST-1

2.27

1.36

4.97

1.40

1.79

1.46

0.47

70SIC

1.53

1.23

4.49

1.41

1.13

1.54

~0

2.50

1.37

4.49

1.41

2.06

1.54

0.89

2.37

1.43

4.49

1.41

1.91

1.54

0.63

Complex

Cy5/
70S

Cy3/
70S

70SIC
A1

A2

B1

B2

B3

PRE-1

PRE-1

PRE-1

PRE-1

PRE-1

0.64

0.68

0.66

0.67

0.55

POST-1

0.78

0.73

0.75

0.70

0.69

Table A2.1 FRET Efficiency Calculations for Equilibrium FRET Experiments seen
in Figure 4.1, 4.2 and A2.1
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Buffer A, (Trial 2)
70SIC
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Wavelength (nm)
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Fluorescence Intensity

Fluorescence Intensity
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D
A
70SIC Fitted D
70SIC Extracted A
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Wavelength (nm)

700
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Wavelength (nm)
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Buffer B, (Trial 2)
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Buffer B, (Trial 3)
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Wavelength (nm)
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Figure A2.1 Equilibrium FRET Efficiencies in Buffers A and B
Complexes were made and equilibrium FRET was measured as in Figure 4.1
(Buffer A) and Figure 4.2 (Buffer B), however, instead of starting with highly charged
initiator tRNA, ~25% charged initiator tRNA was used. FRET efficiency was determined
and can be seen in Table A2.1.
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